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Selenium is an essential nutrient that is beneficial at daily intakes of 50-200µg/day and is 
detrimental at intake rates beyond 800µg/day. Selenium toxicity is an increasing environmental 
problem due to being a waste product of metal, coal, and oil refining. High selenium exposure 
causes developmental defects in wildlife, motor neuron degeneration in livestock and has been 
epidemiologically associated with the human motor neuron disease amyotrophic lateral sclerosis 
(ALS). In order to begin to define the cellular damage pathways activated by selenium, we have 
developed a genetic model of selenium toxicity using Caenorhabditis elegans. In this 
dissertation, we have begun to identify both environmental and genetic factors that affect 
selenium toxicity (like temperature, bacterial metabolism from the food source, calcium in the 
media), as well as a potential source of selenium’s toxic effects, an increase in reactive oxygen 
species. We have also begun to determine which potential mechanism(s) of cell death are 
activated using strains with reduction-of-function mutations in cell death genes and 
pharmacologic treatments. In the second part of thesis, we characterize the neuronal damage 
caused by selenium because of its potential disease relevance. We demonstrate that selenium 
toxicity causes a decrease in cholinergic signaling that results in increased cytosolic protein 
catabolism in muscle which is predictably suppressed by nicotinic agonists and the 
acetylcholinesterase inhibitors. Combined, these data demonstrate that selenium toxicity causes 
muscle denervation, mimicking the pathology observed in ALS. We also demonstrate that 
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selenium causes similar denervation of the muscles mediating egg-laying in C. elegans. Finally, 
we have investigated oxidative stress pathways regulated by DAF-2, a major stress response 
pathway in C. elegans, and identified a gene target of DAF-2 regulation, an iron-manganese 
superoxide dismutase (sod-2), that is a “protective factor” affecting sensitivity to selenium. This 
work demonstrates that selenium-related oxidative stress causes a progressive movement 
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1.0  INTRODUCTION 
1.1 SELENIUM 
Selenium is an essential nutrient that has a narrow exposure window between beneficial 
and detrimental effects. This can be appreciated by simply looking at a periodic table. The 
element selenium falls in the same period as oxygen and sulfur, suggesting that it has properties 
essential for life. In its vertical group, selenium falls between arsenic and bromine, suggesting 
that it could also have toxic properties. While much research has been done on understanding the 
essential properties of selenium, little formal research has been done to investigate its potential 
toxic properties. 
Selenium is found in a variety of forms, including elemental, inorganic (sodium selenite 
and sodium selenate), and organic (selenomethionine and selenocysteine) (Nuttall 2006). In 
whatever form it is found, it is eventually converted to an organic form and then incorporated 
into proteins. Selenomethionine is incorporated randomly in place of methionine, while 
selenocysteine incorporation is tightly regulated (Berry et al. 1991; Muller et al. 1997). Proteins 
that require selenocysteine for their function are referred to as selenoproteins; these include 
glutathione peroxidases, iodothyronine deiodinases, thioredoxin reductases, among others 
(Behne and Kyriakopoulos 2001). 
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Use of selenocysteine in proteins is conserved throughout the animal kingdom (Lee et al. 
1990). Knockout of selenocysteine tRNA in mice have been shown to be embryonic lethal and 
conditional knockouts of selenocysteine tRNA in the liver caused mice to die within 1 to 3 
months (Bosl et al. 1997; Carlson et al. 2004). In heterozygous selenocysteine tRNA knockout 
animals, selenoprotein expression was decreased 50-80%, with the exception of glutathione 
peroxidase, suggesting a critical role in an organism’s survival. Knockout mice of glutathione 
peroxidase 1 are variable and normal in body weight, but are susceptible to myocardial ischemia 
and diquot-induced oxidative stress (Cheng et al. 1997; Yoshida et al. 1997; Fu et al. 1999). 
However, mice contain four glutathione peroxidases and a knockout mouse of all four has yet to 
be developed. 
Selenocysteine is often referred to as the 21st amino acid due to the specific 
incorporation. Specific incorporation of selenocysteine is nearly universal from prokaryotes to 
eukaryotes, utilizing the UGA stop codon along with a 3’ UTR (Berry et al. 1991; Berry et al. 
1993; Fischer et al. 2007). Caenorhabditis elegans differ from mammals by using AUGA as the 
selenocysteine insertion sequence, directing selenium insertion into thioredoxin reductases, the 
only known selenoproteins in C. elegans identified to date (Buettner et al. 1999; Gladyshev et al. 
1999).   
The requirement of proteins to incorporate and utilize selenocysteine instead of cysteine 
is due to the difference in chemical properties of selenium compared to sulfur (Young et al. 
1982; Tinggi 2003). Cysteine contains a thiol side group that has a pKa of around 8.5. With 
selenocysteine, a selenium atom replaces the sulfur and the pKa of selenide side group is 5.2. At 
physiological pH, the thiol side group is partially ionized, while the selenium containing side 
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chain is fully ionized (Young et al. 1982). The ionization state of selenium is likely key to its 
essential role in selenoproteins. 
The random incorporation of selenomethionine is believed to provide storage of selenium 
(Behne and Kyriakopoulos 2001). However, the properties of selenium raise an interesting 
question about the random substitution of selenomethionine in place of methionine, since every 
protein contains at least one methionine amino acid (the ATG start codon for methionine). Can 
this substitution affect protein function or stability, in general? While this is not a widely 
researched topic, there are a couple of studies that investigated selenomethionine substitution 
affects the final protein product. One study compared selenomethionyl thymidylate synthase 
between wild type and a methionine auxotrophic strain of E. coli. In this study, the authors found 
that while the binding kinetics of the enzyme was not altered between the two strains, the 
selenium containing enzyme was eight-times less stable than when exposed to heat and twice as 
sensitive to oxygen (Boles et al. 1991). Another study investigating phosphomannose isomerase, 
using a similar experimental design with a methionine auxotrophic strain of E. coli, reported that 
substitution with selenomethionine resulted in a four-fold increase in its pKa (Bernard et al. 
1995). These studies demonstrate that selenomethionine incorporation can affect the final protein 
product, but the effects vary greatly, likely depending on where selenomethionine is located in 




1.2 PROTECTIVE AND ESSENTIAL ROLES FOR SELENIUM 
An essential biological role for selenium was not proposed until the 1930’s, when selenium was 
detected in a variety of plants (Trelease and Trelease 1938). The essential nature of selenium for 
animals was not understood until the 1950’s, when it was discovered that liver necrosis induced 
by a vitamin E deficient diet could be prevented by selenium supplementation (Schwarz and 
Foltz 1999). Since then, a group of proteins has been identified, collectively known as 
selenoproteins, which require selenium to function by incorporation of selenocysteine. Of the 30 
mammalian selenoproteins identified to date, including glutathione peroxidases, iodothyronine 
deiodinases, and thioredoxin reductases, only half have known functions (Behne and 
Kyriakopoulos 2001). 
Glutathione peroxidase (GPx) was the first identified selenoprotein; it was discovered 
after finding that dietary selenium could protect erythrocytes from oxidative damage (Rotruck et 
al. 1972; Rotruck et al. 1973).  GPx is a selenoprotein that is conserved in mammals, plants, and 
viruses (Rotruck et al. 1973; Zhang et al. 1999; Fu et al. 2002). The function of glutathione 
peroxidase is to convert hydrogen peroxide into water, protecting the cell from oxidative damage 
(Behne and Kyriakopoulos 2001). As mentioned in the previous section, there are multiple 
glutathione peroxidases in mammalian systems and an individual knockout of GPx1 has no 
affect on viability but do affect susceptibility to oxidative stress (Fu et al. 1999).  
The two other main classes of selenoproteins in mammals with known functions are 
iodothyronine deiodinases and thioredoxin reductases. There are three iodothyronine deiodinases 
responsible for activating and inactivating thyroid hormones that are involved in development 
and controlling a variety of metabolic processes (Behne and Kyriakopoulos 2001). Iodothyronine 
deiodinase 1 and 2 knockout mice are viable with no gross abnormalities (Schneider et al. 2001; 
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Schneider et al. 2006). Iodothyronine deiodinase 3 knockout mice were found to have decreased 
fertility and reduced viability (Hernandez et al. 2006; Hernandez et al. 2007). Thioredoxin 
reductases are responsible for reducing oxidized thioredoxin in a NADPH–dependent manner, 
serving a key function in regulating the cellular redox status (Holmgren 1989). Single and double 
knockout mice for thioredoxin reductases are viable but have decreased fertility (Gauthier et al. 
1999; Gauthier et al. 2001; Plateroti et al. 2001). While no knockout on an individual 
selenoprotein were embryonic lethal, they did affect an aspect of overall health with respect to 
oxidative stress and fertility.  
Inadequate dietary selenium has been linked to Keshan disease, a cardiomyopathy, and 
Kaschin-Beck disease, an osteoarthropathy (Behne and Kyriakopoulos 2001). In Keshan disease, 
a coxsackie virus remains dormant in the presence of selenium but becomes virulent in its 
absence due to alterations in the viral genome (Beck et al. 2003). The mechanism involving 
selenium deficiency in Kashin-Beck disease remains elusive (Sudre and Mathieu 2001).  
Deficient dietary intake of selenium alters immune system responses in mice. Selenium 
deficiency exacerbates flu symptoms and alters cytokine responses in mice fed a selenium-
deficient diet compared to those fed an adequate selenium diet (Beck et al. 2003). Dietary 
selenium supplementation has been shown to attenuate lipopolysaccharide-induced expression of 
the pro-inflammatory agents, cyclooxygenase-2 and tumor necrosis factor-alpha in macrophages 
(Vunta et al. 2008). Selenium deficiency also causes hyperoxidant production in T cells, which 
results in suppression of T cell proliferation (Shrimali et al. 2008). These recent findings 
demonstrate an emerging and important role for selenium in immune system function. 
Selenium also has a variety of anti-cancer properties (Zafar et al. 2003; Goel et al. 2006). 
Selenocysteine induces apoptosis in human cancer cells (and not in normal cells) by increasing 
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reactive oxygen species (Goel et al. 2006; Chen and Wong 2008). Selenium compounds also 
induce cell cycle arrest in human prostate cancer cells (Zhao and Brooks 2007). These 
mechanisms appear to be mediated through p53, altering sensitivity to chemotherapy and 
radiation (Fischer et al. 2006; Zhao et al. 2006; Zhao et al. 2006; Zu et al. 2006; Fischer et al. 
2007). Selenium’s sensitizing effect on cancer cells has resulted in ongoing clinical trials using 
selenium treatments in conjugation with cancer treatments, with mixed results (Clark et al. 1996; 
Block et al. 2008). 
Selenium is also reported to have a variety of neuroprotective effects. Sodium selenite 
protects peripheral neurons from methyl-mercury exposure (Chang 1983). Motor neuron 
degeneration resulting from trauma is retarded by selenium (Hall and Braughler 1986; Hall 
1987).  Selenium treatments are neuroprotective in Parkinson’s models of neurodegeneration 
(Imam et al. 2001; Zafar et al. 2003; Dodig and Cepelak 2004). In an Alzheimer’s disease model, 
sodium selenite was recently found to inhibit gamma-secretase activity, which could potentially 
slow β-amyloid production (Tung et al. 2008). Despite the variety of selenium’s essential roles, it 
can be toxic at levels only four times the daily recommended dose in humans (Lemly 1997). 
1.3 SELENIUM TOXICITY 
Initial observations describing selenium toxicity can be traced back to Marco Polo’s travels 
through China during the 13th century (Young et al. 1982). While traveling through high 
selenium areas in China, Marco Polo’s group was warned of “poisonous” plants that we now 
know to be part of the selenium accumulating plant genus Astragalus, that if eaten by “beasts of 
burden” (horses) would cause their hooves to fall off (Spallholz 1994). In humans, the 
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recommended daily level of selenium consumption ranges between 50-200µg per day but 
consumption of as little as 850-900µg per day leads to symptoms of selenium toxicity (Lemly 
1997). Signs of toxicity in humans include nausea, hair loss, nail changes, and with high enough 
exposure, can occasionally progress to death (Young et al. 1982).  
1.3.1 The complexity of selenium toxicity 
It is interesting that for an element which has long been understood to be toxic, little is 
understood about its toxic properties. One source estimates that selenium is 5 times more toxic 
than arsenic, yet arsenic is more widely recognized as being poisonous (Harris 1991). There are 
many reasons for this confusion. Foremost, selenium is an essential nutrient utilized by various 
selenoproteins, as previously described in Section 1.1 (Behne and Kyriakopoulos 2001). Second, 
there is a large and continuously growing body of literature citing the numerous health benefits 
from selenium ranging from helping immune function to having anti-cancer properties as 
described in Section 1.2. Arsenic is not essential in mammals, known to be poisonous, and has 
previously been used as a pesticide (Oremland and Stolz 2003).  
Adding to the confusion is the complexity of selenium toxicity. While all forms of 
selenium are toxic, the concentrations to achieve similar toxic phenotypes vary drastically.  
Given orally to rats, elemental selenium was found to have an LD50 (lethal dose, 50% or the dose 
required to kill 50% of a population) of 6700mg Se/kg of body weight (Nuttall 2006). At the 
other end of the spectrum, sodium selenite was found to have an LD50 of 7mg Se/kg of body 
weight (Nuttall 2006). Also, inorganic selenium was found to be more toxic at lower doses in 
adult animals while a more significant decrease in weight was observed in weaning animals 
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whose mothers were fed organic selenium when compared to offspring of mothers fed inorganic 
selenium (Kim and Mahan 2001).  
In addition to the form of selenium causing toxicity, other factors also need to be 
considered, such as an individual’s diet. The essential role of selenium was found when rats fed a 
vitamin E-deficient diet could be rescued with selenium (Schwarz and Foltz 1999). Conversely, 
selenium toxicity in rats was alleviated by dietary supplementation with methionine and vitamin 
E (Levander and Morris 1970). Selenium levels could be equal in the diets of 2 individuals. One 
individual could be eating a well balanced diet containing excess vitamin E and be physically 
normal, while the other individual could be eating a diet with less vitamin E and show signs of 
selenium toxicity. With the variety of factors affecting signs of selenium toxicity, like type of 
selenium (elemental, organic, or inorganic), as well as dietary components (like vitamin E), it is 
understandable that identifying damage caused by excess selenium is difficult.  
1.3.2 Selenium toxicity is an increasing environmental problem 
Selenium toxicity has become an increasing environmental concern because of bioaccumulation 
attributable to increased industrial refining of metals and petroleum and irrigation of seleniferous 
soils (Harris 1991; Lemly 1997; Lemly 2004). Bioaccumulation occurs as selenium waste is 
incorporated into a bioavailable form, as either selenocysteine or selenomethionine, by bacteria 
and plants (Lemly 1997; Lemly 2004). Plant uptake of selenium can be affected by selenium 
concentration, moisture, pH, salinity, sulfate concentrations, reoxidation conditions, and species 
of plants (Wu 2004). As bacteria and plants are ingested by higher organisms, selenium is 
concentrated and enters the food supply (Lemly 1997). 
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Selenium’s toxic effects on fish and aquatic birds have been studied in Belews Lake, 
North Carolina and at the Kesterson Reservoir Wildlife Refuge in California (Harris 1991; 
Lemly 1997). In both locations, bioaccumulation resulted in selenium concentrations 100-3000 
times greater than neighboring areas (Lemly 1997). Fish and birds laid fewer eggs and fewer 
eggs hatched of those laid (Ohlendorf et al. 1986; Lemly 1997). Those that did hatch were more 
likely to have congenital defects, including deformed spines, heads, limbs, and eyes (Ohlendorf 
et al. 1986; Lemly 1997). 
Kesterson Reservoir provided a lesson in bioaccumulation and insight into the 
complexity of selenium toxicity (Ohlendorf et al. 1986; Harris 1991; Lemly 2004). Selenium 
toxicity in Kesterson resulted from an attempt to revitalize marshlands that had been drained for 
irrigation purposes. The plan was to revitalize the marshes by directing irrigation drainage from 
upstream of Kesterson. Initial reports testing water samples suggested that the plan to revitalize 
the marshlands with irrigation drainage would work lacking side-effects (Harris 1991). However, 
scientists who had visited the location were hesitant because of things they had not observed, like 
birds or insects (Harris 1991). They also observed crystal clear water in the marshland (Harris 
1991). These observations led to sampling of soil, plants, and where they could be found, fish, in 
addition to the previously mentioned water samples. While selenium levels in the water were 
low, even undetectable at times, levels in plants and the few animals tested were startlingly high 
(Harris 1991). This example demonstrates how selenium is actively taken up by organisms and 
that simply measuring selenium concentration in water provided an inadequate representation as 
to selenium content in the overall environment.  
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1.3.3 Comparative selenium toxicity 
As mentioned in Section 1.3.1, selenium is found in a variety of forms, from inorganic to organic 
to elemental, each with varying degrees of toxicity. A few experimental studies addressing 
selenium toxicity have investigated whether the form of selenium (inorganic or organic) affected 
overall toxicity. One such study that examined equivalent amounts of sodium selenite and 
seleno-DL-methionine in mallards and found that seleno-DL-methionine was more teratogenic 
(causing developmental abnormalities) while sodium selenite was embryotoxic (Heinz and 
Hoffman 1996). An experimental study of post-implantation rat embryos found all selenium 
sources to cause teratogenic deformities in the nervous system in all forms but at different 
concentrations (Usami and Ohno 1996). Forms of inorganic selenium (sodium selenite followed 
by sodium selenate) were found to have more toxic effects at lower concentrations when 
compared to organic selenium (Usami and Ohno 1996). Seleno-DL-cysteine and seleno-DL-
methionine were also found to be toxic, but at concentrations 50-times greater than sodium 
selenite (Usami and Ohno 1996). 
Another experimental study, this one in pigs, compared seleno-DL-methionine, sodium 
selenate, and Astragalus bisulcatus (Panter et al. 1996). Pigs were divided into groups and fed 
equivalent selenium amounts in their feed for up to a six week period (Panter et al. 1996). 
Phenotypes observed in severely affected animals included signs of chronic selenosis (hair and 
hoof lesions) as well as ataxia and paralysis that correlated to the development of lesions similar 
to poliomyelomalacia (“polio” refers to paralysis; “myelomacia” is softening of the spinal cord) 
and polioencephalomalacia (cerebrialcortical necrosis) (Panter et al. 1996). All animals given 
feed containing selenium from Astragalus bisulcatus developed paralysis at a faster rate than 
other forms (Panter et al. 1996). Animals fed sodium selenate showed the next most severe 
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symptoms from selenium-supplemented feed, with four animals developing CNS problems 
(posterior ataxia to paralysis) and the other animal showing signs of chronic selenosis (Panter et 
al. 1996). Also of interest was an analysis of the selenium content of various organs. Feeding 
with seleno-DL-methionine resulted in the greatest selenium content in the tissues of all 
selenium sources, but showed the least toxicity (2 animals showing CNS signs and 3 showing 
signs of chronic selenosis) (Panter et al. 1996). Astragalus bisulcatus and sodium selenate fed 
animals had lower selenium concentrations in their tissues than seleno-DL-methionine animals, 
but selenium concentrations in all were still greater than in the non-selenium treated controls. 
This study demonstrated that the severity of neurological damage caused by selenium toxicity 
does not correlate with selenium tissue content. 
Another experimental study looked at selenium effects on the nervous system of mice fed 
organic (seleno-L-methionine) and inorganic (sodium selenite) selenium in drinking water 
(Tsunoda et al. 2000). Sub-lethal doses of inorganic selenium increased some dopamine 
metabolites in the striatum compared to controls or seleno-L-methionine-treated animals 
(Tsunoda et al. 2000). As dopamine is a neurotransmitter, this may suggest a mechanism of 
neurotoxicity by altering neurotransmission, it does not account for seleno-L-methionine toxicity 
in animals.  
Yet another experimental study addressed various concentrations of inorganic and 
organic selenium and the emergence of selenosis in growing-finishing pigs (Kim and Mahan 
2001). Again, the authors found that both forms of selenium caused toxicity. However, inorganic 
selenium caused more severe symptoms and the symptoms presented faster than in adult pigs fed 
organic selenium (Kim and Mahan 2001). Long term exposure to selenium in these pigs 
confirmed findings observed in birds and fish that led to increased reproductive problems (few 
 11 
live pigs being born) (Kim and Mahan 2001). Further, organic selenium appears to lead to 
greater problems in the offspring due to higher selenium content in the tissue.  
Here, the complexity of selenium toxicity is apparent and provides insight as to why 
selenium toxicity is poorly researched. In adults, inorganic selenium is more toxic that organic 
forms (Panter et al. 1996; Kim and Mahan 2001). In animals where the mother is fed selenium, 
organic forms of selenium are more toxic that inorganic when the progeny were examined 
(Heinz and Hoffman 1996). Adding to this, adult animals fed selenium from the same source 
yielded phenotypes that varied from hair and nail lesions to neurological signs (Panter et al. 
1996).  
 
1.3.4 Selenium and oxidative stress 
The mechanism(s) of selenium toxicity is not known but one possibility is that it results from 
increased oxidative stress. This may seem counterintuitive since selenium is widely considered 
to be an antioxidant, since selenium is utilized in the active site of glutathione peroxidases, 
which catalyze the conversion of hydrogen peroxide to water (Behne and Kyriakopoulos 2001). 
An equation proposed by Seko et al. in 1997 suggested that selenite reacts with glutathione and 
hydrogen selenide to produce superoxide anion. This was later confirmed in vitro using 
chemiluminescence (Spallholz 1994; Seko and Imura 1997).  
A variety of literature supports the idea that increased oxidative stress can result from 
both organic and inorganic selenium exposure. A superoxide dismutase mimetic alleviated 
sodium selenite toxicity in rat hepatocytes (Kitahara et al. 1993). In human hepatoma cells, 
sodium selenite was found to induce oxidative stress and subsequent apoptosis (Shen et al. 
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1999). Selenomethionine caused detection of oxidized protein in gastric cancer cells (Verma et 
al. 2004). Injections of reduced glutathione alleviated sodium selenite toxicity in buffalo calves 
(Deore et al. 2005). In Saccharomyces cerevisiae, both selenomethionine and sodium selenite 
resulted in decreased growth of yeast strains involved in DNA repair and oxidative stress, 
suggesting both selenium sources cause reduced growth due to oxidative damage (Seitomer et al. 
2008). From the variety of literature cited, various selenium sources were found to cause 
increased oxidative stress or detect oxidative damage in a variety of cell types, supporting the 
role of oxidative stress in selenium toxicity.  
1.4 DISEASE ASSOCIATION TO HIGH ENVIRONMENTAL SELENIUM 
There is an increasing awareness of and focus on linking diseases to environmental factors.  
Previous research reveals an association between high environmental selenium and the motor 
neuron disease amyotrophic lateral sclerosis (ALS), more commonly referred to as Lou Gehrig’s 
disease. Further evidence supporting toxicity in response to selenium exposure comes from 
accidental selenium poisoning in livestock, which will be discussed later.  
1.4.1 Amyotrophic Lateral Sclerosis 
Amyotrophic lateral sclerosis (ALS) was first described by the French neurobiologist Jean-
Martin Charcot in 1869 and was originally known as Charcot’s sclerosis. ALS is a 
neurodegenerative disorder affecting the motor neurons in the ventral horns of the spinal cord, 
motor cortex, and brainstem (Cleveland and Rothstein 2001). Interestingly, it spares sensory 
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neurons, neurons involved in cognitive processes, and a small specific group of motor neurons 
controlling sphincter and urethral function (Kunst 2004). ALS is a rapidly progressive and fatal 
disease. Death occurs as a result of denervation of the respiratory tract, causing suffocation 
(Kuncl et al. 1988). 
The average age of onset for the disease occurs between 50-60 years, with death 
occurring within 2-5 years of onset (Williams and Windebank 1991). Typically, patients present 
with progressive weakness in the arms and legs (Williams and Windebank 1991). There is 
another form of the disease, differentiated because it presents with swallowing problems and 
difficulty talking, called bulbar ALS (Hillel et al. 1999). At any time, 1-2 individuals per 100,000 
have ALS (Cleveland and Rothstein 2001). As a result, the lifetime incidence for ALS is 
approximately 1 in 800 (Yoshida et al. 1986). There is currently only one drug treatment for ALS 
patients, the anti-glutamatergic drug riluzole, which extends the patients life by an average of 3 
months (Bensimon et al. 1994).  
Until the early 1990’s, there was no known cause of ALS. At that time, researchers 
studying families with the inherited form of the disease identified mutations in the superoxide 
dismutase 1 (SOD1) gene as a cause of familial ALS (Rosen et al. 1993). However, familial ALS 
accounts for only 10% of all ALS cases (Cleveland and Rothstein 2001). Also, it is now known 
that mutations in SOD1 have been identified in approximately 20% of familial ALS cases, 
thereby accounting for approximately 2% of all ALS cases (Cleveland and Rothstein 2001). 
There are more that 90 mutations in SOD-1 linked to familial ALS, causing confusion as to the 
toxic properties of mutant SOD-1 (Gaudette et al. 2000; Andersen 2001). Yet, research on SOD1 
mutations remains the focus the majority of ALS studies.  
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Since identification of the SOD-1 mutation, other genetic mutations linked to familial 
ALS have been identified. These genes have been identified as ALS1-ALS8 (Kunst 2004). Of 
these, only ALS2 (Alsin) and ALS4 (Sentaxin) have known protein products (Ikemoto et al. 
2002; Tudor et al. 2005). Alsin is a guanine nucleotide exchange factor that is predicted in 
interact with kinases that are involved in cytoskeleton rearrangement which plays a role growth 
cones development in neurons (Tudor et al. 2005). Sentaxin/syntaxin is a synaptic vesicle 
associated protein that is differentially expressed in ALS patients (Ikemoto et al. 2002). 
However, the function of both protein products in disease is poorly understood. 
Recently, there has been increasing focus on genetic susceptibility factors in ALS. This is 
a result of research describing decreased expression of EAAT2, a glial glutamate transporter, in 
more than half of the sporadic ALS patients tested (Rothstein et al. 1995).  Other genetic factors 
associated with ALS by affecting disease progression include vascular endothelial growth factor 
(VEGF), neurofilamant, and one allele of Apolipoprotein E (ε4 allele), among others (Rouleau et 
al. 1996; Drory et al. 2001; Lambrechts et al. 2003). Although, it is not clear if these factors are 
necessary and/or sufficient to cause  the disease (Kunst 2004). Recently, multiple genome-wide 
scans were performed of sporadic ALS patients, attempting to identify single nucleotide 
polymorphisms (SNPs) found in ALS patients (Dunckley et al. 2007; Kasperaviciute et al. 2007; 
Schymick et al. 2007; Blauw et al. 2008). These studies provided a list of loci implicating genes 
with know and unknown functions (Dunckley et al. 2007; Kasperaviciute et al. 2007; Schymick 
et al. 2007). Many of the known genes are involved in cytoskeleton regulation (Dunckley et al. 
2007; Kasperaviciute et al. 2007; Schymick et al. 2007). Given that susceptibility factors are 
present in non-disease individuals suggests that a combination of factors and/or an environmental 
trigger may be involved in developing sporadic amyotrophic lateral sclerosis.  
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The growing body of evidence suggests that studying SOD1 mutations to model ALS is 
inadequate to understand non-SOD1 ALS cases. Recent research that focused on identifying 
ubiquitin-positive inclusion in frontotemporal lobar degeneration led to a new class of disorders 
referred to as TAR-DNA binding protein 43 (TDP-43) proteinopathies (Neumann et al. 2007). 
TDP-43 positive inclusions were identified in sporadic ALS and some familial ALS, but not 
familial SOD-1 mutant cases (Neumann et al. 2007). Another study reported that TDP-43 was 
found in SOD-1 transgenic mice, but it was not associated with ubiquinated inclusions like it is 
with sporadic ALS cases (Robertson et al. 2007). Together, these reports suggest that while 
clinical progression of familial and sporadic ALS is nearly identical with a few exceptions of 
adolescence onset, there is a divergence in the molecular mechanisms of the diseases. A variety 
of drugs have been developed  to treat SOD1 mutant mice, only to fail spectacularly when the 
drugs reach clinical trials (Benatar 2007; Scott et al. 2008). This combination of evidence 
reinforces the need for a model of sporadic ALS.  
1.4.2 Epidemiologic studies linking high environmental selenium and ALS 
The initial association between high environmental selenium and motor neuron disease can be 
traced back to the 1930’s in South Dakota where animals that grazed in high selenium areas were 
found to develop alkali disease and “blind staggers” (Tinggi 2003). Later in the 1970’s, the 
original modern connection between high environmental selenium and motor neuron disease was 
made when an ALS cluster was noted in a town whose livestock suffered from endemic selenium 
toxicosis (Kilness and Hichberg 1977). 
More recent evidence linking environmental selenium exposure to ALS comes from an 
epidemiologic study examining the effects of long term exposure to increased environmental 
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selenium through drinking water in an Italian town and found an increased incidence of ALS 
(Vinceti et al. 1996). Investigators identified a cohort of residents that had continuously drunk 
from the town’s water supply containing inorganic selenium during a 5 year period. Of 5,182 
individuals, 4 developed sporadic ALS (Vinceti et al. 1996). All 4 individuals diagnosed with 
sporadic ALS fell into a sub-cohort of 2,065 individuals that was identified for continuously 
having drunk from the municipal tap water for 12 consecutive years (Vinceti et al. 1996). This is 
a significant increase of about 1 in 500-1000 ALS incidence compared to normal (1-2 per 
100,000) which demonstrates a correlative association between high environmental selenium and 
an increased risk for developing ALS.  
1.4.3 Selenium levels in ALS patients 
Since the observations linking environmental selenium to ALS, investigations into an association 
between selenium levels within the body and ALS patients have been performed. A follow up 
study in the Italian town correlation incidence of ALS with high selenium in the drinking water 
could not link tissue selenium levels to ALS status when looking at biomarkers in toe nail 
clipping (Bergomi et al. 2002). However, as the authors of the report note, there is a limited 
potential for using toenail clippings as biomarkers for metal exposure (Bergomi et al. 2002). 
Another report found no increase in selenium levels in the urine of ALS patients compared to 
controls where as another report investigated selenium levels in hair, plasma, and blood and 
found that selenium concentrations in plasma decrease as ALS progressed (Moriwaka et al. 
1993; Norris et al. 1993).  
There are multiple problems with the findings described above. First, these reports 
examine selenium concentrations after disease onset and do not account for exposure prior to 
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disease diagnosis (for example, selenium has a half-life in human tissues between 65-115 days) 
(Mestek 1997). Second, selenium concentrations alone do not determine toxicity; the form of 
selenium is equally important (Panter et al. 1996; Usami and Ohno 1996). In addition, it is 
possible that a relatively brief window of exposure to high selenium could cause cellular 
damage, in a way that might take years to fully manifest.  
The tissue tested for selenium is also critical as selenium is better retained in the nervous 
system. Rats fed selenium deficient diets for multiple generations resulted in a minimal selenium 
decrease in the nervous system when compared to other tissues (Savaskan et al. 2003). When the 
spinal cords of patients with motor neuron disease were examined, selenium levels were found to 
be increased compared to controls (Ince et al. 1994; Markesbery et al. 1995). While these reports 
do not demonstrate a causative relationship between selenium and motor neuron disease, it does 
suggest a potential relationship. Specifically, that selenium could be involved in a fraction of 
overall sporadic ALS cases, similar to SOD1 mutations in the familial ALS cases.  
1.4.4 Selenium and Gulf War Veterans 
There is a growing body of evidence that demonstrates a relationship between military service 
and increased risk of developing sporadic ALS. A review of the literature by the National 
Academies Institute of Medicine concurred that those in military service are at an increased risk 
of developing sporadic ALS (Weisskopf et al. 2005; Institute of Medicine (U.S.). Committee on 
the Review of the Scientific Literature on Amyotrophic Lateral Sclerosis in Veterans. 2006). 
Also of note is the increased incidence of ALS in Gulf War veterans. Two epidemiologic studies, 
using different methodology, identified increased incidence of sporadic ALS in troops deployed 
during the Gulf War, suggesting an environmental or war time trigger (Haley 2003; Horner et al. 
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2003). One report tracked the expected number of sporadic ALS compared to diagnosed cases 
and found that by 7 years post-Gulf War (the last year tracked in the study) that the number of 
observed sporadic ALS cases was more than twice than expected (Haley 2003). The increased 
incidence of developing sporadic ALS from Gulf deployment provides a unique opportunity at 
identifying an environmental or war-time trigger.  
A possible culprit was identified in a report by Richardson et al., in which the authors 
reported near toxic levels of selenium in the Mesopotamian marshes of Iraq (Richardson et al. 
2005). In addition to the marsh, selenium is a major waste product of oil refining and selenium 
content in the oil in the region is some of the highest in the world, containing 1.10ug Se/g of oil 
(compared to 0.369ug/g in Venezuela oil and 0.0094ug/g in Alberta oil) (Yen 1975).  This 
converts to an estimated 140-170g of selenium per barrel of crude oil. During the first Gulf War, 
over 700 hundred oil wells were set on fire and required nearly 9 months to contain (Osman 
1997). Burning from 2-6 million barrels of crude oil each day and released tons of selenium into 
the atmosphere (Osman 1997). These data provide another correlative relationship between 
selenium exposure and ALS. 
1.4.5 Supporting studies from selenosis in livestock 
Further evidence suggesting selenium acts as a motor neuron toxin come from reports of 
accidental selenium poisoning reported in livestock due to excess selenium supplementation of 
their feed. Veterinary analysis was sought after animals (pigs) developed paralysis (Stowe et al. 
1992). After excluding microbial and viral pathogens, investigations ultimately discovered that 
the selenium concentrations in the feed exceeded toxic levels (Stowe et al. 1992). This study 
reported neuronal loss and vacuolation of the neurons, glial cell proliferation in the ventral horn, 
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skeletal muscle swelling, and myocardium vacuolation (Stowe et al. 1992). Accidental selenium 
poisoning has been reported multiple times in the literature, with the most common observation 
being neuronal loss in the spinal cord (Harrison et al. 1983; Goehring et al. 1984; Casteel et al. 
1985; Frank and Bergeland 1988; Stowe et al. 1992; Penrith and Robinson 1996). Another series 
of studies experimentally induced motor neuron degeneration with selenium to provide a 
biological basis for a causative role in the paralytic outbreaks (Harrison et al. 1983; Wilson et al. 
1983; Wilson et al. 1988; Baker et al. 1989; Panter et al. 1996).  
These reports of selenium toxicity in animals are significant in that they mirror ALS 
symptoms. Initial symptoms of affected animals included limb weakness and an inability to stand 
upright (Harrison et al. 1983; Stowe et al. 1992; Casteignau et al. 2006). The majority of ALS 
patients’ initial symptoms include weakness in the hands, arms, or legs (Williams and 
Windebank 1991). Severely affected selenium-treated or exposed animals became quadriplegic 
and had to be euthanaized (Harrison et al. 1983; Casteel et al. 1985; Stowe et al. 1992). 
Similarly, ALS patients progress from muscle weakness to paralysis and eventual death 
(Williams and Windebank 1991). In addition to neuronal loss, glial proliferation in the spinal 
cord was observed of paralyzed selenium-treated animals, a pathology which has also been 
reported in ALS tissue (Harrison et al. 1983; Casteel et al. 1985; Stowe et al. 1992; Anneser et al. 
2004; Casteignau et al. 2006). Further, selenium-treated animals also have neuronal vacuolation, 
which is also observed in ALS (Levine et al. 1999). The damage caused by selenium exposure 
mimics that observed in ALS patients. 
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1.5 STUDYING SELENIUM TOXICITY IN THE GENETICALLY TRACTABLE 
ORGANISM CAENORHABDITIS ELEGANS 
Genetic model systems, including bacteria, yeast, Drosophila, C. elegans, and mice have proven 
useful in modeling processes that occur in higher organisms. While all systems could be used to 
investigate selenium toxicity, C. elegans provides a number of advantages. First, C. elegans has 
the shortest generation time of the multicellular systems; approximately 3 days from when an 
egg is laid until sexually maturity (Brenner 1974). The adult hermaphrodite has 959 somatic cells 
while the male has 1031 cells, including 302 neurons. Transparency of the animal makes it 
possible to visualize selenium-induced cellular changes throughout the animals’ life (Wood 
1988). Animals are easily maintained on agar with E. coli as a food source. C. elegans have 2 
sexes, self-fertilizing hermaphrodites, which account for 99.9% of naturally occurring 
population, and males, which account for 0.1% of the population (Wood 1988). The presence of 
self-fertilizing hermaphrodites allows for maintenance of a mutant clonal population starting 
from a single animal, while the presence of males allow for genetic variability (Brenner 1974).  
Due to the conservation of biological processes and the many useful experimental 
features of C. elegans, the model has proved to be a powerful tool for modeling basic processes 
like apoptosis, and for developing new research tools like RNAi that have been applied across 
multiple fields (Ellis and Horvitz 1986; Fire et al. 1998). The C. elegans nervous system is 
highly conserved in function when compared to mammalian systems, using the same 
neurotransmitters and second messengers as well as pre-synaptic and post-synaptic receptor 
orthologs (Bargmann 1998; Bargmann and Kaplan 1998). For this Reason, C. elegans have also 
been useful in modeling other complex neurodegenerative disorders such as Huntington’s, 
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Parkinson’s, Alzheimer’s disease, and necrotic neuronal death, suggesting it could prove useful 
in modeling selenium toxicity (Driscoll and Gerstbrein 2003).   
Before delving into biochemical and genetic analysis of selenium toxicity, we have 
established a model using Caenorhabditis elegans for studying selenium toxicity. Previous 
studies in our laboratory, we observed decreased fertility and increased occurrence of 
developmental defects observed in C. elegans (Lemly 1997).  
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1.6 RESEARCH PLAN 
Literature searches of selenium recover little in the way of understanding why selenium is toxic. 
Further, there is a well-documented link between high selenium exposure and anatomical motor 
neuron loss, with a more debatable link to the specific motor neuron disease, ALS. Previously in 
our laboratory, we have observed this high selenium exposure causes decreased fertility and an 
increased number of developmental defects. This is similar to what has been observed in other 
organisms, demonstrating the usefulness of using C. elegans as a system for studying selenium 
toxicity (Lemly 1997). Chapter 2 investigates various factors that can affect toxicity in C. 
elegans, such as temperature, bacterial metabolism, and minimal/adequate calcium levels, as 
well as a potential source of toxicity, increased oxidative stress. Chapter 3 examines neuronal 
damage caused by selenium toxicity, specifically decreased cholinergic signaling resulting in 
muscle denervation and damage to the C. elegans egg-laying circuit. Chapter 4 then examines 
the insulin-like pathway in response to selenium exposure. In Chapter 5, we discuss findings 
from Chapters 2-4 and how they are relevant to motor neuron loss and future directions for this 
study.  
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2.0  BASIC SELENIUM TOXICITY IN CAENORHABDITIS ELEGANS 
2.1 ABSTRACT 
Despite the fact that selenium is well-known to be an antioxidant, at high concentrations it is a 
powerful cytotoxin. Work in the existing literature has shown both organic and inorganic 
selenium to be toxic in vivo and in vitro. Similarly, earlier work in our lab demonstrated that 
exposure to high selenium levels in the genetically tractable organism Caenorhabditis elegans 
causes reproductive and developmental defects similar to those reported other species. Here we 
show that both forms are toxic. Selenium exposure to adult animals causes a progressive serious 
of dysfunctional behaviors leading to death. Selenium exposure in adult animals causes a 
progressive impairment of motor function culminating in death. Several key environmental 
factors exacerbate or alleviate selenium toxicity, including calcium levels, temperature, and 
bacterial metabolism. In addition, we determined that the two canonical cell death mechanisms, 
apoptosis and necrosis, were not responsible for selenium-induced cell death. Finally, we 
determined that selenium exposure leads to evidence of increased reactive oxygen species (ROS) 





Selenium was discovered to be essential in the 1950’s when scientists found that selenium 
supplementation in rats fed a vitamin E-deficient diet could prevent liver necrosis (Schwarz and 
Foltz 1999). It is now understood that the organic forms of selenium, selenomethionine and 
selenocysteine, are incorporated into proteins. Selenomethionine can incorporate randomly into 
proteins, while selenocysteine has been found to incorporate specifically using a UGA codon that 
normally codes for stop along with a 200 nucleotide sequence in the 3’ UTR (Berry et al. 1991; 
Muller et al. 1997). The essential function of selenium is limited to selenocysteine incorporation 
while selenomethionine incorporation functions as “storage”. 
Despite its protective functions, selenium is also toxic. In fact, the earliest written 
accounts of selenium’s toxicity date back to Marco Polo’s travels through China in the 1200’s 
(Young et al. 1982; Spallholz 1994). A majority of the literature on “selenium toxicity” is 
composed of descriptive reports that discuss selenium’s effects on wildlife and accidental 
selenosis in livestock along with a few reports of selenium poisoning in humans (Carter 1966; 
Casteel et al. 1985; Koppel et al. 1986; Ohlendorf et al. 1986; Stowe et al. 1992; Lemly 1997; 
Lemly 2004; Casteignau et al. 2006; Nuttall 2006; Sutter et al. 2008). Only studies of its anti-
cancer properties suggest specific mechanisms of toxicity, involving activation of apoptosis (Lu 
et al. 1994; Jiang et al. 2001; Zhu et al. 2002; Shilo et al. 2003; Goel et al. 2006; Xiao et al. 
2006; Zhao et al. 2006; Zhao et al. 2006; Chen and Wong 2008). There is little research into 
what causes selenium to be toxic and what results from the toxicity. Literature studying selenium 
usually investigates physiological levels and beneficial effects.   
The few studies investigating selenium toxicity have found organic and inorganic forms 
of selenium to be toxic, but to varying degrees. For example, equivalent amounts of 
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selenomethionine and sodium selenite given to mallard ducks demonstrated that organic 
selenomethionine caused developmental defects whereas inorganic sodium selenite was lethal to 
embryos (Heinz and Hoffman 1996). Another study in post-implantation rat embryos found 
inorganic selenium to be fifty-times more toxic than organic selenium (Usami and Ohno 1996). 
Comparative toxicity in adult vertebrate animals found selenium from the selenium accumulating 
plant species Astragalus bisulcatus to be more toxic than inorganic selenium (sodium selenite) 
which was more toxic than organic selenium (selenomethionine) (Panter et al. 1996). 
Additional reports of selenium toxicity come from accidental selenium poisoning in 
livestock, where selenium was found to be the cause of paralytic outbreaks. In one study, post-
mortem analysis of affected animals identified skeletal muscle swelling and disintegration and 
vacuolation of the myocardium (Stowe et al. 1992). Damage to the gastrointestinal and 
hematopoietic systems has also been reported as a result of selenium toxicity in livestock 
(Raisbeck 2000). One pathological finding that the reports shared was that selenium toxicity 
caused neuronal loss, vacuolation, and gliosis in the spinal cord of affected animals, 
demonstrating that excess selenium acts as a neuronal toxin (Harrison et al. 1983; Casteel et al. 
1985; Frank and Bergeland 1988; Stowe et al. 1992; Casteignau et al. 2006). 
Selenium toxicity is becoming an increasing environmental problem, as it is a major 
waste product from fossil fuels and soil irrigation. Fossil fuels contain high concentrations of 
selenium. Crude oil can contain over 2g Se/L and refined oils contains up to 250µg Se/L that 
enters the atmosphere when burned (Lemly 2004). Excess environmental selenium resulted in 
reproductive failure and developmental defects in a variety of fish (including Lepomis cyanellus, 
Pomoxis annularis, Micropterus salmoides, Gambusia affinis, Notropis latrensis, and Ictalurus 
punctatus) at Belews, NC where waste from a coal burning plant was released into a nearby 
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water basin (Ohlendorf et al. 1986; Harris 1991; Lemly 1997). Selenium is an increasing concern 
in landfills, as selenium is being used more frequently in electronics due to its photosensitive and 
semi-conductive properties (Sharma 1983; Lemly 2004).  In addition, areas of the western 
United States have high selenium in the soil due to shale deposits (Lemly 1997). As these areas 
are arid and require irrigation for crop production, irrigation results in selenium leaching from 
the shale into the ground water (Lemly 1997). Such practices resulted in poisoning of wildlife in 
Kesterson, CA (Ohlendorf et al. 1986; Harris 1991; Lemly 1997). With increasing amounts of 
selenium being released into the environment each year, more research is needed to understand 
the potential impact on the human population as selenium is known to be toxic and has been 
documented to act as a motor neuron toxin in other mammals (Casteel et al. 1985; Panter et al. 
1996; Casteignau et al. 2006). 
The genetic model C. elegans is a useful tool for dissecting the mechanisms of selenium 
toxicity. The worm provides a simple model to address potential genetic and environmental 
factors that may influence selenium toxicity and when culturing animals, there are environmental 
conditions that can be altered that can differentiate the phenotypes of mutant animals. 
Maintenance of C. elegans was first described by Sydney Brenner (Brenner 1974). For example, 
culturing some mutants at 25°C, a non-permissive temperature, instead of the permissive 20°C, 
can cause the mutants to enter an alternate developmental stage called dauer larva and wild-type 
animals have a decreased lifespan at 25°C (Klass 1977; Riddle 1977). One consequence of 
growing wild-type animals at increased temperatures is an increase in metabolic rate, 
subsequently increasing oxidative stress (Van Voorhies and Ward 1999).  
Another factor to be considered when working with C. elegans is a potential role for 
bacterial metabolism from their E. coli food source, strain OP50. Bacterial metabolism has been 
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a limiting factor in drug screens since the bacteria metabolize the drug compound before it can 
reach the animal and affect lifespan or another observable phenotype (Kaletta and Hengartner 
2006; Saiki et al. 2008). To address possible contributions of bacterial metabolism to selenium 
toxicity, chemically defined media can be used. The idea of culturing animals on/in chemically 
defined media has been around since Brenner’s initial paper (Brenner 1974). However, until 
recent understanding of C. elegans carbohydrate requirements, culturing animals on chemically 
defined media would also stress the animals (Lu 1993; Szewczyk et al. 2003).  
Calcium is another factor in C. elegans media that could potentially contribute to toxicity. 
Calcium is a second messenger signaling molecule and is an important molecule in regulating 
neurotransmission (Rasmussen et al. 1976; Reid et al. 2003). Increases in intracellular calcium 
have been implicated in models of stroke, and heart disease, among others (Braun 1983; Gelmers 
1985). In C. elegans, calcium is normally added to the media in addition to other ions. Media 
without additional calcium has no observable phenotype on wild-type animals. However, in 
animals with mutated calcium channels, minimal calcium (where no additional calcium is added 
to the media) increases the observed mutant phenotypes (unpublished observations from our 
laboratory with unc-2). It is possible that the difference between no additional calcium and 
physiological calcium concentrations established by Brenner could increase selenium toxicity 
and subsequent cell death.  
Until 1972, cell death was widely thought to be a passive process where cells would die 
when they were too damaged to function. The idea of “programmed cell death” grew out of 
developmental observations that specific cells would die during the course of development (Kerr 
et al. 1972). Currently, cell death is conceptually divided into two categories; necrosis and 
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programmed cell death. Both types of cell death are active areas of research in the C. elegans 
community and numerous genetic tools for studying these processes are readily available.  
Necrosis is a cell death process characterized by cellular swelling leading to membrane 
rupture resulting in inflammation of surrounding tissues. Necrosis was once thought to be a 
passive process, but has now been shown to have specific molecular signaling components. 
Necrosis begins by cells receiving an insult like an influx of ions via the degenerin channel or 
calcium channel (Driscoll and Chalfie 1991; Bianchi et al. 2004). Subsequently, intracellular 
calcium levels increase, leading to calpain activation (Samara and Tavernarakis 2003; Bianchi et 
al. 2004). Activated calpain then proceeds to rupture the lysosome (Artal-Sanz et al. 2006). The 
interior of the lysosome is acidic and the pH is maintained by a V-ATPase (Syntichaki et al. 
2005). Lysosomal rupture results in cellular acidification, releasing cathepsins that proceed to 
degrade various cellular components (Kourtis and Tavernarakis 2007).   
In contrast, programmed cell death can be divided into 2 sub-categories; programmed cell 
death I (apoptosis) and programmed cell death II (autophagic cell death). Apoptosis is 
characterized by cellular shrinking, DNA degradation, and engulfment of cellular corpses 
without cytoplasmic contents “leaking” out and causing inflammation in neighboring cells 
(Savill and Fadok 2000; Nathan 2002). In C. elegans, apoptotic cells increase in refractility that 
is easily observed under Nomarski differential interference contract optics (Ellis and Horvitz 
1986). The initial work in this field identified ced-3 (CEll Death abnormal) as being involved in 
developmental programmed cell death (Ellis and Horvitz 1986). CED-3 was later found to be 
similar to mammalian interleukin1β-converting protein that acts as a cysteine protease, or 
caspase (Yuan et al. 1993). Subsequent work demonstrated that ced-4 (C. elegans ortholog of 
mammalian APAF) could activate CED-3. Since then, work in programmed cell death has 
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exploded to identify other genes involved in the killing phase (ex: egl-1 and ced-9) as well as 
genes involved in DNA degradation (nuc-1 and crn-6) and corpse engulfment (ced-1, ced-10, 
etc.) (Conradt and Xue 2005).   
Here, we demonstrate that both organic and inorganic selenium sources cause toxicity in 
C. elegans. Various environmental factors were found to affect toxicity, such as temperature and 
calcium levels. Bacterial metabolism was not required for selenium toxicity, but may be 
protective. Additionally, we have made use of genetic information relating to cell death 
mechanisms in C. elegans to attempt to define how selenium toxicity leads to death.   
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2.3 MATERIALS AND METHODS 
2.3.1 Strain maintenance and growth conditions 
The following strains were obtained from the Caenorhabditis Genetics Center located in 
Minneapolis, MN; wild-type N2, MT1522: ced-3(n717)IV, MT2547: ced-4(n1162)III, MT4470: 
ced-9(n1950)III, TJ1: cep-1(gk138)I, KJ216: crt-1(jh101)V. Strains PJ1: cad-1(j1)II and PJ13: 
cad-1(j013)II were kind gifts from Lew Jacobson. With the exception of the experiment testing 
chemically defined media (2.4.4), animals were grown on standard nematode growth media 
(NGM) plates.   
NGM plates were made as follows: 3g NaCl, 2.5g Bactopeptone, 17g agar to 975ml of 
de-ionized water. The media was autoclaved for 60 minutes. After autoclaving, the following 
reagents were added (in order), swirling the flasks after each addition: 1ml of nystatin (0.446g of 
nystatin in 28ml EtOH and 4ml H2O), 1ml cholesterol (5mg/ml in EtOH), 1ml 1M MgSO4, 25ml 
of 1M potassium phosphate buffer (pH 6.0). For the experiments addressing altered sensitivity to 
selenium with calcium, 1ml of 1M CaCl2 was added to media after the cholesterol and before the 
magnesium, for a final concentration of 1mM (Brenner 1974).  
After the plates were poured (10ml for small plates and 30ml for large plates) and 
solidified, the uracil auxotrophic E. coli strain OP50 was added as a food source. Animals were 
maintained and experiments performed at 20°C unless otherwise stated.  
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2.3.2 Developmental synchronization  
Developmental synchronization of C. elegans is required to remove potential variability of age 
from affecting relative selenium sensitivity. Developmental synchronization was obtained in one 
of 2 ways.  
1) Hypochlorite/NaOH (Bleach Method): Plates containing hundreds of gravid adult 
hermaphrodites were washed with de-ionized water into 15ml conicals. The wash, with worms, 
was brought to 8.5ml. 1ml of bleach and 500ul of 5N NaOH was added to the tube and capped. 
The tube was shaken vigorously for at least 30 seconds then gently shaken for a minimal total 
time of 5 minutes. The shaking times were extended to account for a larger number of worms or 
microbial contamination to a maximum time of 8 minutes. Prolonged exposure to NaOH/bleach 
solution was avoided because it compromises egg viability. At that time, tube(s) were placed into 
a swinging bucket centrifuge for 2 minutes at 2000rpm. The supernatant was aspirated to waste 
leaving the eggs and adult debris as a pellet at the bottom of the tube. The NaOH/bleach solution 
was washed away through 3-4 washes of autoclaved de-ionized water (washes were of an equal 
volume as the NaOH/bleach solution). After the final wash, 3-4ml of M9 buffer (6g Na2HPO4, 
3g KH2PO4, 5g NaCl, 1ml of 1M MgSO4 per 1 L) was added. The tube(s) were then placed 
overnight on a shaker with gently agitation and with the caps slightly agar (1/4 of a turn) to allow 
for ventilation. The hatched eggs developmentally arrest in the first larval stage (L1). The next 
day, the hatched animals were plated (Stiernagle 2006).  
2) Alternatively, developmentally synchronized worms were identified and transferred in 
the final larval stage (L4) to a new plate. L4 stage animals are easily recognizable with a white 
crescent in the posterior third of the body that contains a dark spot in the center of crescent 
 32 
(Wood 1988). This method requires manual transfer of each animal to a new plate. As a result, it 
is used when fewer animals are required.  
2.3.3 Selenium treatment 
Initially, seleno-L-methionine (SeMet) was purchased from both Spectrum Chemical (Gardena, 
CA, USA) and later from Sigma-Aldrich (St. Louis, MO, USA). Seleno-L-methionine plates 
were made by dissolving SeMet in de-ionized water and adding to plates to achieve the desired 
concentration for each experiment. Sodium selenite, purchased from Spectrum Chemical 
(Gardena, CA, USA), was made into a 100mM stock solution in de-ionized water. An 
appropriate volume was added to plates immediately before use to obtain the desired final 
concentration. The sodium selenite solution was stored at 4°C for no more than 30 days.  
2.3.4 Movement assay for selenium damage 
 A behavioral assay was developed in order to measure/monitor selenium damage. In normal, 
untreated C. elegans, an animal move forward with sinusoidal body turns when touched on the 
tail with a platinum wire (considered a “harsh” touch compared to a “soft” touch with an 
eyelash). When an animal is moving forward and tapped on the head, it will reverse direction. 
Exposure to selenium causes several movement deficits. In our initial studies (inorganic versus 
organic selenium and SeMet not working), we scored movement as “normal”, paralyzed (i.e. 
failure to complete one sinusoidal turn of their body with in five seconds of tapping the tail), or 
dead (i.e. lack pharyngeal pumping).  
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Subsequent observation of animals noted an additional more subtle movement deficit 
resulting from selenium exposure, a failure to reverse direction. An animal will move forward in 
a sinusoidal motion when touched on the tail. But when the head is tapped to induce it to reverse 
direction, the animal pauses and continues forward. When scoring for the backing deficit, an 
animal had to fail this test twice to be scored as having impaired backing. 
From Figure 3 on, the three movement deficits, movement, paralyzed, and death are 
grouped together as being damaged. The Y-axis for this assay contains the percent of the 
population of animals with normal movement behavior. Animals were considered “percent (%) 
motile” if they were able to complete one sinusoidal wave backward or forward within 5 seconds 
after tactile stimulation to the head or tail, respectively.  
If any animals crawled onto the side of the plate, they were not scored or included in the 
final count because we could not tell if the animals died due to selenium exposure or desiccation. 
When calculating the percent of the population that was motile, the animals on the plate were 
scored as described. The population number was then adjusted to reflect the number of animals 
on the plate. Calculation for percent of population normal:  
(# of normal animals/# of animals on plate) *100= percent motile   
2.3.5 Treatment with weak bases to protect from necrotic death 
Treatment with weak bases, like acridine orange and ammonium chloride, partially protect 
against necrotic cell death (Artal-Sanz et al. 2006). Water soluble acridine orange was obtained 
from Molecular Probes-Invitrogen (Carlsbad, CA, cat. # A3568). Ammonium chloride was 
purchased from Sigma-Aldrich (St. Louis, MO, cat # 9434). Concentrations of ammonium 
chloride and acridine orange were obtained from a previous publication (Artal-Sanz et al. 2006). 
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Ammonium chloride (NH4Cl) was added to selenium treated and untreated NGM plates to a final 
concentration of 5mM.  Acridine orange was added to selenium treated and untreated plated for 
final concentrations of 50μM, 100μM, and 150uM. Animals were scored for movement deficits 
as described in 2.3.4.  
2.3.6 Reactive Oxygen Species (ROS) detection  
Developmentally synchronous N2 animals were obtained as described in Section 2.3.2 and 
grown to young adults without being allowed to starve. To detect changes in ROS levels, a non-
fluorescent dye was used that fluoresces when oxidized. The oxidation sensitive dye, Carboxy-
H2DCFDA [5-(and-6)-carboxy-2’, 7’ dichlorodihydrofluorescein diacetate], was purchased from 
Molecular Probes-Invitrogen (Carlsbad CA, cat # C-400). Animals were plated on untreated or 
5mM sodium selenite treated plates in the presences and absence of 50µM carboxy-H2DCFDA 
dissolved in 100% ethanol (Smith and Luo 2003).  
 For imaging: At one hour intervals after plating, 10-15 animals were removed to fresh 
plates for each condition (with no carboxy-H2DCFDA or sodium selenite) and allowed to clear 
their intestine, since the carboxy-H2DCFDA also causes the bacteria to fluoresce. Individual 
animals were analyzed and documented by visualization on a Leica DM IRB microscope 
equipped with fluorescence optics and a DC300F imaging system (Leica Microsystems Inc., 
Bannockburn, IL).  The images were processed for publication using the Adobe Creative Suite 2 
premium software package (Adobe Systems Inc., San Jose, CA). 
For quantification: Animals were treated for 6 hours with 5mM sodium selenite and 
50µM carboxy-H2DCFDA or with 50µM carboxy-H2DCFDA. Animals were washed off the 
plates in M9 buffer into 15ml conicals. Animals were washed three times with M9 buffer, 
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allowing the animals to sediment and removing the supernatant between each wash. Animals 
were analyzed using the COPAS Biosorter (Union Biometrica, Holliston MA) using a 
fluorescein filter. Theresholds were set to eliminate non-adult animals (by size) and background 
fluorescence. The Biosorter then measured the percentage of animals in the populations that were 
positive for green fluorescence.  
2.3.7 Antioxidant treatments 
Several antioxidants were tested to determine if they protected selenium induced movement 
impairment. Reduced glutathione (G4251, Sigma-Aldrich, St Louis, MO) was re-suspended in 
de-ionized water and used at 200μg/ml. Quercetin dihydrate (cat # 32782, Riedel-de Haën, 
Seelze, Germany) was re-suspended in 1N NaOH and used at 800ug/ml. α-tocopherol or Vitamin 
E (T3376, Sigma-Aldrich, St Louis, MO) was dissolved in 100% ethanol and tested at 200μg/ml. 
Plates without antioxidants (contained 1N NaOH for quercetin or ethanol equivalent for α-
tocopherol) were tested simultaneously as controls. Animals were scored for movement deficits 
as described in Section 2.3.4.  
2.3.8 Statistical analysis 
Statistical analysis was performed using Microsoft Excel software (Microsoft 
Corporation, Redmond, WA).  The means and standard deviations (SD) reported were 
determined by averaging data obtained from all the plates of each strain or population type (eg. 
treated or untreated) counted.  P values were determined by applying a one-tailed Student’s t-test 
with unequal variance.  A one-tailed test was chosen since normal motility was being calculated 
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and each experiment started with a fixed population number, subsequently, a fixed number for 
normal motility. Therefore, deviations from normal motility could only go in one direction. 
Unequal variance was used instead of equal variance because it was more stringent for 
calculating P values. Comparisons were defined as significant if they were determined to have a 
p value less than 0.05.  Graphs were initially drawn using Excel and were prepared for the 
dissertation using Adobe Illustrator CS2 (Adobe Systems Inc., San Jose, Ca.).   
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2.4 RESULTS 
2.4.1 Organic and inorganic selenium cause a dose dependent effect in wild-type C. 
elegans    
Selenium is found in a variety of forms in the environment. But ingested selenium is eventually 
metabolically incorporated into an organic form as either selenomethionine or selenocysteine 
(Behne and Kyriakopoulos 2001). Many literature reports have found all forms of selenium to be 
toxic but at varying concentrations (Panter et al. 1996; Kim and Mahan 2001; Nuttall 2006). 
However, it has also been repeatedly reported that inorganic forms of selenium (sodium selenite) 
are more toxic to adult animals than organic forms of selenium (Panter et al. 1996; Usami and 
Ohno 1996; Kim and Mahan 2001). Selenium has also been implicated in as a causative a 
causative agent in paralytic outbreaks in swine (Panter et al. 1996; Casteignau et al. 2006). We 
hypothesized that selenium toxicity in C. elegans could be monitored by observing the 
emergence of paralysis and subsequent death after exposure to selenium. To determine whether 
both organic and inorganic forms of selenium cause toxicity in C. elegans, developmentally 
synchronized adult N2 hermaphrodites were placed on NGM plates treated with increasing 
concentrations of organic selenium (seleno-L-methionine or SeMet), and an inorganic form of 
selenium (sodium selenite or NaSe). Animals were scored at 24-hour intervals for survival 
compared to paralysis and death (Figure 1).  
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 Figure 1 Comparative selenium toxicity between seleno-L-methionine and sodium selenite 
Both organic selenium (A-seleno-L-methionine or SeMet) and inorganic selenium (B-sodium selenite or 
NaSe) caused a dose dependent increase in paralysis and mortality over time. Fifty developmentally 
synchronized adult N2 hermaphrodites were placed on standard NGM plates treated with increasing 
concentrations of an organic selenium source, SeMet (A), or an inorganic selenium source, NaSe (B). 
Animals were scored for normal movement versus paralysis and death at 24 hour intervals. Statistically 
analysis was performed using a one-tailed student’s t-test with unequal variance as described in Materials 
and Methods Section 2.3.9 comparing each concentration (SeMet or NaSe) to untreated (0µM) animals. 
The graph above is the average of 3 populations (n=150). The experiment was repeated 3 times with similar 
results. 
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Both organic and inorganic forms of selenium were found to have a dose-dependent toxic 
effect over time on the paralysis and mortality of wild-type N2 animals (Figure 1A and 1B). 
Exposure to 500μM seleno-L-methionine maintained a greater than 90% normal motility over 
the first 48 hours of SeMet exposure with a significant decrease in normal motility at 72 hours 
when compared to untreated animals (Figure 1A, p<0.01). At 500μM of sodium selenite, greater 
than 80% of normal motility was observed after 96 hours of exposure; this is a significant 
decrease when compared to non-selenium treated animals (Figure 1B, p<0.05). This 
demonstrates that both organic and inorganic forms of selenium are toxic in C. elegans as in 
vertebrates. Comparing equivalent concentrations of organic and inorganic selenium, organic 
selenium would appear to be more toxic in this system (Figure 1A and 1B?10mM p<0.005, not 
indicated in Figure 1). This is different from previously published reports of comparative 
selenium toxicity which have generally found that selenomethionine to be less toxic than sodium 
selenite (Panter et al. 1996; Usami and Ohno 1996; Kim and Mahan 2001). It is possible that this 
difference in toxicity reflects differences in absorption of the two forms in C. elegans. For 
example, SeMet is better absorbed in mammalian systems and may more efficiently reach 
physiological toxic levels in the nematode (Panter et al. 1996). 
A problem with these experiments was the variably severity of the toxicity even when 
using the same batch of SeMet. For example, there would be only 2% survival after 72 hours of 
500µM seleno-l-methionine exposure (Figure 1A). But a repeat experiment would show a 60-
80% survival on 500µM seleno-l-methionine after the same exposure (Figure 2-Spectrum). 
Variability was observed both from lot to lot and from day to day, although it is unknown if the 
stability of SeMet was an issue. This led us to test seleno-L-methionine from multiple suppliers 
to find a more stable source. As shown in Figure 2, animals still had a greater than 50% normal 
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motility rate after 72 hours of selenium exposure from two different sources despite earlier 
experiments that demonstrated nearly 100% mortality at this time point. While all sources of 
SeMet induced statistically significant mortality and paralysis compared to untreated animals 
(p<0.05), no source of SeMet was found that gave reproducible toxicity.  
Methodological testing of various potential factors including temperature, age of plates, 
age of food source, and remaking/replacing each plate component, also failed to identify the 
source of this variability (data not shown). Subsequent experiments use 5mM sodium selenite as 
the selenium source due to the reproducible steady decline in movement over 96 hours at that 
concentration (Figure 1B).  
 
 
Figure 2 Seleno-L-methionine variability 
Organic selenium from two sources (Spectrum Chemical and Sigma-Aldrich) was variable as to the 
severity of toxicity. Fifty developmentally synchronized N2 hermaphrodites were placed on standard NGM 
plates treated with 500μM seleno-l-methionine from either Spectrum Chemical or Sigma-Aldrich. Animals 
were scored at 24 hour intervals normal movement compared to paralysis and death. Statistically analysis 
was performed using a one-tailed student’s t-test with unequal variance as described in Materials and 
Methods Section 2.3.9 by comparing selenium treated animals to untreated animals at the corresponding 
time points.  The graph above is a compilation of 3 populations (n=150). 
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2.4.2 Selenium causes progressive movement problems 
Observation of selenium-treated animals resulted in the identification of an additional movement 
deficit that was not seen in the controls. In addition to high selenium leading to paralysis and 
death, animals displayed a backing problem. Animals would move forward normally when 
touched on the tail but would fail to reverse direction when tapped on the head. There also 
appeared to be a progressive order of these behaviors. The number of individual animals that 
were observed to have a backing problem at one time point was similar the number of individual 
animals that were paralyzed at the next time point. Similarly, the number of individual animals 
that were observed to be paralyzed one day would be dead the next day. Because of this 
correlation, we hypothesized that there was a progressive order to these behaviors. Initially after 
selenium exposure, animals behaved as untreated animals, moving forward and reversing 
directions upon tapping the tail and head, respectively. After some time, animals would fail to 
reverse direction when touched on the head after they had been stimulated to move forward by a 
touch to the tail. Eventually, animals would slow or fail to respond to the touch (paralyzed) but 
were still alive as determined by the pharyngeal bulb pumping. Lack of pharyngeal bulb 
pumping was used to determine that the animal had died.  
To determine whether the observed behaviors were progressive in response to exposure 
to selenium, single age-synchronous adult animals were scored for movement deficits at 6 hour 
intervals after being placed on NGM plates treated with 5mM sodium selenite. Table 1 
demonstrates that the observed movement deficits, abnormal backing, paralysis, and death, 
occurred in a stereotypic order, suggesting they represent progressive nervous system injury. For 
example, in Table 1, Animal 3 behaved normally for 24 hours. Six hours later, the animal 
displayed backing problems and 6 additional hours after that the animal became paralyzed, and 
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six hours after that, the animal was dead. Animal 10 displayed a much different temporal 
development of movement deficits on selenium. The animal behaved normally for only the first 
6 hours. Afterwards, the animal displayed a backing problem for the remainder of the assay. 
However, not all animals developed backing deficits within the time points observed. For 
example, Animal 11 never displayed the backing problem (or it progressed too rapidly to be 
observed at the set time points for this assay) and progressed to paralysis and death during the 
observed 6 hour intervals. The variability in the timetable in which animals developed scoreable 
movement deficits led us to represent selenium induced injury as the number of animals 
remaining fully motile. These studies demonstrate that even within a developmentally 
synchronized, clonal population of animals, individual animals progress to more severe deficits 




Table 1 Progressive movement deficits observed after selenium exposure  
Selenium exposure causes a progressive sequence of movement deficits. Twenty wild-type N2 
hermaphrodites were placed on individual NGM plates and scored as normal (N) forward and backward 
movement in response to touch; failure to back (B) in response to touch; paralysis (P) the failure to 
complete one sinusoidal turn with in 5 seconds of being touched, and death (D) as failure to respond to 
touch and lack of pharyngeal pumping at 6 hour intervals. Untreated wild type animals do not display this 
progression of behavioral deficits (data not shown). 
Animal # 6hr 12hr 18hr 24hr 30hr 36hr 42hr 48hr 
1 N N N N N B B P 
2 N N N N B B B B 
3 N N N N B P D D 
4 N N B B B B B B 
5 N N B B B B B B 
6 N N B B B B P P 
7 N N B B B P P P 
8 N N B B B P D D 
9 N N B B B D D D 
10 N B B B B B B B 
11 N P D D D D D D 
12 B B B P P P P P 
13 B P D D D D D D 
14 B P D D D D D D 
15 P D D D D D D D 
16 P D D D D D D D 
17 P D D D D D D D 
18 P D D D D D D D 
19 P D D D D D D D 
20 D D D D D D D D 
 
The observed movement deficits also suggest that selenium is either damaging the 
nervous system or causing muscle damage sufficient to impair movement, or both. Part of our 
movement assay mirrors a previously described assay used to map the mechanosensory circuit in 
C. elegans (Kaplan and Horvitz 1993). In their assay, a “soft” touch using an eyelash to touch on 
the head to reverse was used as a behavioral assay for investigating which ciliated neurons were 
involved in avoidance. Genetic mutants and laser ablation of individual neurons identified as 
ASH, FLP, and OLQ as being necessary for “soft” touch avoidance (Kaplan and Horvitz 1993).  
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Similar assays have been used to determine the specific neurons required for backing. 
Forward and backing movement in response to touch involves sensory neurons, interneurons, 
and motor neurons (Wicks and Rankin 1995). Using a platinum wire to deliver a “harsh” touch, 
laser ablation studies have shown PVD neurons to be involved in backing (Way and Chalfie 
1989; Ernstrom and Chalfie 2002). Therefore, the current understanding of the regulation of 
backward movement suggests that backing deficits induced by selenium exposure are due to 
neurons being damaged.   
The slow progression of movement dysfunction (i.e., in worm life-span terms given the 
fact that they go from egg to adult in 3.5 days and live 2 weeks in well-fed conditions) from 
backing to the observed paralysis and eventual death suggests that cellular damage accumulates 
over time (Brenner 1974). This notion of progressive, cumulative neuronal damage leading to 
movement deficits mirrors the disease course of the motor neuron disease ALS. Intriguingly, an 
epidemiologic study has shown that long-term exposure to selenium in the drinking water is 
associated with an increased risk of sporadic ALS, suggesting that selenium could be one 
environmental risk factor for developing this disease (Vinceti et al. 1996; Cleveland and 
Rothstein 2001).   
2.4.3 Temperature alters C. elegans sensitivity to selenium 
C. elegans can be grown at different temperatures, with the most common temperatures being 
20°C and 25°C. Twenty-degrees Celsius is considered to be a permissive temperature, at which a 
majority of experiments reported in the literature are performed, while twenty-five degrees 
Celsius is considered as a non-permissive and is used to induce metabolic stress. Wild-type 
animals grow faster, have a shorter lifespan, and have a smaller brood size at the non-permissive 
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temperature (Klass 1977). Certain mutant phenotypes are enhanced or only expressed at the 
higher temperature. For example, animals with the reduction-of-function mutation in the gene 
encoding an insulin-like receptor, daf-2, enter an alternate development larval stage when grown 
at a non-permissive temperature (Riddle 1977). Although the mechanisms by which higher 
temperature cause these phenotypic changes are likely complex, increased metabolism resulting 
from increased oxidative stress may be one of its most important factors.  
Selenium is also known to cause oxidative stress (Seko and Imura 1997; Shen et al. 1999; 
Verma et al. 2004). We have found that increased temperature enhanced selenium toxicity in C. 
elegans roughly three-fold (Figure 3, p<0.001). Given the pro-oxidative affects of excess 
selenium and the increased temperature in C. elegans, our results suggest that selenium induced 
movement deficits are caused by oxidative damage. If true, the decreased survival at higher 
temperature may be due to an increase in damage from oxidative stress. Consistent with this 
hypothesis, mutations in DAF-2 have been shown to control a large number of genes, including 
antioxidant and antimicrobial proteins (McElwee et al. 2003; Murphy et al. 2003; Oh et al. 
2006). C. elegans lifespan in wild-type animals can be extended by treatment with superoxide 
dismutase and catalase mimetics (Sampayo et al. 2003). Similarly, co-enzyme Q10 has been 
shown to extend lifespan by lowering oxidative stress and quercetin, a component of Gingko 
biloba leaf extract, has also been shown to extend lifespan in C. elegans by reducing oxidative 




 Figure 3 Increased temperature accelerates movement deficits caused by selenium toxicity 
Increasing the temperature to non-permissive conditions accelerates the movement deficits caused by 
selenium toxicity. N2 animals were grown at 20°C and 25°C on NGM plates. Twenty developmentally 
synchronized N2 hermaphrodites were placed on NGM plates treated with 5mM sodium selenite as adults 
and returned to either 20°C or 25°C. Animals were scored at 24 hour intervals for movement deficits as 
described in Section 2.3.4. Statistical analysis was performed as described in Section 2.3.9 comparing 
selenium treated animals at 20°C to 25°C. Animals grown and treated with selenium at 25°C were 
significantly more sensitive to selenium at all three time points (p<0.001 at 24 and 48 hours,  p<0.005 at 72 
hours). The graph above represents 6 plates with 20 animals per plate (n=120). Untreated animals at 20°C 




2.4.4 Selenium toxicity does not require bacterial metabolism (in collaboration with Nate 
Szewczyk) 
In their natural habitat, the soil, C. elegans ingest a variety of bacteria. However, under 
laboratory conditions, the C. elegans food source is an auxotrophic strain of E. coli, OP50 
(Brenner 1974). While this contributes to the ease of culturing animals, it has also caused 
problems. Bacterial metabolism has been a limiting factor in using C. elegans for drug screens 
due to the bacteria metabolizing the drug before it can reach the animals (Kaletta and Hengartner 
2006). A recently developed chemically defined liquid medium known as C. elegans 
Maintenance Medium (CeMM) provided us with a method of addressing the role, if any, of 
bacterial metabolism on selenium toxicity (Szewczyk et al. 2003).   
Essentially, if bacterial metabolism contributes to selenium toxicity by metabolizing 
sodium selenite into by-products that are the real toxic factor, selenium should be non-toxic to C. 
elegans in CeMM. We worked with a collaborator using CeMM to address the role of bacterial 
metabolism in selenium toxicity (Szewczyk et al. 2003). Four populations of one hundred 
animals were grown in either normal CeMM or CeMM supplemented with 5mM sodium 
selenite. Looking at survival only, sodium selenite treated animals had a 29.75%±11.81 survival 
after 24 hours where the untreated controls had a 100% survival (p<0.001) demonstrating that 
bacterial metabolism is not required for selenium toxicity in C. elegans.  
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2.4.5 Calcium increases selenium toxicity 
Calcium has been shown to be a central cellular signal involved in cell death induction in 
vertebrate models. Multiple lines of evidence have demonstrated that induction of cell death is 
closely linked to the regulation of intracellular calcium (Ca2+) levels in the vertebrate nervous 
system. For example, in the presence of apoptotic stimuli, calcium influx through the IP3 and 
ryanodine receptors can activate of calpain, calcineurin, and subsequent activation of apoptosis  
(Hajnoczky et al. 2000). 
To determine whether calcium levels might play a role in the toxicity of selenium in C. 
elegans, developmentally synchronized N2 populations were grown on standard NGM (with a 
final Ca2+ concentration of 1mM) plates and minimal Ca2+ plates (without an additional Ca2+). 
Animals were transferred as adults to plates containing the equivalent calcium concentration that 
they were grown on, with or without 5mM NaSe (i.e., the concentration of NaSe that leads to 
approximately 50% paralysis over 48 hours). Growth and movement of non-selenium treated 
animals on NGM plated with and without calcium supplementation did not lead to any 
significant movement deficits over the 4 day interval of the experiment. However, selenium 
treated animals that were grown on NGM plates containing 1mM calcium showed a 2-fold 
increase in the emergence of movement deficits (Figure 4). By 48 hours of selenium treatment, 
significantly more animals had movement deficits on calcium plates (Figure 4, p<0.05), a trend 
that became more prominent by the 72 hour time point (Figure 4, p<0.005). Also, NGM plates 
contain 25mM phosphate, which chelates free Ca2+, making the actual concentration of Ca2+ well 
below 1mM. Even with such low levels, there was a detectable difference in an animal’s 
sensitivity to selenium when they were grown on the different Ca2+ concentrations. Given the 
relationship of selenium and motor neuron disease and the increased calcium observed in motor 
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neurons of ALS patients, it is possible that evolutionarily conserved cell toxicity mechanisms are 
related to the movement deficits induced by selenium exposure in C. elegans (Siklos et al. 1996).  
  
 
Figure 4 Calcium enhances selenium toxicity 
Increased calcium levels increase the rate at which movement deficits were observed after treatment with 
selenium. No difference in survival was observed at 24 hours. Significant differences in survival were 
observed at the remaining time points. (48hours: p<0.005, 72hours: p<0.005, 96hours p<0.05). 
Developmentally synchronous wild-type N2 hermaphrodites were placed on NGM plates containing 
minimal calcium or 1mM calcium (1mM Ca+) in addition to 5mM sodium selenite. Animals were scored at 
24 hour intervals for movement deficits as described in Section 2.3.4. Statistical analysis was performed 
using a one-tailed student’s t-test with unequal variance as described in Section 2.3.9, comparing minimal 
calcium to 1mM calcium at the corresponding time points. Significance is indicated on the graph as * 
(p<0.005) or ** (p<0.05). This graph represents six populations of 20 animals per population (n=120). 





2.4.6 Cell death mutants are not resistant to selenium exposure 
Programmed cell death I, or apoptosis, was first identified in C. elegans by identifying mutants 
that prevented death of cells that normally die during development (Ellis and Horvitz 1986). The 
C. elegans ortholog of mammalian caspase, ced-3, and the ortholog of mammalian APAF 
(Apoptotic Protease Activating Factor), ced-4, are responsible for the killing phase of apoptosis, 
and loss-of-function in either of these genes results in survival of cells that would normally 
undergo developmental apoptosis (Ellis and Horvitz 1986; Yuan and Horvitz 1992). ced-9, the C. 
elegans ortholog of mammalian BCL-2, inhibits cell death and the loss-of-function of ced-9 
causes embryonic lethality (Hengartner et al. 1992). These three genes have been shown to act in 
a simple pathway, where ced-9 is upstream of ced-4, inhibiting cell death (Hengartner et al. 
1992; Conradt and Xue 2005). ced-3 is downstream of ced-4, both promoting developmental cell 
death (Yuan and Horvitz 1992; Conradt and Xue 2005). Yet another player in cell death 
regulation is cep-1, the C. elegans ortholog of p53, which is a tumor suppressor that has been 
shown to be involved in DNA repair and apoptosis.  Loss-of-function of the gene results in 
animals that are sensitive to hypoxia and have decreased longevity as a result of starvation-
induced stress (Derry et al. 2001).  
To test this hypothesis that programmed cell death is responsible for the movement 
deficits and organismal death caused by selenium exposure, three strains containing mutations in 
genes involved in the final stage of apoptotic cell death ced-3(n717), ced-4(n1142), ced-9(n1950) 
were tested for altered resistance/sensitivity to 5mM sodium selenite. The ced-3 and ced-4 
mutants tested are loss-of-function mutants, and the ced-9(n1950) contains a point mutation that 
results in a gain-of-function phenotype (i.e. the mutation results in increased survival of cells that 
would normally undergo apoptosis) (Ellis and Horvitz 1986; Yuan and Horvitz 1992; Hengartner 
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and Horvitz 1994). Interestingly, animals containing mutations for apoptotic genes were found to 
have significantly increased sensitivity to high selenium relative to N2 (ced-3, ced-4, and ced-9, 
in Figure 5, p<0.001 by a student’s t-test comparison of the percentage of the population without 
movement deficits in N2 versus cell death mutant strain). Similarly, cep-1(gk138) was also found 
to be more sensitive (Figure 5, p<0.01 at 24 hours). This suggests that apoptosis that was defined 
by developmental cell death is not involved in cell death caused by selenium.  
Since developmental apoptosis does not appear to be involved in selenium toxicity, we 
then hypothesized that necrosis could be involved. Expression of the C. elegans ortholog of 
calreticulin, crt-1, is induced by stress and CRT-1 has been shown to bind to calcium and 
suppress heat induced protein aggregation. Reduction-of-function mutants of calreticulin in C. 
elegans have been shown to block necrosis (Smith 1992; Park et al. 2001; Xu et al. 2001). Wild-
type animals treated with NaSe develop movement deficits that progressively proceed to 
paralysis and eventual death. Since these movement deficits suggest loss of neurons, we 
hypothesize that necrosis is induced by selenium exposure.  
One of the final steps in necrosis involves release of cathepsin D from the lysosome, 
which contributes to cellular degradation leading to cell death (Kourtis and Tavernarakis 2007). 
If a cell was dying by necrosis, decreased cathepsin D expression should result in increased 
survival. However, animals that contained mutations that caused reduced cathepsin D expression 
also had significantly increased sensitivity to selenium (Figure 5, cad-1(j1) and cad-1(j13), 
p<0.001 at 24 hours). Null mutations of calreticulin have been shown to block necrosis induced 
by the degeneration mutation (Xu et al. 2001). The reduction-of-function mutant for calreticulin 
(crt-1) was also found to be sensitive to selenium (Figure 5, p<0.001 at 24 hours). These data 
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Figure 5 Animals containing mutations for apoptotic and necrotic cascades have increased sensitivity 
to selenium. 
Animals containing mutations in genes involved in cell death cascades are not resistant to selenium. 
Mutants tested included; cad-1(j1) which has 90% reduced Cathepsin D expression, cad-1(j13) which had 
30% reduced cathepsin D expression, ced-3(n717) an ortholog of mammalian caspase, ced-4(n1162) an 
ortholog of mammalian APAF, ced-9(n1950) an ortholog of mammalian BCL-2, cep-1(gk138) an ortholog 
of p53, and crt-1(jh101) an ortholog of calreticulin. All mutants were found to have a statistically increased 
sensitivity to selenium at the 24 hour and 48 hour time points. Twenty developmentally synchronized adult 
hermaphrodites were placed on NGM plates treated with 5mM sodium selenite and scored at 24 hour 
intervals for movement deficits described in Section 2.3.4. Statistical analysis was performed using a one-
tailed students T-test with unequal variance as described in Section 2.3.9 comparing mutants strains treated 
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with selenium to wild-type populations (N2). Significance was indicated on the graph as * (p<0.01) or ** 
(p<0.001). The graph above is the average of three populations of 20 animals per population (n=60). The 
experiment was repeated three times with similar results.  Non-selenium treated animals had greater than 
90% normal movement after 96 hours (data not shown).  
2.4.7 Weak bases do not protect wild-type animals from selenium damage  
Necrosis, a type of cell death, is characterized by cellular swelling and subsequent 
membrane rupture and secondary inflammation. Cells undergoing necrosis cell develop 
decreased cytoplasmic pH, demonstrating that the pH shift is integral to necrotic death. 
Consistent with this, reduction-of-function mutations in a vacuolar H+-ATPase that regulates 
acidification of the intracellular compartment protects against necrosis induced by the 
degeneration cascade (Syntichaki et al. 2005). Similarly, increasing intracellular pH by utilizing 
lysotropic bases such as ammonium chloride and acridine orange can alleviate necrotic cell death 
in the same neurodegeneration model (Artal-Sanz et al. 2006).  
To determine whether necrosis is involved in wild-type N2 animals dying from selenium 
exposure, animals were also exposed to weak bases to prevent cellular acidification. Animals 
were simultaneously exposed to 5mM sodium selenite and 5mM ammonium chloride and 50μM, 
100μM, and 150μM acridine orange, concentrations that were found to suppress MEC-4(d) 
degeneration in C. elegans (Artal-Sanz et al. 2006). Animals scored at 24 hour intervals for the 
movement deficits described in Section 2.3.4 demonstrated that NH4Cl and acridine orange 
conferred no protection against the selenium-induced movement deficits and mortality (Figure 6, 
p>0.05 as determined by a student’s t-test comparing the percent of the population that did not 
exhibit movement deficits with and without weak bases).  
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The motility of animals exposed to 5mM ammonium chloride, a concentration that was 
found to suppress MEC-4(d) degeneration in C. elegans, in addition to selenium were found to 
be statistically the same as animals treated only with selenium at all time points (Figure 6, 
p>0.05) (Artal-Sanz et al. 2006). Similarly, the motility of animals treated with selenium and 
50μM acridine orange were also not different statistically when compared to selenium treated 
animals (Figure 6, p>0.05). Animals treated with selenium and 100μM and 150μM acridine 
orange were found to have significantly decreased survival by the 24 hour time point compared 
animals treated with selenium alone. These data suggest that lysosomal degradation is protective 
against selenium induced movement deficits and death and shows that necrosis is not the 
etiology of these deficits.  
 
   
Figure 6 Weak bases do not protect from selenium toxicity 
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Treatment of wild-type animals exposed to lysotropic bases (acridine orange and ammonium chloride) does 
not protect animals from selenium damage. Significant increases in movement deficits was observed at the 
24 hour and 96 hour time points of 100μM and 150μM acridine orange (p<0.05). Twenty developmentally 
synchronous wild-type animals were placed on NGM plates treated with 5mM sodium selenite and either 
5mM NH4Cl, 50μM acridine orange, 100μM acridine orange, or 150μM acridine orange and scored at 24 
hour intervals for movement deficits as described in Section 2.3.4. Statistical analysis was performed as 
described in Section 2.3.9 using a 1-tailed student’s t-test comparing each populations treated with NaSe + 
base to NaSe-treated populations with significance indicated as * on the graph. The graph above is the 
average of 3 populations of 20 animals per population (n=60). The experiment was repeated two times with 
similar results. Non-selenium treated animals exposed to 5mM NH4Cl, 50μM acridine orange, 100μM 
acridine orange, and 150μM acridine orange had greater than 90% normal movement at 96 hours (data not 
shown). 
 
2.4.8 ROS detection 
Existing literature has shown that when some forms of selenium are combined with reduced 
glutathione, superoxide anions can be detected (Seko and Imura 1997; Spallholz 1997). Since 
selenium is known to produce superoxide anions, we predicted that selenium exposure might 
cause a detectable increase in levels of ROS in our model. Using a peroxide sensitive dye, 
H2DCFDA, we assayed levels of ROS in populations of N2 and selenium exposed populations of 
N2. Essentially, age-synchronous adult animal populations were placed on NGM plates with 
H2DCFDA or NGM plates with H2DCFDA and 5mM sodium selenite. These plates were 
incubated at 20°C for 6 hours and then the animals were washed off the plates and the oxidation 
of H2DCFDA was visualized by observing green fluorescence (Figure 7A or 7B) or quantified 
(Figure 7C). The six hour time point was chosen to allow enough exposure to selenium to cause 
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selenium-induced damage but not enough time where a large fraction of the animals were dead 
(Table 1). Selenium-treated animals have a visually observed increase in green fluorescence 
(Figure 7B) when compared to non-selenium treated control animals (Figure 7A-images were 
captured using equivalent exposure times) after 6 hours of selenium exposure. When quantified, 
0.2% of non-selenium-treated animals were positive for green fluorescence while 4.4% of the 
selenium-treated population was positive, a twenty-fold increase, demonstrating that an increase 




Figure 7 Selenium toxicity causes an increase in ROS 
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Wild-type animals treated with 5mM sodium selenite have increased levels of ROS when compared to 
untreated animals. Developmentally synchronized adult wild-type animals were transferred to NGM plates 
containing 50uM carboxy-H2DCFDA (Invitrogen, Carlsbad, CA) with and without 5mM sodium selenite. 
(A) An untreated animal examined around the vulva. White arrowhead is pointing to the vulva. Yellow 
arrow is pointing to an egg that has been expulsed by the animal. (B) N2 animal after 6 hours of selenium 
treatment. White arrowhead is pointing to the vulva. Note: despite the extra pressure from the cover slip 
and extra eggs being retained, no eggs have been extruded (will be addressed in Chapter 3). (C) 
Quantification of green fluorescent positive animals in the population. Selenium treatment results in a 
twenty fold increase in green fluorescent animals in the population. (control: n=893, selenium treated: 
n=481). 
  
2.4.9 Movements deficits caused by selenium toxicity can be alleviated by antioxidants 
Selenium is often considered to be an antioxidant since selenocysteine occupies the active site of 
glutathione peroxidase, an enzyme that catalyzes the breakdown of hydrogen peroxide into water 
and oxygen (Behne and Kyriakopoulos 2001). However, as noted before, multiple sources of 
evidence suggest that selenium causes oxidative damage (Kitahara et al. 1993; Seko and Imura 
1997; Spallholz 1997; Shen et al. 1999; Verma et al. 2004; Deore et al. 2005; Seitomer et al. 
2008). Given these studies, we hypothesized that co-treatment with antioxidants might alleviate 
the movement deficits caused by exposure to high selenium.  
Vitamin E (α-tocopherol), reduced glutathione, and quercetin were tested for their ability 
to suppress movement deficits and death caused by exposure to selenium. Vitamin E (or α-
tocopherol) has a well documented history with selenium, since the essential nature of selenium 
was understood only when researchers found that it could suppress liver damage that resulted 
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from a vitamin E deficient diet (Schwarz and Foltz 1999). Reduced glutathione was tested 
because it is a cofactor for glutathione peroxidase and has been shown to alleviate selenium 
toxicity in a vertebrate model (Deore et al. 2005). Quercetin is a flavinoid which has been the 
focus of growing interest in medical research, as it has been shown to be a free radical scavenger, 
prevents lipid peroxidation, suppress ROS production, as well as having numerous 
neuroprotective effects (Smith and Luo 2003).  
To determine whether the above mentioned antioxidants could suppress the behavioral 
deficits observed from selenium exposure, developmentally synchronized adults were placed on 
NGM plates with increasing concentrations of the antioxidants with and without 5mM sodium 
selenite. The concentrations that provided the maximum protection are graphed in Figure 8. As 
would be predicted by the increased ROS detected by H2DCFDA in Figure 7, these studies show 
that quercetin, reduced glutathione, and vitamin E all conferred significant protection against 
selenium as observed by increased observation of normal motility (Figure 8A p<0.05 at 24hours, 
8B p<0.05 at 24 hours, and 8C p<0.005 at 48 hours). Given these findings, it is possible that the 
movement deficits and mortality that we observe are due to increased oxidative cellular damage.  
The damage may occur predominantly or exclusively in neurons or muscle, an issue that we will 
address in a subsequent chapter. These experiments were performed separately, which makes it 
difficult to approximate each antioxidants relative protection from selenium to another. α-
tocopherol was dissolved in ethanol and was observed to precipitate into oil-like drops on the 
surface of the plates, resulting in variable exposure of the antioxidant to individual C. elegans. 
However, under the conditions tested, quercetin provided the best protection from selenium, with 
significant increases in normal motility when compared to selenium-treated animals observed at 
24 hours, 48 hours, and 72 hours. 
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Figure 8 Antioxidants partially suppress selenium induced movement deficits 
Co-treatment with one of three antioxidants, quercetin, reduced glutathione, and α-tocopherol (vitamin E) 
was found to partially, but significantly suppress the movement deficits caused by selenium exposure. (A) 
800 μg/ml of quercetin was found to significantly suppress the movement deficits at the first three time 
points (24 hours: p<0.05, 48hours: p<0.005, 72hours: p<0.05) (B) 200μg/ml of reduced glutathione was 
found to significantly suppress the movement deficits at the 24 hours time point (p<0.05) (C) 200 μg/ml of 
α-tocopherol was found to significantly suppress the movement deficits at three time points (48hours: 
p<0.005, 72hours: p<0.005, 96hours: p<0.05). Twenty developmentally synchronized wild-type 
hermaphrodites (N2) were placed on NGM plates treated with the specified antioxidant and 5mM sodium 
selenite and scored at 24 hour intervals for movement deficits described in Section 2.3.4. Statistical 
analysis was performed as described in Section 2.3.9 using a one-tailed student’s t-test with unequal 
variance, comparing selenium co-treatment with an antioxidant to selenium treatment alone. Significance is 
indicated on the graph as either * (p<0.05) or ** (p<0.005). Non-selenium treated controls (including the 
corresponding vehicle as NaOH control for quercetin and EtOH control for α-tocopherol) had greater than 




Here, we show that inorganic and organic forms of selenium are toxic in C. elegans, as has also 
been reported in vertebrate models (Panter et al. 1996; Usami and Ohno 1996). Further, we 
identified a series of movement deficits that occur progressively in response to selenium 
exposure that suggests that neurons are being damaged. These movement deficits mimic deficits 
observed in a vertebrate model of selenium toxicity and some symptoms of human ALS patients 
(Kuncl et al. 1988; Panter et al. 1996). We further demonstrate that exposure to selenium causes 
an increase in ROS, contributing to toxicity. Other factors that we investigated are more 
complicated in their overall implications, specifically the role of calcium in selenium exposure 
and mechanisms of cell death.  
 
2.5.1 Bacterial metabolism and selenium toxicity 
Bacterial metabolism was found not to be a factor contributing to selenium toxicity. 
However, bacterial metabolism may be protecting animals from selenium. In CeMM, the average 
survival in a population after 24 hours was 30% whereas 24 hours on NGM plates result in 
greater that 50% survival in the population (Figures 1B and 3). Additionally, bacterial 
metabolism has been shown to alter lifespan in C. elegans (Saiki et al. 2008). While not formally 
tested, evidence for a potential protective affect from bacterial metabolism was observed when 
sodium selenite was added to seeded (with OP50 as a food source) and unseeded (no OP50) 
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plates. Unseeded plates did not change color while seeded plated turned orange over time. This is 
significant because elemental selenium is know to be orange in color and significantly less toxic 
(Nuttall 2006). It is likely in this case that bacterial metabolism is providing a protective function 
by metabolizing sodium selenite into elemental selenium or by altering the pH of the plate, 
causing selenium to precipitate into its elemental form. This could also explain the large 
variability of toxicity observed between experiments, and between individual plates throughout 
this dissertation. While it was determined that bacterial metabolism was not necessary to observe 
the toxic effects of selenium, it was not determined whether bacterial metabolism could have 
provided protection. This could be examining wild-type animals for movement deficits on UV 
irradiated seeded plates (plates containing OP50 as a food source) and comparing them to non-
irradiated plates treated plates, both containing selenium. Another possible test would involve 
altering the pH of the media and test for changes in animal’s movement deficits when exposed to 
selenium. 
 
2.5.2 Potential role of calcium in selenium toxicity 
In these studies we have shown that exposure to high levels of selenium gives rise to a 
progressive paralysis in the genetic model C. elegans as in a previous vertebrate experimental 
model (Panter et al. 1996).  This paralysis was dose-dependent, suggesting a direct association 
between selenium exposure and the subsequent neuronal or muscle damage leading to 
paralysis. Our results also suggest that pre-existing stores of intracellular calcium exacerbate 
selenium toxicity and that elevated calcium levels may act as a co-toxin. If this model is 
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correct, increased levels of calcium during selenium exposure may represent an environmental 
factor influencing the severity of toxicity.   
Ongoing and future work from this observation has involved testing animals containing 
mutations in genes involved in calcium regulation for altered sensitivity to selenium. Mutants 
being tested for altered sensitivity include L-type calcium channel (egl-19 gf and rf), IP3 
receptor (itr-1(rf)), ryanodine receptor (unc-68(rf)), and calcineurin (tax-6(rf)). Differential 
sensitivity/resistance to a gain- or loss-of-function in egl-19 will help us elucidate the role of 
calcium in response to selenium toxicity. Given our results with calcium enhancing selenium 
toxicity (Figure 4), we hypothesize that gain-of-function mutations which increase the flow of 
calcium and subsequently, calcium signaling, will enhance the emergence of the movement 
deficits caused by selenium exposure, while reduction-of-function mutations which decrease 
calcium signaling, will suppress the emergence of these movement deficits. Intriguingly, 
increased calcium has been implicated in the pathology of sporadic ALS and a SNP of the IP3 
receptor has been implicated in sporadic ALS (Siklos et al. 1999; van Es et al. 2007).  This 
hypothesized role for calcium in a motor neuron disease is not surprising, given that calcium is 
involved in a variety of cell death mechanisms (Hajnoczky et al. 2000; Arundine and 
Tymianski 2003).  The potential implication here is that calcium signaling increases the 
emergence of the observed movement deficits in response to selenium exposure, and similar 
alterations in calcium signaling have been implicated in sporadic ALS, adding to the possibility 
that selenium toxicity could be used to model sporadic ALS. 
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2.5.3 Cell death caused by selenium toxicity 
Although mutations preventing apoptosis are available in C. elegans (e.g., ced-3(rf),  ced-
9(gf), and ced-4(rf)), these mutations actually paradoxically enhanced the emergence of selenium 
induced movement deficits resulting in mortality. There are several potential problems with the 
interpretation of our data that have been addressed by the experiments in this chapter. The data 
suggests at least superficially that neither classical apoptotic nor necrotic mechanisms are the 
cause to the movement deficits and mortality seen in selenium exposed animals. In fact, the data 
paradoxically suggest that apoptosis and necrosis are protective. 
An alternative explanation for these results is that in the absence of apoptotic pathways, 
there is a super-physiologic enhancement to necrotic and autophagic (programmed cell death II) 
cell death mechanism. Conversely, in the absence of key proteins required for necrotic-mediated 
cell death, apoptotic pathway proteins maybe super-physiologically active. Hence, it may not be 
as simple as the notion that both apoptotic and necrotic signaling pathways somehow confer 
protection. One way to address this conundrum would be to make a cad-1(rf);ced-3(rf) double 
mutant and test its sensitivity to selenium. However, again an alternative cell death mechanism 
(autophagy) may be “hyper-activated” in the absence of normal apoptotic and necrotic signals 
leading to increased selenium sensitivity. The potential for developmental effects on viability in 
general in the absence of these two pathways can also not be discounted. Future work will 
attempt to address these issues further using inducible RNAi inactivation of apoptotic and 
necrotic pathway genes in adults. Despite these problems, our data clearly show that selenium-
induced oxidative stress gives rise to the movement deficits and mortality in our model. In 
addition, given our results with necrotic and apoptotic pathway genes, it is likely that individuals 
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with mutations in these genes may have altered susceptibility to selenium exposure in the 
environment. 
Another mechanism of cell death, autophagic cell death or programmed cell death II, was 
not investigated here. However, autophagy is not only a cell death mechanism but is involved in 
cellular degradation and organelle turnover (Gozuacik and Kimchi 2004). One hypothesis for 
this process would be that increasing autophagy would be protective by degrading oxidized 
proteins/organelles damaged by selenium exposure. Indeed, ongoing studies in the lab 
investigating genes encoding proteins required for formations of the autophagosome complex 
suggests autophagy protects against selenium-induced movement deficits and death, as has been 
shown for the C. elegans model of Huntington’s disease (Jia et al. 2007). In addition, these data 
are consistent with my findings that decreased cathepsin D function, an autophagy-related 
protease, increases the rate at which movement deficits emerge when exposed to selenium 
(Figure 5).  
2.5.4 Conclusion 
This chapter provided insight into mechanisms of selenium toxicity by identifying 
environmental factors that provide insight into potential signaling mechanisms (like calcium). 
Here, we also demonstrated that canonical cell death mechanisms are not involved in the 
observed movement deficits and mortality. Finally, we have observed an etiology behind 
selenium toxicity, an increase in reactive oxygen species. This was further confirmed by partial 
suppression of movement deficits and mortality by treatment with multiple antioxidants.  
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3.0  SELENIUM TOXICITY AND NEURONAL DAMAGE 
3.1 ABSTRACT 
Selenium is an essential nutrient that has been demonstrated to cause motor neuron damage in 
vertebrates and has been epidemiologically linked to the motor neuron disease, ALS. Here, 
treatment with high selenium is observed to cause neuronal swelling in the genetic model C. 
elegans, while gross morphology of muscle fibers is unchanged. In addition, selenium exposure 
was found to cause an increase in cytosolic muscle protein catabolism that could be suppressed 
by acetylcholinesterase inhibitors and nicotinic agonists, demonstrating cholinergic denervation. 
Further, selenium-damaged animals were found to have a decrease in cholinergic signaling, 
demonstrating motor neuron damage. Selenium was also shown to cause neuronal damage to a 




Selenium toxicity has been repeatedly shown to cause decreased fertility and developmental 
defects in wildlife (Ohlendorf et al. 1986; Lemly 1997; Lemly 2004). Excess selenium exposure 
has also been found to cause neuronal damage in developing embryos and adult livestock (Panter 
et al. 1996; Usami and Ohno 1996). Post-implantation rat embryos treated with various forms of 
selenium were all found to develop abnormalities in the nervous system, ranging from swollen 
rhombencephalon, small/swollen optic vesicles, deformed otic vesicles, hypoplastic 
telencephalon, and a zigzag neural tube (Usami and Ohno 1996).  
Comparisons of selenium toxicity in livestock revealed that all forms of selenium led to 
behavioral indications of nervous system damage, ranging from posterior ataxia to complete 
paralysis (Panter et al. 1996). Post-mortem analysis of the spinal cord and brain of these animals 
found a positive correlation between the behavioral abnormalities indicating nervous system 
damage and the severity of lesions found in the spinal cord (Panter et al. 1996). Interestingly, the 
animals that did not exhibit behavioral abnormalities did have indicators of chronic selenosis 
(hair abnormalities and hoof lesions) and animals that exhibited signs of nervous system damage 
did not have any signs of selenosis, suggesting that distinct damage pathways can be activated by 
this metalloid (Panter et al. 1996). 
Other evidence of neuronal damage from high selenium exposure have been reported 
from numerous cases of accidental selenium poisoning in livestock. Several cases of outbreaks of 
swine paralysis have been linked to excess selenium supplementation in feed (Harrison et al. 
1983; Casteel et al. 1985; Stowe et al. 1992; Casteignau et al. 2006). Post-mortem analysis of 
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these animals revealed loss of motor neurons in the spinal cord that correlated with paralysis. 
Other studies have experimentally reproduced incidents of accidental selenosis in pigs and 
confirmed that excess selenium causes loss of motor neurons in the spinal cord (Harrison et al. 
1983; Wilson et al. 1988). In addition to neuronal loss, other pathological observations included 
gliosis and vacuolation (Harrison et al. 1983; Stowe et al. 1992; Casteignau et al. 2006).  
In addition to the selenium livestock studies, epidemiologic studies have been published 
linking high environmental selenium to the motor neuron disease, ALS. The first study linked a 
cluster of 4 unrelated patients with ALS living in an area with high ground selenium that was 
also known to have animals suffering from blind staggers (Kilness and Hichberg 1977). In 
another formal epidemiologic study, a town was identified that had high inorganic selenium in 
the municipal water supply and increased risk of developing sporadic ALS (Vinceti et al. 1996). 
In a population of 5,182 that was found to have used the water supply continuously for 5 years, 4 
individuals developed sporadic ALS (Vinceti et al. 1996). Analysis of this population was further 
refined to identify a group within the cohort that drank continuously from the municipal water 
supply for 10 years and all 4 ALS cases fell within this group (Vinceti et al. 1996). This is 
significantly higher than the baseline incidence of ALS (1-2 individuals in 100,000) (Cleveland 
and Rothstein 2001).  
In Chapter 2, the movement assay we developed monitored a progressive series of 
movement deficits that mimics an assay developed in a vertebrate model to measure severity of 
nervous system damage caused by selenium toxicity (Panter et al. 1996). This assay detected 
progressive weakness and eventual paralysis and death as is observed in ALS patients (Williams 
and Windebank 1991). However, we did not definitively address whether the observed 
movement deficits were due to muscle or neuronal damage in the model system C. elegans. 
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While paralysis could be a result of muscle damage or neuronal damage, the initial backing 
deficit observed suggests that the neurons are damaged first, as it is a neuronally controlled 
behavior (Way and Chalfie 1989; Wicks and Rankin 1995; Ernstrom and Chalfie 2002). 
Subsequent paralysis could be due to either muscle or neuronal damage.  
Here, we investigate potential neuronal damage resulting from selenium toxicity as 
suggested by the backing deficit that has been used to observe selenium damage in Chapter 2. 
We examine neuronal morphology to determine if selenium exposure causes any alterations in 
structure when compared to untreated animals and found neuronal swelling with a corresponding 
loss in chromatin staining, axonal blebbing along the ventral cord, and egg retention that were 
not observed in untreated controls.  
Similarly, we then examined muscle structure to determine is selenium exposure altered 
the structure and discovered no gross differences in muscle morphology. However, this does not 
reveal the cytosolic state of the muscle cells. Altered cytosolic protein catabolism has been 
demonstrated in a variety of neuromuscular diseases, including ALS (McKeran et al. 1977; Kar 
and Pearson 1978; Corbett et al. 1982). Examination of cytosolic muscle protein revealed an 
increase in protein catabolism that could be suppressed by a nicotinic agonist or by an 
acetylcholinesterase inhibitor, suggesting decreased cholinergic signaling. Further, selenium-
treated animals displaying movement deficits had increased resistance to the cholinesterase 
inhibitor aldicarb, also suggesting a decrease in cholinergic signaling in response to selenium 
exposure. This is significant as cholinergic receptors are decreased in ALS patients (Manaker et 
al. 1988; Berger et al. 1992). In addition, animals paralyzed by selenium exposure hyper-
contracted when exposed to the nicotinic agonist, levamisole, demonstrating that the muscles 
were still functional.  
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Finally, we examined the egg-laying circuit in response to selenium exposure, since 
decreased egg-laying was observed as a result of selenium exposure. Egg-laying provides 
another measure of determining muscle or neuronal damage, since egg-laying is controlled by a 
well-defined circuit which includes uterine muscles and two types of neurons. We observed a 
significant increase in egg-laying that was partially, but significantly, rescued by serotonin, 
demonstrating that the muscles could still function in the egg-laying process. The incomplete 
rescue was then determined to be due to increased apoptosis occurring in the germ line of 
selenium treated animals. The combined data suggest that the phenotypes observed resulting 
from selenium exposure are due to neuronal damage. 
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3.3 METHODS AND MATERALS 
3.3.1 Strains and strain maintenance 
Animals were maintained as described in Section 2.3.1 on nematode growth media (NGM) 
without additional calcium. The following strains were obtained from the Caenorhabditis 
Genetics Center; wild-type N2, RB756: gar-2(ok520)III, and OH441: otIs45(unc-119::GFP). 
Animals expressing myo-3::GFP were a kind gift from Lew Jacobson.  
3.3.2 Nuclear staining of C. elegans 
Developmentally synchronized animals from the strain expressing unc-119::GFP were 
transferred to NGM plates that were untreated or contained 5mM sodium selenite. After 24 
hours, animals were transferred to a microcentrifuge containing 10μg/ml of ethidium bromide 
(EtBr) for 1 hour. Animals were then transferred onto new NGM plates and allowed to recover 
for 1 hour before being analyzed by fluorescence microscopy. 
3.3.3 Fluorescence Microscopy 
Individual animals were analyzed and documented by visualization on a Leica DM IRB 
microscope equipped with fluorescence optics and a DC300F imaging system (Leica 
Microsystems Inc., Bannockburn, IL).  The EtBr staining was visualized using a rhodamine 
filter, while a GFP-specific filter was used for observing both the muscle- and neuron-specific 
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GFP fluorescence.  The images were processed for publication using the Adobe Creative Suite 2 
premium software package (Adobe Systems Inc., San Jose, CA). 
3.3.4 Staining for cytosolic Lac-Z in the muscle (in collaboration with Nate Szewczyk) 
Age-synchronized adult animals with unc-54::lac z fusion were transferred to untreated NGM 
plates or NGM plates supplemented with 5mM sodium selenite for 24 hours. Subsets of these 
control and selenium-treated populations were also co-treated with the nicotinic agonist 
levamisole (1mM) or the cholinesterase inhibitor aldicarb (40μM, 80μM, and 400μM). X-Gal 
staining was performed as previously described (Szewczyk et al. 2000). 
3.3.5 Aldicarb assay to determine pre-synaptic damage 
Developmentally synchronized adult N2 hermaphrodites were plated on 5mM sodium selenite or 
untreated plates as adults and incubated for 24 hours at 20°C. Selenium-treated animals tested for 
aldicarb resistance/sensitivity were animals that failed the backing test. This was to test for 
animals that had minimal damage from selenium since selenium damage was determined to be 
progressive (Table 1). Animals that still moved normally (moved and reversed direction like 
untreated controls) were not included, as they would have skewed the population towards 
aldicarb sensitivity. Also, paralyzed and dead animals were also not included in this assay, since 
it would be difficult to determine if animals were paralyzed/dead due to selenium or aldicarb 
exposure. Untreated controls and selenium damaged animals that failed the backing test of the 
touch assay were plated on 0.5mM aldicarb and were scored for paralysis at 30 minute intervals 
(Mathews et al. 2003). 
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3.3.6 Levamisole assay for determining post-synaptic damage 
N2 animals were developmentally synchronized and treated with 5mM sodium selenite for 24 
hours at 20°C as adults. Animals picked for this assay demonstrated paralysis (failure to 
complete one sinusoidal turn within 5 seconds of touching the tail with a platinum wire). 
Animals with little (backing deficit) to no damage were not included as they were likely to be 
sensitive to levamisole and skew the results toward levamisole sensitivity, resulting in a false 
positive. Animals were plated on 100mM levamisole and examined after 30 minutes for muscle 
hypercontraction. 
3.3.7 Egg-laying assay 
Developmentally synchronized adult wild type N2 or gar-2(ok520)III hermaphrodites were 
plated on 5mM sodium selenite treated and untreated plates and incubated at 25°C. At one hour 
intervals following plating, 10 animals were moved to a new, untreated plate and returned to the 
25°C incubator. After 24 hours on the untreated plates following the selenium treatment, the 
adult animals were removed and the eggs/progeny were counted. As the eggs/progeny were 
counted, they were removed by aspiration. Total egg numbers for each plate were calculated. 
Then the number of eggs was divided by the number of animals on the plate to determine the 
number of eggs per animal. If adult hermaphrodites died, they were removed from the number of 
adult animals on the plate, since they likely died as a result of the transfer.   
 74 
3.3.8 Serotonin treatments for egg-laying 
To determine if the decreased egg laying was due to neuronal or muscle damage, animals were 
treated with the neurotransmitter, serotonin. N2 animals were plated on untreated and 5mM 
selenium treated plates for 6 hours and transferred to a plate containing 3mg/ml of 5-
hydroxytryptamine hydrochloride (5-HT, H2195 Spectrum Chemical, Gardena, CA, USA), for 1 
hour. Afterward, the adult hermaphrodites were removed and the eggs were counted to determine 
the rate of egg-laying per animal per hour in response to serotonin.  
3.3.9 Acridine orange treatment for apoptotic bodies in germ line 
N2 animals were developmentally synchronized and grown to gravid adults. Animals were either 
left untreated or transferred to 5mM sodium selenite containing plates. After 24 hours of 
selenium exposure, animals were transferred to NGM plates containing 0.02mg/ml of acridine 
orange (cat # A3568, Invitrogen, Carlsbad, CA) for one hour (Lettre et al. 2004). Then animals 
were transferred to a new plate for one hour to reduce acridine orange staining in the gut lumen 
and analyzed by fluorescence microscopy for fluorescent puncta.  
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3.4 RESULTS 
3.4.1 Selenium exposure causes gross neuronal damage  
As mentioned in Chapter 2, the behavioral assay that was developed to measure relative 
resistance to high selenium scored normal movement, backing deficits, paralysis, and death. The 
backing deficits suggest that neuronal damage was an early event resulting from selenium 
exposure, since backing is neuronally controlled (Way and Chalfie 1989; Wicks and Rankin 
1995; Ernstrom and Chalfie 2002).  
In order to determine whether selenium caused gross neuronal damage, animals 
expressing green fluorescent protein (GFP) under control of the pan-neuronal promoter for unc-
119 were utilized. Developmentally synchronized animals were treated with 5mM sodium 
selenite as adults. Animals were examined after 24 hours of selenium exposure since 
approximately half of selenium exposed animals have some type of movement deficit at that time 
point (Figure 1B). Neuronal swelling was observed in selenium treated animals that was not 
observed in untreated animals (Figure 9A and 9B). Selenium-treated animals lost a majority of 
chromatin staining in the swollen neurons (Figure 9D) when compared to untreated controls 
(Figure 9C). Further analysis of selenium-treated animals revealed axonal blebbing (Figure 9F) 
that was not present in the control (Figure 9E). In addition, selenium treated animals had more 
eggs including late stage embryos in hermaphrodites (Figure 9H) that were not observed in the 
untreated control (Figure 9G). These observations suggest that selenium toxicity is damaging 
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neurons in adult hermaphrodites, as has been reported with selenium toxicity in vertebrates 





Figure 9 Neuronal morphological damage observed at 24hours of 5mM sodium selenite (NaSe) 
treatment 
Analysis of animals expressing the pan-neuronal marker unc-119::GFP. Several morphological changes 
were observed in NaSe-treated animals, including neuronal swelling, loss of chromatic staining, axonal 
blebbing along the ventral cord, and egg retention. Panels A, C, G, and E represent untreated controls 
while panels B, D, F, and H are images of neuronal damage from 24 hours of 5mM NaSe treated worms. B 
shows neuronal swelling in NaSe-treated worms as compared to untreated control in A. In D, loss of 
chromatin staining was visualized by EtBr but colloquial staining was observed in the neurons observed in 
B. E normal ventral cord. F Axonal blebbing in a NaSe-treated animal along the ventral cord. G shows 
normal egg retention, while 24 hour exposure to NaSe causes increased egg retention. H Animals 
expressing unc-119::GFP were developmentally synchronized and placed on untreated NGM plates or 
NGM plates treated with 5mM NaSe and examined after 24 hours by fluorescence microscopy.  
 
3.4.2 Gross morphology of muscle fibers appear normal  
In chapter 2, selenium exposure was shown to cause progressive movement deficits (Table 1) 
that begin with backing problems, and proceed to paralysis and eventual death. As discussed 
earlier, the observed backing problem suggests early nervous system damage that was grossly 
observed in Figure 9. The next abnormal behavior observed was paralysis, or failure to complete 
one sinusoidal body turn within 5 seconds of a harsh touch to the tail with a platinum wire. 
Selenium-induced paralysis could also be due to either muscle or neuronal damage. Previously, it 
has been shown that aging causes breakdown of the body wall muscle sarcomeres between 4 
days and 18 days, by examining an animal that expresses myo-3::GFP (Herndon et al. 2002).  
To determine whether muscle sarcomeres are breaking down as a result of selenium 
toxicity, we used animals expressing myo-3::GFP to label the body wall muscle sarcomeres. 
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Developmentally synchronized animals were examined after 48 hours of selenium treatment. 
Analysis of selenium-treated animals (Figure 10b) and untreated controls (Figure 10A) after 48 
hours led to no observable difference between the two groups. This suggests that the muscle 
sarcomeres are not being damaged (when sarcomeres are damaged, myosin fibers appear as short 
segments rather than a continuous fiber). While the structure appears undamaged, it does not 
demonstrate whether cytosolic differences that may be occurring as a result selenium exposure, 
which were next examined.  
 
 
Figure 10 Gross muscle morphology appears normal after 48 hours of selenium exposure 
No gross differences in muscle morphology were observed in selenium-treated animals. Developmentally 
synchronized animals expressing myo-3::GFP were placed as adults on untreated NGM plates or NGM 
plates containing 5mM sodium selenite (NaSe). Animals were examined by fluorescent microscopy after 
48 hours for changes in muscle morphology. No obvious differences were noted between untreated animals 
(A) and selenium-treated animals (B). 
 80 
3.4.3 Evidence of cytosolic muscle protein turnover in response to selenium exposure (in 
collaboration with Nate Szewczyk) 
Another possibility is that selenium exposure alters the intracellular status of cytosolic 
muscle proteins. Decreased cholinergic signaling has been found to affect cytosolic protein 
turnover by turning acetylcholine synthesis off using a temperature sensitive reduction-of-
function mutation in the choline acetyltransferase gene, cha-1 (Szewczyk et al. 2000).  As a 
result, the stability of soluble muscle proteins can be used as an indirect assay for the synaptic 
function of cholinergic motor neurons.   
To test the hypothesis that selenium toxicity involves decreased cholinergic signaling to 
the muscle, synchronized wild-type adult populations expressing a β-galactosidase (β-gal) 
transgene in muscle were placed on NGM plates with or without selenium and tested for 
maintenance of β-gal activity, with and without addition of the addition of the direct nicotinic 
agonist (levamisole) and acetylcholisterase inhibitor (aldicarb) (Figure 11).  The selenium-
treated animals showed significant loss of β-gal enzymatic activity (Figure 11A, 24 and 48 hours 
time points). The direct nicotinic agonist levamisole prevented selenium-induced breakdown of 
soluble muscle proteins, consistent with the requirement for nicotinic acetylcholine receptor(s) 
activation for muscle protein stability (Figure 11B).  This loss of β-gal activity could also be 
rescued using an acetylcholinesterase inhibitor, aldicarb, across a range of concentrations (Figure 
11C). This rescue of β-gal activity suggests that decreased cholinergic signaling was at least 
partially responsible for the observed protein catabolism. These studies provide evidence that 
selenium toxicity causes cholinergic denervation, a classical finding in the pathology of human 
ALS (Gould et al. 2006).   
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 Figure 11 Selenium exposure causes increased cytosolic muscle protein catabolism as observed by 
loss of cytosolic β-gal  (figure by Nate Szewczyk) 
Selenium exposure causes increased cytosolic protein catabolism that can be suppressed by the nicotinic 
agonist, levamisole, and the acetylcholinesterase inhibitor, aldicarb. (A) Animals expressing cytosolic β-
galactosidase in the muscle were exposed to untreated NGM plates or NGM plates treated with 5mM 
sodium selenite (represented in figure as Se). Untreated animals are in the top.  Selenium-treated animals 
for the 24 and 48 hours time points are in the bottom row. (B) Selenium-treated animals were also treated 
with the nicotinic agonist levamisole showing that levamisole can suppress the cytosolic protein catabolism 
(as observed by β-gal staining) caused by selenium treatment. (C) Selenium-treated animals co-treated with 
the cholinesterase inhibitor, aldicarb (40μM, 80μM, and 400μM) which was also found to suppress the 
cytosolic muscle protein catabolism caused by selenium treatment.   
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3.4.4 Determining whether selenium damage is pre-synaptic and/or post-synaptic 
As previously mentioned, the movement deficits and eventual paralysis resulting from exposure 
to sodium selenite could be due to either post-synaptic damage, to muscles, or pre-synaptic 
damage, to the neurons, or both, although analysis of cellular morphology suggests that the 
neurons are being damaged resulting in increased muscle protein catabolism. Pre-synaptic/post-
synaptic damage can be differentiated by observing the behavior of selenium damaged animals 
treated with an acetylcholinesterase inhibitor, aldicarb, and a nicotinic agonist, levamisole.  
Aldicarb prevents the breakdown of acetylcholine in the synaptic clefts (Riddle 1997). As 
a result, aldicarb treatment of animals with normal cholinergic signal causes super-physiologic 
acetylcholine accumulation causing paralysis and death (Riddle 1997). Animals containing gene 
mutations have been identified that are resistant to aldicarb, a majority of which have been 
shown to be involved in cholinergic signaling (Nguyen et al. 1995). The principle behind the 
assay is that if mutations are involved in cholinergic signaling, paralysis and death will be 
delayed or prevented when animals are exposed to aldicarb, as has been observed in mutants for 
UNC-2, a voltage-gated calcium channel that controls cholinergic and GABAergic signaling in 
motor neurons (Mathews et al. 2003).  
To determine whether cholinergic signaling was decreased as a result of selenium 
exposure, selenium-damaged animals were tested for resistance to aldicarb-induced paralysis. 
For this assay, we specifically tested the selenium-treated animals that failed the backing portion 
of the movement assay were tested for aldicarb resistance. This subset of animals was selected to 
avoid false negatives (animals that respond normally to the touch assay) and false positives 
(animals that were already paralyzed). After 30 minutes of aldicarb treatment, there was no 
difference in paralysis between selenium-treated animals and untreated controls (Figure 12, as 
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determined by a one-tailed student t-test with unequal variance). No significant difference was 
observed after 60 minutes of aldicarb treatment, although the two populations began to trend 
apart (Figure 12). After 90 minutes of aldicarb treatment, the selenium-treated population was 
statistically more resistant to aldicarb-induced paralysis (p<0.01). This resistance was also 
observed at 120 minutes of aldicarb treatment (p<0.01).  These results demonstrate an apparent 
decrease in cholinergic signaling, although not as prominent as mutants resistant to aldicarb, like 
UNC-2 (Mathews et al. 2003). However, potential post-synaptic damage must also be addressed.  
 
Figure 12 N2 animals damaged by selenium have partial resistance to the AChE inhibitor, aldicarb 
Animals that displayed backing deficits resulting from selenium treatment had increased resistance to the 
acetylcholinesterase inhibitor, aldicarb. Untreated and selenium-treated animals were measured at 30 
minute intervals for paralysis in response to 0.5mM aldicarb treatment. At 30 minutes, there was no 
difference between untreated animals and selenium damaged animals. After 60 minutes, untreated animals 
trend towards greater paralysis, but were determined to be statistically not different (p>0.05). By 90 
minutes of aldicarb treatment, selenium-treated animals were statistically more resistant to aldicarb induced 
paralysis (p<0.01). Increased resistance was also observed at 120 minutes of aldicarb treatment (p<0.01). 
Statistical significance was determined as described in Section 2.3.9 using a one-tailed student’s t-test with 
unequal variance comparing untreated to selenium-treated populations.  
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After determining that selenium damaged animals have an increased resistance to 
aldicarb, we next needed to determine if there was postsynaptic damage. By determining whether 
selenium damaged animals would respond to the nicotinic agonist, levamisole. In wild-type 
animals, levamisole acts post-synaptically on muscles to cause the body wall muscles to hyper-
contract resulting in paralysis (Culetto et al. 2004). For this assay, selenium-treated animals that 
failed to complete one sinusoidal turn within 5 seconds of being tapped on the tail were tested for 
altered sensitivity/resistance to the nicotinic agonist, levamisole, since they are the most severely 
affected animals that are still alive. Less severely affected animals will likely be sensitive to 
levamisole since they are less likely to have developed muscle damage and potentially skew the 
data with potentially false positives. 
In Figure 13A, 10 untreated wild-type animals were plated within a 1cm circle on a plate. 
After 5 minutes (Figure 13B), all but one animal had moved outside of the 1cm circle, 
confirming their motility. In Figure 13C, fifteen animals that failed to complete one sinusoidal 
turn within 5 seconds of a harsh touch after selenium treatment were plated within a 1cm circle. 
After 5 minutes (Figure 13D), the animals had moved, but all fifteen remained inside the 1cm 
circle. This demonstrates the motility of the untreated animals and the relative paralysis of the 
selenium-treated animals. Animals from Figure 13A,B (untreated) and Figure 13C,D (animals 
paralyzed by selenium) were then treated with levamisole. Figure 13E shows a N2 control 
animal while Figure 13F shows the same animal post-levamisole treatment. The animal appears 
shorter and eggs are extruded after levamisole treatment, both phenotypes due to muscle 
hypercontraction. Similar results are observed with levamisole treatment of selenium paralyzed 
animals (Figure 13G and 13H). This data suggests that the muscles can still function.  
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Figure 13 Levamisole causes hypercontraction in sodium selenite-paralyzed animals 
The muscles of animals paralyzed by selenium hyper-contract when treated with levamisole, demonstrating 
that they are still functional. (A) Untreated animals placed in a 1cm circle at t=0. (B) Untreated animals 
plated in a 1cm circle at t=5minutes. (C) Animals paralyzed by selenium treatment placed inside a 1cm 
circle at t=0. (D) Animals paralyzed by selenium treatment were placed inside a 1cm circle at t=5 minutes. 
(E) Untreated animal, prior to levamisole treatment. (F) Untreated animal after levamisole treatment. Black 
points to post-levamisole treatment. Animal is hypercontracted as observed by decreased length. White 
arrows point to early staged eggs released due to levamisole-induced hypercontraction. (G) Animal 
paralyzed by selenium before levamisole treatment. (H) Animal paralyzed by selenium after levamisole 
treatment. Black arrow points to eggs released by levamisole-induced muscle hypercontraction.  
 
3.4.5 Egg-laying is decreased by selenium exposure 
One of the initial observations in selenium-treated animals was that they retained eggs, as 
indicated by the presence of late stage embryos (Figure 9H). This phenotype provides another 
method of differentiating whether selenium causes neuronal or muscle damage, since egg-laying 
in C. elegans is a well-defined circuit involving two hermaphrodite specific neurons (HSNs), six 
ventral cord neurons (VC), and 16 vulval muscles (White 1986; Desai et al. 1988; Bany et al. 
2003). Mutants that have abnormal egg-laying phenotypes are termed egg-laying defective or 
egl. This category is divided into two subcategories; egg-laying defective (Egl-d) and egg-laying 
constitutive (Egl-c).  
Early work in C. elegans demonstrated that exogenous treatment of wild-type animals 
with the neurotransmitter serotonin causes them to lay eggs (Horvitz et al. 1982). Subsequently, 
HSNs were shown to contain serotonin and acetylcholine, suggesting a stimulatory role of 
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serotonin in the HSNs (Desai et al. 1988; Riddle 1997). Mutants that lack HSNs were found to 
be Egl-d (Desai et al. 1988). Laser ablation of the HSNs also caused defective egg laying, that 
could be rescued by treatment with exogenous serotonin (Waggoner et al. 1998). Combined, 
these studies demonstrate a stimulatory role of serotonin from the HSNs in the egg-laying 
phenotype. Animals in which the vulval muscles were laser ablated failed to respond to 
serotonin, demonstrating that serotonin acts on the uterine muscles to stimulate egg-laying (Trent 
et al. 1983).  
 
 
Figure 14 Egg laying circuit in C. elegans  
Modified from (Bany et al. 2003). Ventral cord neurons (VCs) synapse to the hermaphrodite-specific 




If selenium exposure caused neuronal damage, treatment with exogenous serotonin 
would rescue the egg-laying phenotype. Conversely, if selenium exposure caused muscle 
damage, the muscles would fail to respond to serotonin and the egg-laying phenotype would not 
be altered. To test this hypothesis, we first needed to determine how long after selenium 
exposure we could measure a significant decrease in the number of eggs laid when compared to 
untreated controls. Developmentally synchronized adult N2 animals were placed on untreated 
NGM plates or NGM plates containing 5mM sodium selenite. Animals were transferred to new 
plates at one hour intervals and incubated for 24 hours to determine the rate of eggs laid per 
animal per hour. After 6 hours, animals were found to have a statistically significant decrease in 
egg laying (Figure 15A). A significant decrease in egg lay was also observed after 5 hours of 
selenium treatment. However, the large deviation in the untreated populations made this time 
point less desirable than the 6 hour time point. This large deviation is likely due to a switch 
between active and inactive periods of egg laying, which has previously been reported and can 
be observed in Figure 15A-untreated (Hardaker et al. 2001). Untreated N2 animals had an 
average egg lay of 5.7+/-1.1eggs laid per animal per hour, while selenium treated animals had an 
average egg lay of 1.4+/-0.1 eggs laid per animal per hour (p<0.01). 
Next, we determined whether the decreased egg-laying phenotype observed in selenium-
treated animals was due to muscle damage by treating animals that had been exposed for 6 hours 
to 5mM sodium selenite with exogenous serotonin (Figure 15). First, untreated animals and 
selenium-treated animals were compared to confirm that selenium-treated animals had a 
statistically significant decrease in egg-laying, demonstrating that the selenium treatment  
damaged the animals as observed in Figure 15A (Figure 15B, p<0.01). Non-selenium-treated 
animals that were treated with serotonin were found to increase their egg-laying from 3.9+/-0.5 
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eggs/animal per hour to 15.5+/-1.1 eggs per animals per hour (Figure 15B, p<0.001). Selenium-
treated animals also significantly increased the egg-lay in response to serotonin, from 1.8+/-0.3 
eggs/animals/hour to 11.1+/-0.9 eggs/animal/hour (Figure 15B, p<0.001). It was also noted that 
there was a significant difference between untreated and selenium-treated animals when exposed 
to serotonin, demonstrating that the egg-laying was not completely rescued (Figure 15B, 
p<0.01).  
There are several possible reasons for the incomplete rescue of egg-laying. This 
experiment only addressed the role of serotonin and the HSNs, and not the role of acetylcholine 
in the VCs. Cholinergic signaling is also involved in egg-laying, and acetylcholine is found in 
both HSNs and VCs (Bany et al. 2003). Agonists of nicotinic receptors have been found to 
stimulate egg-laying (Kim et al. 2001). However, the ventral cord expresses a muscarinic 
acetylcholine receptor that has an inhibitory role in egg-laying (Bany et al. 2003).  
Selenium has also been shown to trigger apoptosis in a variety of cell types (Shen et al. 
1999; Zhou et al. 2003; Goel et al. 2006; Xiao et al. 2006; Zhao et al. 2006; Zhao et al. 2006; 
Chen and Wong 2008). However, animals containing mutations for apoptotic and necrotic genes 
were found to be sensitive to selenium exposure (Figure 5). However, apoptosis in the worm was 
identified in a developmental setting as opposed to death induced by an environmental factor 
(Ellis and Horvitz 1986). While developmental apoptosis may not be responsible for death in the 
adult hermaphrodite, it may be responsible for cell death in the germ line. Both of these 




 Figure 15 Decreased egg-laying in N2 hermaphrodites observed after 6 hour selenium exposure 
Treatment of type hermaphrodites with 5mM sodium selenite causes decreased egg-laying that is partially 
rescued by the serotonin.  (A) A significant decrease in egg-laying was observed after 6 hours of selenium 
exposure. Developmentally synchronized adult N2 hermaphrodites were placed on untreated NGM plates 
or NGM plates containing 5mM NaSe. At one hour intervals of NaSe, 10 animals were transferred to fresh 
untreated NGM plates for 24 hours. Adult hermaphrodites were then removed, and the eggs/progeny were 
counted and the average number of eggs laid per animal per hour was calculated (average of 3 plates). A 
student t-test (two-tailed, unequal variance) determined this difference to be significant between untreated 
and NaSe-treated populations at corresponding time points (p<0.05 or 0.01 as indicated on the graph). The 
animals were grown and the experiment performed at 25°C. (B) Treatment with the serotonin partially but 
significantly restored the egg-laying deficit. All conditions were found to yield statistically different 
numbers of eggs laid. Untreated hermaphrodites were found to lay significantly more eggs than selenium-
treated animals (p<0.01). Serotonin treatment of non-selenium-treated animals caused a significant increase 
in egg-laying compared to non-selenium-treated animals (p<0.001). Serotonin treatment of selenium-
treated animals caused a significant increase in egg-laying compared to selenium-treated animals 
(p<0.001). However, serotonin-treatment of selenium treated animals did not completely rescue egg-laying 
behavior when compared to serotonin treatment of non-selenium-treated animals (p<0.01). 
Developmentally synchronized N2 hermaphrodites were placed on untreated or 5mM NaSe supplemented 
NGM plates for 6 hours. Three hermaphrodites were then transferred to plates containing 3mg/ml of 
serotonin. After one hour, the adult animals were removed from the plates, the eggs were counted, and the 
number of egg laid per animal was calculated.  
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3.4.6 Reduction-of-function mutation of a G-protein coupled muscarinic acetylcholine 
receptor confers resistance to selenium 
One possible explanation for the incomplete rescue of egg-laying in selenium-treated 
animals treated with serotonin could be due to the role of acetylcholine. While HSNs are both 
cholinergic and serotonergic, the ventral cord neurons are primarily cholinergic (Wood 1988). 
Egg-laying can be stimulated acutely by nicotinic agonists acting on the vulva muscle and adapt 
over time, resulting in egg-laying returning to pre-nicotinic agonist rates (Waggoner et al. 2000). 
When analyzed, a majority of Egl-c mutants were found to have defects in ventral cord structure. 
Laser ablation of the VCs led to hyperactive egg laying, suggesting an inhibitory role from the 
VCs in the egg-laying phenotype (Bany et al. 2003). Further, mutants that have decreased 
acetylcholine synthesis also exhibit hyperactive egg-laying (Schafer et al. 1996). This evidence 
suggests that the VCs, which contain acetylcholine, have an inhibitory role in egg-laying.  
When originally designing the experiment to determine whether serotonin could rescue 
the decreased egg-laying phenotype in selenium-treated animals, we sought to use a mutant for 
the G-protein coupled acetylcholine receptor, GAR-2. GAR-2 is a muscarinic type acetylcholine 
receptor but also has distinct unrelated properties that is expressed mid-embryogenesis through 
adulthood in the VCs, HSNs, as well as in ciliated head neurons. GAR-2 has been shown to have 
an inhibitory effect on egg-laying by inhibiting serotonin release from the HSNs (Bany et al. 
2003). If this inhibitory mechanism on egg-laying could be removed, exposure to exogenous 




Figure 16 Reduction-of-function mutation in a AChR, GAR-2, have increased resistance to 5mM 
sodium selenite  
A reduction-of-function mutation in the muscarinic acetylcholine receptor, gar-2, confers resistance to the 
effects of selenium exposure on egg-laying and motility. (A) The egg-laying assay was performed as 
described in Section 3.3.7. N2 animals were found to have a statistically significant decrease in egg-laying 
when exposed to selenium (p<0.01). gar-2(ok520) was found to have no affect on egg-laying after exposure 
to selenium (p=0.5). Developmentally synchronized adult hermaphrodites were plated on 5mM NaSe 
supplemented plates and untreated plates for 6 hours at 25°C. Four hermaphrodites were then transferred to 
fresh, unsupplemented plates for 24 hours. The adult hermaphrodites were then removed and the 
eggs/progeny were counted to calculate rate of egg lay. Statistical analysis was performed as described in 
Section 2.3.9, with the exception of using a two-tailed test.  (B) Adult gar-2(ok520) hermaphrodites were 
found to have an increased resistance to selenium at all time points, as observed by retaining normal 
motility (24 hours: p<0.005, 48 hours: p<0.005, and 72 hours: p<0.01). Developmentally synchronized 
adult gar-2(ok520) hermaphrodites were grown at 25°C and then placed on NGM plates treated with 5mM 
sodium selenite and scored at 24 hour intervals for movement deficits. Statistical analysis was performed 
using a one-tailed student t-test with unequal variance as described in Section 2.3.9 comparing mutant gar-
2 to N2 at corresponding time points.   
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As seen in Figure 16A, a significant decrease in egg-laying was observed in the N2 
animals (p<0.01), demonstrating that 6 hours of selenium exposure was sufficient to decrease 
egg-laying in wild-type animals. However, when the rate of egg-laying was calculated for 
animals with a reduction-of-function mutation in the G-protein coupled acetylcholine receptor, 
gar-2(ok520), no decrease was observed between untreated and selenium treated animals. 
However, this measure for lack of neuronal damage is limited due to a statistical concept called 
floor or basement effect. Untreated gar-2(ok520) animals have an average egg lay of 1-1.5 eggs 
per animal per hour, which could make it difficult to obtain a measurable decrease with selenium 
exposure. Eggs could accumulate in the adult hermaphrodites as a result of selenium exposure, 
resulting in some eggs randomly being extruded due to lack of physical space and a vulval 
opening.  
To confirm that the gar-2(ok520) mutations conferred resistance to selenium, adult 
animals were examined using the motility assay. As shown in Figure 16B, mutant gar-2(ok520) 
animals have a statistically significantly increased resistance to selenium treatment at all time 
points tested in this assay (Figure 16B, 24hours: p<0.005, 48hours: p<0.005, 72hours p<0.01). 
Hence, gar-2(ok520) provides resistance to selenium toxicity. It is intriguing that wild-type 
animals exposed to selenium have a decrease in cholinergic signaling as determined by aldicarb 
resistance and a mutation in an acetylcholine receptor provides protection to selenium exposure. 
While these combined data could support the hypothesis that neuronal dysfunction causes 
impaired movement and decreased egg-laying, it must also be remembered that when a gene is 
mutated, other genes can alter expression to compensate. For example, compensatory up-
regulation of other receptors may alter these two phenotypes. 
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In order to develop firm hypothesizes and conclusions, additional information would 
need to be obtained about the gar-2(ok520) mutant. For example, gar-2(ok520) is resistant to the 
aldicarb when suppressing egg-laying (Bany et al. 2003). If cholinergic signaling is decreased, 
then are adult gar-2(ok520) animals resistant to aldicarb-induced paralysis? Are other 
acetylcholine receptors up-regulated when GAR-2 is mutated? Is GABAergic or serotonergic 
signaling altered in animals with in gar-2(ok520) mutants? Despites these caveats, the fact that a 
gene mutation of a neuronally-expressed protein resulted in significant protection from selenium 
exposure, suggesting that selenium is damaging neurons.  
 
3.4.7 Incomplete rescue is at least partially due to increased apoptotic figures in the turn 
region 
Serotonin treatment of selenium-treated animals partially rescued the observed egg-laying 
deficit. However, the rescue was not complete (Figure 15B). One possibility for the remaining 
deficits is that fewer eggs are being made as a result of increased apoptosis in the germ line, 
since, as stated previously, selenium exposure has been shown to increase apoptosis in a variety 
of cell types (Shen et al. 1999; Zhou et al. 2003; Goel et al. 2006; Xiao et al. 2006; Zhao et al. 
2006; Zhao et al. 2006; Chen and Wong 2008). In Figure 5, adult hermaphrodites with mutations 
in genes involved in apoptosis were not protected from selenium exposure. However, this does 
not exclude the possibility that the germ line cell population is undergoing increased apoptosis as 
a result of selenium exposure.  
C. elegans contains two gonads that connect to the uterus. The distal tip of each gonad 
contains the growth factor LAG-2, which promotes mitosis in neighboring germ cells (Lettre et 
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al. 2004). As the germ cells leave the distal tip, they enter meiosis and either develop into 
oocytes or undergo apoptosis as they travel through the turn region to enter the uterus (Lettre et 
al. 2004). Apoptosis can be measured in the germ line by detection of apoptotic bodies after 
feeding animals acridine orange-stained E. coli (Gumienny et al. 1999). If selenium treatment is 
causing increased apoptosis, an increased number of acridine orange-stained apoptotic bodies 
would be observed in germ line.  
To test this hypothesis, developmentally synchronized animals were placed on NGM 
plates that were unsupplemented or supplemented with 5mM sodium selenite for 24 hours. 
Animals were then stained with acridine orange and examined for apoptotic bodies in the turn 
region of the gonad (Figure 17A-D). Animals treated for 24 hours with selenium were found to 
have approximately 3 times more apoptotic bodies than untreated animals (Figure 17E, p<0.001). 
This number is an estimate due to egg retention in selenium-treated animals making an accurate 
count difficult. However, the increased number of apoptotic bodies suggests that there is a 
decrease in the number of eggs being produced.  
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Figure 17 Increased apoptosis observed in the germ line of selenium treated animals  
 Increased apoptosis was observed in the germ line of selenium-treated animals. Animals were analyzed 
first using Nomarski optics to identify the distal tip/turn region in the uterus. A Untreated, B selenium-
treated. Black arrows identify the region of interest). Animals were then analyzed by fluorescence 
microscopy in order to count fluorescent apoptotic bodies. C Untreated, D Selenium-treated. White arrows 
identify apoptotic bodies in the region of interest). E Graph representing the average number of apoptotic 
bodies in the uterine turn region of untreated and selenium treated animals. A two-tailed student t-test with 
unequal variance determined there to be a significant difference between untreated and selenium-treated 
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animals (n=20, p<0.001). Developmentally synchronous N2 hermaphrodites were placed on NGM plates 
treated with 5mM selenium or untreated. After 24 hours, untreated and selenium treated hermaphrodites 
were placed on new NGM plates treated with 0.02mg/ml acridine orange for 1 hour (Lettre et al. 2004). 
The animals were then transferred to a new untreated plate for an hour to clear their intestinal track and 




This section provides significant evidence that selenium causes neuronal damage, 
specifically decreasing cholinergic signaling. This work also is important in establishing a model 
of neurodegeneration using selenium toxicity in C. elegans that differs from previous models. 
Neurodegenerative models for Alzheimer’s disease and Huntington’s disease in C. elegans both 
require expression of a human transgenic protein (Faber et al. 1999; Link et al. 2003; Link 2006).  
The description of gross morphological changes resulting from selenium exposure is 
significant because it differs from the MEC-4(d) model of neurodegeneration. The MEC-4(d) 
model of neurodegeneration results from a dominant mutation in an amiloride sensitive Na+ 
channel that results in the swelling of a subset of neurons, which are involved in sensing touch 
along the animal’s body wall (Driscoll and Chalfie 1991). Of note, MEC-4(d) neurodegeneration 
causes large vacuoles to form that are nearly half width of the body (Bianchi et al. 2004). This 
was never observed in animals exposed to selenium. MEC-4(d) vacuole formation is also 
suppressible by treatment with weak bases, a treatment that did not confer protection in selenium 
treated animals (Chapter 2, Figure 6) (Artal-Sanz et al. 2006). Further, mutations in calreticulin 
were found to suppress MEC-4(d) neurodegeneration, whereas we found that the crt-1(rf) 
mutation increased sensitivity to selenium (Chapter 2, Figure 5) (Xu et al. 2001). The differing 
morphology, effects of weak bases on survival, and survival with calreticulin mutations 
demonstrate that selenium induced neuronal damage is different from the MEC-4(d) model of 
neurodegeneration. 
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While there was no observable damage in gross muscle morphology as a result of 
selenium exposure, there was an increase in cytosolic protein turnover. This increase in protein 
catabolism was suppressible by treatment with the nicotinic agonist levamisole and the 
acetylcholinesterase inhibitor, aldicarb, suggesting that the increased protein catabolism is due to 
decreased cholinergic. This is significant, as ALS disease progression is associated with 
prominent muscle wasting that has been shown to involve catabolism of muscle proteins, a 
finding suggesting that loss of cholinergic motor neuron innervation leads to increased 
breakdown of muscle proteins (Corbett et al. 1982).   
The decreased cholinergic signaling suggested by the increased muscle catabolism was 
confirmed when animals determined to be damaged by selenium (i.e. exhibited backing deficits) 
showed increased resistance to paralysis induced by the acetylcholinesterase inhibitor, aldicarb.  
This is intriguing, since decreases in cholinergic receptors have been reported in ALS tissue, 
although the etiology of this is unknown (Manaker et al. 1988; Berger et al. 1992). In addition, 
the muscles of severely selenium-damaged animals were retained the ability to hyper-contract 
when treated with the nicotinic agonist, levamisole. This is unsurprising, as selenium-treated 
animals were observed to be hyper-contracted or shorter when compared to untreated animals 
(personal observation and non-formally confirmed with the Biosorter in Chapter 2 where the 
“time-of-flight” was observed to be decreased in selenium-treated animals when compared to 
untreated animals, suggesting that selenium treated animals were shorter in length). Combined, 
these data suggest that high selenium exposure causes neurotoxicity that results in decreased 
cholinergic signaling, resulting in increased muscle catabolism. However, the studies in this 
dissertation do not address the possibility that neuronal neurotransmission in general is being 
affected, and not only cholinergic signaling. 
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This chapter also demonstrated that selenium causes damage to the egg-laying circuit. An 
irreversible decrease in egg-laying was observed after only 6 hours of selenium treatment. This 
decrease was significantly but incompletely rescued by treatment with serotonin and the 
incomplete rescue appears to be due to increased apoptosis in the germ line. Combined, these 
data demonstrate that the decreased egg-laying caused by selenium exposure is due to pre-
synaptic (neuronal) damage, since the muscles can still respond to serotonin. What remains 
unknown is what neurotransmitter(s) is being affected. The most direct possibility is that 
serotonin signaling is being decreased, and that supplementation with exogenous serotonin 
rescues the deficit. Another school of thought is that egg-laying is controlled by cholinergic 
signaling and that serotonin is simply “priming” the muscles to for acetylcholine (Weinshenker 
et al. 1995). This introduces a subtle distinction in the role of neurotransmission control of C. 
elegans egg-laying. With either possibility, the data presented here demonstrates that the vulval 
muscles can still function and that neurotransmission (either serotonin and/or acetylcholine) is 
being decreased. 
The increased resistance of the muscarinic cholinergic receptor mutant, gar-2(ok520), 
underscores the fact that selenium is damaging neurons. GAR-2 is only expressed in neurons, 
including ventral cord neurons (VCs) and hermaphrodite specific neurons (HSNs); however, 
more research is required to understand the protective role of gar-2(ok520). One potential 
hypothesis is that the decrease in cholinergic signaling may be a protective adaptation in 
response to selenium exposure. However, to date, the only known function for gar-2 is an 
inhibitory role on egg-laying. If GAR-2 has other unknown inhibitory functions, this would 
suggest that cholinergic signaling is increased in gar-2 mutants, and that the protection in 
motility is a result of maintaining higher levels of cholinergic signaling compared to wild-type 
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animals when exposed to selenium. Before addressing either of these possibilities, more 
information needs to be learned about gar-2(ok520). The mutant appears to be a knockout 
containing a 1.3kb deletion that encompasses part of the 5’ UTR, as well as the first exon and 
intron. However, C. elegans contains two additional mAChR, GAR-1 and GAR-3, that, although 
less well characterized, could potentially compensate for gar-2(ok520).  
This chapter primarily focused on changes in cholinergic signaling in response to 
selenium exposure. However, alterations in GABAergic signaling resulting from selenium 
toxicity are unknown at this time. Potential methods of investigating altered GABAergic 
signaling involve two possible assays. One involves touching the animals and scoring a 
“shrinker” phenotype (McIntire et al. 1993; McIntire et al. 1993). That is, causing the body wall 
muscles to contract simultaneously, causing the animal to temporally shrink. Decreased 
cholinergic signaling may be difficult to measure with this assay, as selenium-treated animals 
already appear to be shorter than untreated animals (personal observation). A second possible 
assay to test defects in GABA neurotransmission would be to measure defecation since the 
enteric muscle contractions resulting in expulsion of waste is controlled by GABA (McIntire et 
al. 1993; McIntire et al. 1993). 
This chapter provides significant evidence that excess selenium exposure causes neuronal 
damage and could potentially be used as a model for sporadic ALS, the first model of sporadic 
ALS. However, further work needs to be done in investigating alterations in neurotransmitters 
other than acetylcholine. 
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4.0  THE ROLE OF THE INSULIN PATHWAY IN SELENIUM TOXICITY 
4.1 ABSTRACT 
The DAF-2-insulin-like pathway is a major stress response in C. elegans that controls 
gene expression of stress responsive genes, including superoxide dismutases (SOD), glutathione 
peroxidases, catalases, etc.  Previously in Chapter 2, we have shown that increased oxidative 
stress contributes to selenium toxicity. Here, we show that mutations in genes from the DAF-2-
insulin pathway alter sensitivity/resistance of animals to toxic selenium toxicity. Animals with 
mutations in the insulin-like receptor, daf-2, are known to have an extended life as well as altered 
metabolism. Previous studies have shown that tissue-specific expression of wild-type daf-2 in 
daf-2 mutants differentially rescues the long life and altered metabolism in the neurons and gut, 
respectively. We investigated whether tissue-specific expression of wild-type daf-16 in the 
neurons, muscle, or gut, thus allowing a responsive wild-type insulin pathway, could restore 
resistance to selenium. Here, we show that addition of wild-type DAF-16 in any tissue can 
partially restore resistance to selenium toxicity, with the most protection provided by intestinal 
expression. A reduction-of-function mutation in the iron-manganese superoxide dismutase gene, 
sod-2, was found to partially restore selenium sensitivity to daf-2(rf) mutants.  
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4.2 INTRODUCTION 
In chapter 2, we showed that selenium toxicity causes an increase in ROS (Figure 7). Further, 
movement deficits caused by selenium exposure could be alleviated by various antioxidants in 
wild-type C. elegans (Figure 8). To gain insight into potential mechanism(s) of selenium 
toxicity, common stress pathways were screened for sensitivity/resistance to selenium toxicity. 
Mutations in genes encoding members of the DAF-2-insulin signaling pathway provided the 
most strikingly altered sensitivity.  
In a permissive growth environment, a single wild-type C. elegans will develop from an 
egg passing through four larval stages before reaching adulthood in 3.5 days at 20°C and live 
approximately two weeks (Brenner 1974). Under conditions of environmental stress, such as 
decreased food supply or overcrowding, C. elegans can enter an alternate third larval stage called 
dauer. Animals in the dauer larva stage can live for months and have increased resistance to heat, 
microbials, and others stresses (Cassada and Russell 1975; Albert et al. 1981; Riddle et al. 1981; 
Golden and Riddle 1984). Mutations in genes have been identified that alter an animal’s ability 
to enter the dauer larva stage and are referred to as having abnormal dauer larva formation, or 
Daf. There are two classes of daf genes, dauer larva constitutive (daf-c) or dauer defective (daf-
d). Daf-c animals enter the dauer larva stage at an increased rate when exposed to high 
temperature (Swanson and Riddle 1981). While Daf-d animals fail to enter the dauer larva state 
regardless of environmental conditions (Wood 1988). Both daf-d and daf-c mutations can be 
found in the DAF-2 insulin-like pathway. 
Mutations in the gene encoding the insulin-like receptor, DAF-2, have been found to 
regulate dauer larva development, with temperature-sensitive reduction-of-function mutations 
causing dauer larvae formation in the absence of other environmental cues, like overcrowding or 
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starvation  (Riddle 1977; Kenyon et al. 1993). Adult animals containing mutant daf-2 share 
characteristics with dauer larvae, such as increased lifespan, resistance to oxidative stress, and 
themotolerance (Kenyon et al. 1993; Lithgow et al. 1995; Honda and Honda 1999).  Under 
normal growth conditions, the DAF-2-insulin-like receptor initiates a signaling cascade leading 
to the subsequent phosphorylation and inactivation of the FOXO transcription factor DAF-16, 
preventing it from entering the nucleus (Dorman et al. 1995; Vanfleteren and De Vreese 1997; 
Paradis and Ruvkun 1998; Lin et al. 2001). When under environmental stress, these signaling 
events do not occur and DAF-16 constitutively localizes to the nucleus initiating the transcription 
of stress-related response genes.  
Mutations in the daf-2 gene and its downstream effector, the phosphoinositide 3-kinase, 
AGE-1, exhibit increased lifespan and levels of antioxidant enzymes (Kenyon et al. 1993; 
Dorman et al. 1995; Honda and Honda 1999; McElwee et al. 2003). Additionally, both daf-2 and 
age-1 mutations confer antimicrobial properties and decreased metabolism (Vanfleteren and De 
Vreese 1995; Garsin et al. 2003). Mutations in the gene encoding the major downstream target 
DAF-16 confer the opposite phenotypes, resulting in decreased lifespan, inability to form dauer 
larvae, and sensitivity to external stress (Gottlieb and Ruvkun 1994; Larsen et al. 1995; 
Murakami and Johnson 1996). A number of studies have been performed to identify downstream 
targets of the DAF-16 transcription factor. These have identified a large number of stress 
response genes, including catalases and iron-manganese superoxide dismutases (McElwee et al. 
2003; Murphy et al. 2003; Oh et al. 2006).  
Since discovery of the increased longevity and stress resistance of daf-2 mutants, focus 
has turned to the targets of DAF-16 that are responsible for various phenotypes (Honda and 
Honda 1999; Ookuma et al. 2003; Lamitina and Strange 2005). A popular theory for aging 
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involves an accumulation of cellular damage from free radicals, leading to dysfunction and death 
(Harman 1960). DAF-16 targets that are involved in antioxidant responses, like iron manganese 
superoxide dismutases (SOD) and catalases, have been investigated for their potential roles in 
longevity. One Mn-SOD, SOD-3, has increased mRNA expression in both dauer larvae and daf-
2 mutants, suggesting that SOD-3 is important in extending lifespan (Honda and Honda 1999; 
Lee et al. 2003; McElwee et al. 2003; Murphy et al. 2003). However, individual reduction-of-
function mutants for either sod-3 or sod-2 had no effect on stress resistance or longevity (Honda 
et al. 2008). Decreased expression of both Mn-SODs in the daf-2 mutant background reversed 
the increased resistance to oxidative stress but did not affect longevity (Honda et al. 2008). 
Treatment of wild-type animals with superoxide dismutase and catalase mimetics has been found 
to have conflicting effects on C. elegans lifespan (Melov et al. 2000; Keaney et al. 2004). The 
evolving role of Mn-SODs suggests that their function is more complex than simply reducing 
oxidative stress.  
Alterations in insulin signaling have been shown to exhibit different phenotypes 
depending upon the tissue in which it is expressed. Neuronal expression of wild type DAF-2 or 
AGE-1 in daf-2 or age-1 respective mutant backgrounds rescues the extended life span found in 
these mutants, while muscle-specific expression of DAF-2 and AGE-1 rescues the metabolism 
phenotype (Wolkow et al. 2000). Another study found that intestinal expression of DAF-16 in a 
daf-16 mutant background partially restored the decreased lifespan phenotype of the mutant 
(Libina et al. 2003). This differential tissue-specific rescue of metabolism and lifespan poses 
similar questions as to which tissue the insulin pathway is functioning in to provide protection 
from toxic environmental exposures, such as with selenium. 
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Here, we show that disinhibiting the insulin pathway alters the organisms’ sensitivity to 
high selenium exposure. Conversely, mutations in the gene encoding the insulin-like receptor 
DAF-2 and its downstream target AGE-1, which have been shown to confer increased resistance 
to oxidative stress, were also found to protect against selenium toxicity. Similarly, mutations in 
the downstream target, the FOXO transcription factor daf-16, confer sensitivity to selenium 
toxicity. Next, we investigated if there is a tissue specific requirement for insulin signaling with 
selenium toxicity. Over-expression of the FOXO transcription factor DAF-16 under the control 
of tissue specific promoters demonstrates that expression in any tissue confers protection while 
the greatest protection is provided by intestinal expression. Two targets of DAF-16 were also 
investigated, SOD-2 and SOD-3 for altered sensitivity to selenium exposure. Interestingly, 
mutations in the gene sod-2 conferred sensitivity while mutations in gene sod-3 provided 
resistance to selenium. A double sod-2;sod-3 mutant revealed an epistatic relationship in which 
SOD-3 is epistatic to SOD-2. Introducing mutant sod-2 into the daf-2 mutant background was 
found to marginally, but significantly, increase sensitivity to selenium.  
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4.3 MATERIALS AND METHODS 
4.3.1 Strain maintenance and growth conditions 
The following strains were obtained from the Caenorhabditis Genetics Center; wild-type 
Bristol N2, TJ1052: age-1(hx546)II, GR1310: akt-1(mg144)V, DR26: daf-16 (m26)I, CF1038: 
daf-06(mu86)I, DR1564: daf-2(m42)III, CB1370: daf-2(e1370)III, RB1072: sod-2(ok1030)I, 
VC433: sod-3(gk235)X, GR1333: tph-1::GFP; rol-6(su1006)V, CF1442: daf-16(mu86)I;daf-
2(e1370)III; muEx169 [unc-119p::GFP::daf-16 + rol-6(su1006)], CF1514 daf-16(mu86)I;daf-
2(e1370)III; muEx211 [pNL213(ges-1p::GFP::daf-16) + rol-6(su1006)], CF1515 daf-
16(mu86)I;daf-2(e1370)III; muEx212 [pNL212(myo-3p::GFP::daf-16) + rol-6(su1006)].  
Strains GA410: wuIs56[sod-3::GFP;pRRF4 rol-6(su1006)] indicated in the text as sod-
3::GFP and GA429: wuIs72[sod-2::GFP;pRRF4 rol-6(su1006)] indicated in the test as sod-
2::GFP were kinds gifts from David Gems in the Institute of Healthy Living at the University 
College of London. All strains used were maintained on standard NGM plates and experiments 
performed at 20°C unless otherwise stated without additional calcium as described in 2.3.1. 
4.3.2 Developmentally synchronizing worm populations 
Age synchronous animals were obtained as described in Section 2.3.2. 
 108 
4.3.3 Selenium treatment 
Sodium selenite was added to NGM plates (without additional calcium) to a final concentration 
of 5mM. Developmentally synchronized adult animals were then plated on 5mM sodium selenite 
supplemented plates and analyzed at 24-hour intervals for the behavioral deficits described in 
Section 2.3.4. 
4.3.4 Movement assay 
After plating developmentally synchronized adult animals on various conditions, animals were 
scored at 24-hour intervals for the following behaviors as described in Section 2.3.4. Animals 
were defined to be motile if they were able to move forward and reverse direction upon touching 
to the head and tail. Impaired backing was defined by the inability to reverse direction upon 
tactile stimulation to the head/tail. This test was performed twice to ensure that the behavior was 
reproducible for the animal. Animals had to fail this test twice to be considered as having 
impaired backing. Paralysis was defined as failure to complete one sinusoidal turn forward after 
a touch. Death was defined by lack of pharyngeal pumping. “Selenium-damaged animals” 
encompass those defined as “backing”, “paralyzed”, and “dead”.  
4.3.5 Statistical analysis 
Statistical analyses were performed as described in Section 2.3.9. 
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4.3.6 Isolation of genomic DNA 
Genomic DNA used for genotyping mutants was obtained from a small number of animals by 
the following lysis procedure: lysis buffer contained the following chemical composition: 50mM 
KCl, 10mM Tris-HCl, pH 8.3, 2.5mM MgCl2, 0.45% NP40, 0.45% Tween 20 in autoclaved de-
ionized water (Wicks et al. 2001). 100-250µl of lysis buffer was added to a separate 
microcentrifuge tube along with a fresh pinch of Proteinase K. Then, 20µl of lysis buffer was 
aliquoted into polymerase chain reaction (PCR) tubes and 20 well-fed F2 cross progeny were 
added to each tube. The PCR tubes containing the lysis buffer and worms were placed in the 
PCR machine (Eppendorf Mastercycler, Westbury, NY) running a program containing the 
following steps: 60°C for 60 minutes to lyse the worms, 95°C for 15 minutes to inactivate the 
Proteinase K, and 4°C for a continuous hold until the tubes were removed from the machine and 
the isolated DNA was then used for genotyping.  
4.3.7 PCR genotyping  
4.3.7.1 sod-2(ok1030)I  
RB1072 is the strain containing the mutant allele sod-2(ok1030)I. This mutant allele has a 900bp 
deletion and was created by the C. elegans Gene Knockout Consortium located at the Oklahoma 
Medical Research Foundation funded by the National Institutes of Health. The mutant has no 
observable phenotype and has to be identified through genotyping by the PCR. The primer 
sequence for genotyping was provided by the C. elegans Gene knockout Consortium.  
RB1072L (Internal Left) 5’ TCG AGG CTG GAA CTT CAA CT 
RB1072R (Internal Right) 5’ CCC CTA ATA ACT GCA CCG AA 
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The PCR reaction for RB1072 was as follows: 12.5μl of GoTaq Green Master Mix from 
Promega (Cat # M7123), 15pmol of each primer, 1ul of worm lysis as prepared in Section 4.3.6, 
and brought to a final volume of 25μl with nuclease-free water. The PCR was run under the 
following conditions on an Eppendorf Master Cycler (Westbury, NY):  
Step 1: 94°C for 2 minutes 
Step 2: 94°C for 30 seconds 
Step 3: 61°C for 30 seconds 
Step 4: 72°C for 2 minutes and 30 seconds 
Step 5: Go to Step 2 and repeat 30 times 
Step 6: HOLD 4°C indefinitely 
Amplified samples were run on a 1% agarose 0.5X TAE gel. The gels were then stained 
with SYBR Gold (1:10,000, Invitrogen, Carlsbad, CA) to stain the DNA. The gels were then 
visualized on a UV light box and a picture was taken for documentation. The wild-type band was 
2320bp in length and the mutant band was 420bp in length. 
4.3.7.2   sod-3(gk235)X 
VC433 is the strain containing the mutant allele sod-3(gk235)X. This mutant allele has a 390bp 
deletion and was created by C. elegans Gene Knockout Consortium at the C. elegans Reverse 
Genetics Core Facility at the University of British Columbia. Like the mutant for sod-2, sod-
3(gk235)X has no observable phenotype so PCR genotyping was utilized when creating double 
mutants.  
PCR primers were designed using the bioinformatics program Primer Design which is 
part of the larger bioinformatics bundle, DNA STAR program (DNASTAR, Inc, Madison WI). 
sod-3 genomic DNA sequence was obtained from the NCBI database. Primer Design delimited 
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the location for potential primers to sequences left and right of the deletion. The program was 
further delimited to create primer sets that generated a 800-1200bp wild-type gene product over 
the deletion location so that the mutant PCR product containing a 390bp deletion could easily be 
viewed on an agarose gel. The following primer set was chosen and ordered from IDT DNA 
Technologies, Inc (Coralville, IA). 
VC433L 5’ CGG TTG CGG GGT AAG TC  
VC433R 5’ CGA AGT CGC GCT GAA ACA A 
The PCR reaction for VC433 was as follows: 12.5ul of GoTaq Green Master Mix from 
Promega (Cat # M7123), 15pmol of each primer per reaction, 1ul of worm lysis, and brought to 
volume with nuclease-free water to a final volume of 25ul. The PCR was run under the following 
conditions on an Eppendorf Master Cycler (Westbury, NY):  
Step 1: 94°C for 2 minutes 
Step 2: 94°C for 30 seconds 
Step 3: 61°C for 30 seconds 
Step 4: 72°C for 1 minute 
Step 5: Go to Step 2 and repeat 30 times 
Step 6: 72°C for 2 minutes 
Step 7: HOLD 4°C indefinitely 
Amplified samples were run on a 1% agarose 0.5X TAE gel. The gels were then stained 
with SYBR Gold (1:10,000, Invitrogen, Carlsbad, CA) to stain the DNA. The gels were then 
viewed on a UV light box and a picture was taken for documentation. The wild-type band was 
952bp and the mutant band was 562bp in length. 
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4.3.8 Mutant phenotypic selection  
4.3.8.1 daf-2(e1370)III mutant selection 
F1 cross progeny were grown at 25°C and F2 dauer larva were selected from unstarved plates. 
These animals exhibited the constitutive dauer phenotype, which confirms that they were 
homozygous for the daf-2(e1370) allele. The dauer larvae were allowed to recover at 15°C and 
PCR genotyping was used to confirm the presence of sod-2(ok1030).  
4.3.8.2 Strains containing rol-6(su1006) 
The following selection method was used for creating double mutant strains in which one gene 
was linked to rol-6(su1006). This gene encodes cuticle collagen that when mutated alters the 
animals movement. The mutant allele rol-6(su1006) results in dominantly inherited right-handed 
rolling phenotype (Cox et al. 1980). Strains containing this mutant allele were created by 
crossing males containing the other mutation of interest into young hermaphrodites containing 
rol-6(su1006). Hermaphrodite F1 progeny were clonally picked to new plates, allowed to lay 
eggs overnight, and removed. For each plate, the F2 progeny were analyzed for the rolling 
phenotype. Rollers from a plate containing a combination of rollers and non-rollers was 
expanded clonally, since the segregation of phenotypes in the F2 progeny demonstrated that the 
original cross was successful. F3 progeny were then tested for additional phenotypic analysis, as 
with daf-2(e1370)III, or by genotyping as described in Section 4.3.6. Clonal expansion of roller 
mutants was continued until the progeny of a single plate were homozygous for the rolling 
phenotype and the other mutant confirmed by phenotype or genotype.  
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4.3.9 Western blot analysis  
Age-synchronous animals from wuIs56[sod-3::GFP;pRRF4 rol-6(su1006)], sod-
2(ok1030)I;wuIs56[sod-3::GFP;pRRF4 rol-6(su1006)], wuIs72[sod-2::GFP;pRRF4 rol-
6(su1006)], sod-3(gk235)V;wuIs72[sod-2::GFP;pRRF4 rol-6(su1006)], were treated with 5mM 
sodium selenite for 6 hours. After that time, 30 animals were transferred to a labeled 
microcentrifuge tube containing 20µl of de-ionized water. Samples were reduced by adding 7µl 
of 4X LDS sample buffer (cat# NP0007, Invitrogen, Carlsbad, CA) immediately before 
incubating the samples at 70°C for 10 minutes. During the 10 minute incubation, 3µl of 10X 
reducing agent (cat# NP0004, Invitrogen, Carlsbad, CA) was added to each sample tube, which 
was briefly agitated, and returned to 70°C for the remainder of the 10 minutes.  
Samples were electrophoresed on a 3-8% acrylamide tris-acetate gel (cat# EA037ABOX, 
Invitrogen, Carlsbad, CA) using 1X tris-acetate running buffer (cat# LA0041, Invitrogen, 
Carlsbad, CA) under reducing conditions (addition of 500µl of antioxidant to inner chamber, 
cat# NP0005, Invitrogen, Carlsbad, CA). The gel was run for 1 hour at 150 volts (constant). 
Proteins in the gel were transferred to polyvinylidene fluoride (PVDF) membrane using 1X 
NuPage transfer buffer (cat# NP0006, Invitrogen, Carlsbad, CA) under reducing conditions 
(1:1000 antioxidant to transfer buffer). The gel was transferred at 30 volts (constant) for 1 hour. 
Transfer efficiency of the gel to the PVDF membrane was confirmed using SimplyBlue Safe 
Stain (cat# LC6060, Invitrogen, Carlsbad, CA).  
The PVDF membrane containing the transferred proteins was blocked using 3% dry milk 
to prevent indiscriminate binding of the antibodies to the PVDF membrane. The blot was then 
incubated with rabbit polyclonal anti-GFP (cat# ab290-50, Abcam, Cambridge, MA) diluted to 
1:4,000 in 3% milk for 2 hours at room temperature. The blot was washed twice for 5 minutes 
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each in tris-buffered saline, twice for 5 minutes each in tris-buffered saline with 0.1% tween-20, 
and again washed twice for 5 minutes each in tris-buffered saline. The blot was then incubated 
with goat anti-rabbit-HRP (horse radish peroxidase) at 1:5,000 (resuspended to 0.4 mg/ml, cat# 
111-035-003, Jackson Immuno Research, Inc, West Grove, PA) for 2 hours at room temperature. 
The blot was again washed twice for 5 minutes each in tris-buffered saline, twice for 5 minutes 
each in tris-buffered saline with 0.1% tween-20, and again washed twice for 5 minutes each in 
tris-buffered saline. The blot was exposed to chemiluminescence (LumiGlo Chemiluminescent 
substrate kit, cat# 54-61-02, KPL, Gaithersburg, MD) to catalyze the oxidation of HRP that was 
conjugated to the secondary antibody that results in light emission that is then detected on film. 
Since protein from equal numbers of developmentally synchronized adult animals was used for 
each condition in the Western blot, a subsequent loading control blot was not performed.  
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4.4 RESULTS 
4.4.1 Insulin pathway mutants have altered sensitivity to selenium 
The C. elegans DAF-2 insulin pathway plays a major role in one stress response cascade 
that controls transcription of genes including glutathione S transferase, Mn-superoxide 
dismutases, catalases, and HSP20 (Honda and Honda 1999; Lee et al. 2003; Murphy et al. 2003; 
Oh et al. 2006). To determine whether the insulin pathway is altered in response to high selenium 
exposure, mutants for various proteins in the DAF-2 insulin pathway were tested for altered 
sensitivity/resistance to selenium. In Figure 18, a reduction-of-function mutant in the insulin-like 
receptor, daf-2(m41), had an increased resistance to selenium exposure based on the behavioral 
assay described in Section 2.3.4 when compared to wild-type animals. This was expected, since 
in Chapter 2 it was demonstrated that oxidative stress is a contributing factor in selenium toxicity 
(Figures 7 and 8, and Table 1) and mutations in daf-2 confer resistance to oxidative stress as 
evidenced by previous studies demonstrating increased expression of antioxidant proteins and 
longevity (Honda and Honda 1999; Lee et al. 2003; Oh et al. 2006).  
A mutation in the PI-3 kinase downstream of DAF-2, age-1(hx546), also confers 
increased resistance to selenium toxicity (Figure 18 p<0.005 at 48 hours and p<0.05 at 72 hours), 
which is consistent with the results observed with mutation in daf-2. Disruption of AKT-1 
consensus phosphorylation sites on DAF-16 causes DAF-16 to accumulate in the nucleus 
(Paradis and Ruvkun 1998; Lin et al. 2001). A gain-of-function allele of the serine threonine 
kinase akt-1(mg144), shown to increase phosphorylation of DAF-16, and therefore inhibiting it 
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from entering the nucleus, is shown in Figure 18 to have increased sensitivity to selenium 
(p<0.05 at 24 hours and p<0.005 at 48 and 72 hours) (Paradis and Ruvkun 1998). Mutations in 
daf-16 result in decreased lifespan and increased sensitivity to stress (Kenyon et al. 1993; 
Murakami and Johnson 1996). A mutation in the FOXO transcription factor daf-16(m26) confers 
significantly increased sensitivity to selenium (Figure 18, p<0.005 at all time points). All of the 
mutations tested have altered sensitivities to selenium that correspond to their roles in responding 
to stress. Mutations in daf-2 and daf-16 have opposite responses to selenium exposure, similar to 
their divergent effects on lifespan and response to stress (Kenyon et al. 1993). The enhanced 
sensitivity of akt-1(mg144), which has previously been shown to prevent dauer arrest in multiple 
age-1alleles, suggests that DAF-16 function is responsible for the resistance observed in daf-2 




Figure 18 Mutations in the insulin pathway have altered sensitivity to sodium selenite 
Animals containing mutations in the daf-2 insulin pathway have altered sensitivity to selenium. daf-2(m41) 
was found to be resistant to selenium when compared to wild-type N2 at the 48 and 72 hour time points 
(p<0.05 and p<0.005, respectively). age-1(hx546) was also found to be resistant to selenium at the 48 and 
72 hour time points (p<0.005 and p<0.05, respectively). akt-1(mg144) was found to have an increased 
sensitivity at all three time points (24hours: p<0.05, 48hours: p<0.005, 72hours: p<0.005). daf-16(m26) 
was also found to be more sensitive to selenium than wild type N2 at all three time points (24hours: 
p<0.005, 48hours: p<0.005, 72hours: p<0.05). Twenty developmentally synchronous adult hermaphrodites 
were placed on NGM plates supplemented with 5mM sodium selenite and scored at 24 hour intervals for 
movement deficits as described in Section 2.3.4. Mutants were compared to wild-type N2 animals using a 
one-tailed student t-test with unequal variance as described in Section 2.3.9. Non-selenium-treated animals 
had a greater than 90% normal movement at 72 hours (data not shown). The graph represents the average 
of 3 populations (n=60). Similar results were obtained in repeated experiments (data not shown).  
 
4.4.2 Selenium resistance of daf-2(e1370)I is due to the function of DAF-16 
Different alleles were tested to ensure that the daf-2(m41) resistance to selenium and daf-
16(m26) sensitivity to selenium observed in Figure 18 were not allele-specific. In Figure 19, a 
second reduction-of-function allele daf-2(e1370) also displayed an increased resistance to 
selenium when compared to wild type N2 (p<0.001 at all four time points). Another reduction of 
function allele daf-16(mu86) was found to be sensitive at 24 hours and 48 hours when compared 
to N2 (Figure 19, p<0.05 and p<0.001, respectively). These results demonstrate that the observed 
resistance of daf-2(m41) and sensitivity of daf-16(m26) in Figure 18 were not allele-specific 
phenotypes. 
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While DAF-2 is known to regulate a number of genes though control of DAF-16, it also 
has less understood roles that are independent of DAF-16 function. Increasing protein catabolism 
via the autophagic process is essential for dauer larva formation, resulting in increased stress 
resistance and longevity in daf-2 mutants, although bioinformatics, chip arrays, and chromatin 
immunoprecipitation of DAF-16 targets have not identified any known autophagic genes (Lee et 
al. 2003; McElwee et al. 2003; Melendez et al. 2003; Murphy et al. 2003; Oh et al. 2006). In the 
daf-2(e1370) background, autophagy rates did not change when daf-16(mu86) was also included 
in the background, again suggesting that the increased autophagy is not controlled by DAF-16 
(Hansen et al. 2008). Autophagy was shown to be partially regulated by another FOXO 
transcription factor which is not a known target of DAF-16, PHA-4 (Hansen et al. 2008). 
Therefore, it is critical to determine whether daf-2 resistance to selenium is due to the function of 
DAF-16 or another downstream regulator.  
To determine whether the selenium resistance observed in the animals carrying mutations 
for insulin-like receptor, DAF-2, are due to the function of the downstream effector, the FOXO 
transcription factor DAF-16, a double mutant, daf-2(e1370);daf-16(mu86) was screened for 
altered sensitivity/resistance to selenium exposure. When daf-16(mu86)I was included in the daf-
2(e1370)III background, sensitivity to selenium was restored (Figure 19; p<0.001). This 





 Figure 19 daf-2 mutant resistance is due to function of the FOXO-transcription factor DAF-16 
Different alleles of daf-2 and daf-16 retained altered sensitivity to selenium and daf-2 resistance depends on 
the function of DAF-16. daf-2(e1370) was found to be significantly more resistant to selenium than wild-
type N2 at all four time points (p<0.001). daf-16(mu86)I was found to be significantly more sensitive at the 
24 hour and 48 hour time points (p<0.05 and p<0.001, respectively). daf-2(e1370); daf-16(mu86) was 
found to be more sensitive than N2 at 24 hours (p<0.05). daf-2(e1370); daf-16(mu86) was also found to be 
significantly more sensitive than daf-2(e1370)  (p<0.001 at all four time points). Twenty developmentally 
synchronous adult hermaphrodites were placed on NGM plates supplemented with 5mM sodium selenite 
and scored at 24 hour intervals for movement deficits as described in Section 2.3.4.  Statistical analysis was 
preformed using a one-tailed student’s t-test with unequal variance as described in Section 2.3.9. On the 
graph, significance is indicated as * (p<0.05) or ** (p<0.001). Mutant populations were compared to wild-
type N2 unless indicated by bars.  Non-selenium-treated animals had greater than 90% normal motility at 
96 hours (data not shown).  
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4.4.3 Temporal expression of daf-2 affects sensitivity to selenium 
A variety of phenotypes can be observed when examining animals containing a gene mutation. 
However, since the mutation is present during development, viability can be achieved by causing 
compensatory alterations in other signaling cascades. In mammalian systems, this problem can 
be addressed by using conditional knockouts, where a gene’s expression can be controlled 
through pharmacologic treatments. Conditional knockouts exist in C. elegans as temperature-
sensitive alleles, where altering the temperature alters the function of the product of the gene 
mutation. While multiple alleles of daf-2 are temperature-sensitive, one allele, m41, is a “true” 
temperature sensitive allele. When grown at 15°C, daf-2(m41) animals have a lifespan and 
thermotolerance similar to wild-type animals (Gems et al. 1998). When grown at 25°C, animals 
have a significantly longer lifespan than wild-type animals, similar to other daf-2 alleles (Gems 
et al. 1998). These phenotype combinations suggest that m41 synthesis or function is 
thermolabile (Gems et al. 1998). Shifting the temperature at which the animals are incubated 
allows the insulin receptor to be “turned off” acutely to determine whether the daf-2 mutant 
acquires selenium resistance due to changes during development or if acutely turning the 
receptor off can confer protection from selenium exposure.  
To determine whether turning off DAF-2 acutely in young adults can still confer 
selenium resistance, the mutant strain carrying the temperature sensitive allele, m41, and another 
allele, e1370, for DAF-2, along with wild type N2 were grown at 15°C until they were adults. 
The allele e1370 is not considered a “true” temperature sensitive allele because it retains the 
increased lifespan and thermotolerance when grown at 15°C (Gems et al. 1998). The animals 
were then transferred to selenium supplemented and untreated plates as adults and shifted to 
25°C, “turning off” the DAF-2 receptor function in animals containing the m41 allele. The 
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animals were then scored for movement deficits as previously described in Section 2.3.4. The 
non-temperature-sensitive allele (e1370) retained an increased resistance to selenium when 
compared to wild-type N2 through the temperature shift which had been observed in Figure 18 
and Figure 19 (Figure 20; p<0.005 at all time points). The temperature sensitive allele, m41, 
however, was found to have a statistically significant increase in sensitivity, not only to e1370 
(Figure 20; p<0.005 at all time point) but also to N2 (Figure 20; p<0.005 at 24 and 48 hours). 
This suggests that the increased resistance in the DAF-2 mutant background is due to 
developmental effects and cannot be protected acutely. However, no time was allowed for 
dephosphorylation of DAF-16 and transcription/translation of new proteins. While the results are 
intriguing, the experiment would need to be performed again after determining the time period 
required after “turning off” the receptor for the downstream consequences to occur.  
 
 
Figure 20 Controlling temporal function of DAF-2 using a “true” temperature sensitive allele  
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Temporal function of DAF-2 alters daf-2 resistance to selenium. daf-2(e1370) animals were significantly 
more resistant to selenium when compared to wild-type N2 (p<0.005 at all time points). daf-2(m41) 
animals were more sensitive to selenium when compared to wild type N2 (p<0.005 at 24 and 48 hours). 
daf-2(m41) was found to be significantly more sensitive than daf-2(e1370) at all time points (p<0.001, not 
shown on graph). Animals were grown at 15°C until adulthood. Twenty developmentally synchronous 
adult hermaphrodites were placed on NGM plates supplemented with 5mM sodium selenite and shifted to 
25°C for the remainder of the experiment. Animals were then scored for movement deficits as described in 
Section 2.3.4 Non-selenium-treated animals had a greater than 90% normal motility at 96 hours (data not 
shown). Statistical analysis was performed using a one-tailed student t-test with unequal variance as 
described in 2.3.9 comparing mutant populations to N2. The graph above represents 3 populations of 20 
animals per population (n=60). The experiment was repeated tree times with similar results.  
 
4.4.4 Any tissue-specific expression of DAF-16 partially rescues from a daf-16-deficient 
selenium sensitivity 
Previous work has shown that neuronal tissue-specific expression of wild-type DAF-2 and AGE-
1, in their corresponding mutant backgrounds, rescued their mutant extended lifespan phenotype, 
while specific muscle expression is sufficient to rescue their metabolic defects (Wolkow et al. 
2000). Additionally, tissue-specific expression of DAF-16 in the intestine of daf-16(-) animals 
rescues their decreased longevity (Libina et al. 2003).  
To determine in which tissue DAF-16 is functioning to provide protection from selenium 
toxicity, animals expressing tissue-specific daf-16+ constructs were used. In addition to 
expressing a translational fusion of DAF-16::GFP under control of various tissue-specific 
promoters (unc-119p for the nervous system, ges-1p for the intestine, and myo-3p for the 
muscles), these animals also contained a daf-2(e1370);daf-16(mu86) mutant background. The 
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daf-16(mu86) background allowed for wild-type DAF-16 expression only in the tissue-of-interest 
while the daf-2(e1370) background ensured that the product of the DAF-16::GFP tissue-specific 
transgene would localize to the nucleus. Additional controls were added to this experiment, since 
the strains containing the tissue-specific DAF-16 transgenes also contained the rol-6(su1006) 
reporter. Previous observations with rollers and selenium exposure noted increased sensitivity in 
rollers when compared to non-rollers (data not shown). For this reason, strains containing daf-
2(e1370) and daf-16(mu86) were crossed into GR1333, a strain containing a rol-6(su1006), to be 
used as controls.  
When the GR1333 strain was included in the daf-2(e1370) background, animals were 
found to have a significant increase in resistance to selenium when compared to wild-type 
animals (GR1333) (Figure 21; p<0.005, at all time points, not indicated on graph). Conversely, 
when GR1333 was crossed into the daf-16(mu86), the animals were found to be significantly 
more sensitive to selenium toxicity than wild-type animals (Figure 21; p<0.005 at 24 and 48 
hours, not indicated on graph). Also, when daf-16(mu86) was introduced into the daf-2(e1370) 
background, animals were found to be more sensitive to excess selenium when compared to 
wild-type animals (Figure 21; p<0.005, not indicated on graph). These results demonstrate that 
rol-6(su1006) did not alter the relative sensitivity to selenium toxicity of daf-2(e1370) and daf-
16(mu86) to wild-type animals. 
Tissue-specific DAF-16 expressing animals were compared to GR;daf-2(e1370);daf-
16(mu86) since the DAF-16 transgenes are expressed in this background. Expression of DAF-16 
in any tissue was found to provide significant protection from selenium exposure, with the 
greatest protection provided by DAF-16 expression in the intestine (Figure 21; p<0.005 at 24 and 
48 hours and p<0.05 at 72 and 96 hours).  
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 Figure 21 The effect of tissue-specific expression of DAF-16 on selenium sensitivity 
As observed previously, GR;daf-16(mu86) was more sensitive to selenium than “wild-type” GR (p<0.005 
at 24 and 48 hours-not indicated on graph).  GR;daf-2(e1370) was found to be resistant at all time points 
(p<0.005-not indicated on graph). GR;daf-2(e1370);daf-16(mu86) was found to be sensitive to selenium 
(p<0.005 at 24 and 48 hours-not indicated on graph). DAF-16 tissue-specific strains were then compared to 
GR;daf-2(e1370);daf-16(mu86) as indicated by * or ** on graph. All DAF-16 tissue-specific expressing 
strains had a statistically significant increased resistance to selenium at all time points as labeled on the 
graph. Statistical analysis of the DAF-16 tissue specific strains was performed by comparing the results 
from each tissue-specific expressing stain to GR; daf-16(mu86);daf-2(e1370). Significance was determined 
using a one-tailed student t-test with unequal variance as described in Section 2.3.9. Non-selenium-treated 
animals had a greater than 90% survival after 96 hours (data not shown). Twenty developmentally 
synchronous animals were placed on NGM plates supplemented with 5mM sodium selenite and scored as 
for movement deficits as described in Section 2.3.4. Graphed above is the average of 10 populations of 20 
animals per population (n=200). GR is GR1333: tph-1::gfp;rol-6(su1006)  was used as a control for this 
experiment due to expression of a rol-6(su1006) reporter in the DAF-16 tissue-specific expressing animals. 
Animals that contain rollers are more sensitive to selenium than non-rollers (data not shown). 
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4.4.5 Investigating DAF-16 targets that potentially contribute to selenium resistance 
In Chapter 2, increased ROS were detected in selenium-treated wild-type animals along with 
oxidized amino acids when C. elegans were exposed to selenium (Figure 7). In addition, three 
antioxidants: reduced glutathione, quercetin, and α-tocopherol (vitamin e), all partially, but 
significantly, suppressed the movement deficits caused by excess selenium exposure (Figure 8A-
C). Also, DAF-16 has also been shown to be activated by quercetin exposure (Kampkotter et al. 
2008). These data are consistent with selenium toxicity involving a response to oxidative stress. 
In Figure 19, the daf-2 mutant phenotype of relative selenium resistance was demonstrated to be 
controlled by the FOXO transcription factor DAF-16. During stressed conditions, DAF-16 is de-
phosphorylated and re-locates into the nucleus, where it is involved in transcriptional regulation 
of a variety of stress response genes (McElwee et al. 2003; Murphy et al. 2003; Oh et al. 2006). 
Additionally, targets of DAF-16 that are involved in oxidative stress response have been 
identified, including 2-iron-manganese superoxide dismutases and 3-catalases. These function in 
a stepwise fashion. First, superoxide dismutase converts the superoxide anion into hydrogen 
peroxide, while catalases catalyze the conversion of hydrogen peroxide into water and oxygen. 
Here, we focused on the two-iron-manganese superoxide dismutases (MnSOD, SOD-2 and 
SOD-3), since they are involved in the first step of reducing the superoxide anion.  
Age-synchronous mutants for sod-2 and sod-3 were therefore tested for altered sensitivity 
to selenium. sod-2(ok1030), which contains a 900bp deletion from a gene whose wild-type size 
is 1285bp, had an expected statistically significant increase in sensitivity to selenium (Figure 
22A; p<0.005 at 24 hours). Unexpectedly, sod-3(gk235), which contains a 390base pair deletion 
in a 1.5kb gene was highly resistant to selenium exposure (Figure 22A, p<0.05). Since SOD-2 
and SOD-3 are both iron-manganese superoxide dismutases, it is reasonable to consider that 
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when one MnSOD (SOD-2) is mutated, that the other MnSOD (SOD-3) could compensate. To 
address this possibility, the sod-2(ok1030);sod-3(gk235) double mutant was created and 
confirmed by PCR genotyping (since the double mutants, like the single mutants, have no 
observable phenotype). These animals were found to have increased sensitivity to selenium when 
compared to sod-3(gk235) and sod-2(ok1030), suggesting that the resistance observed in sod-
3(gk235) is due to SOD-2 (Figure 22A, p<0.005). However, it should also be noted that the sod-
2(ok1030);sod-3(gk235) double mutant was significantly more sensitive that sod-2(ok1030) 
which was more sensitive than N2. 
One possibility for the increased resistance to selenium observed in sod-3(gk235) animals 
is that SOD-2 protein levels increased in this mutant background. To examine this possibility, a 
Western analysis was performed using transgenic strains expressing SOD-2::GFP or SOD-
3::GFP in the reciprocal mutant background (sod-3(rf) and sod-2(rf), respectively) and analyzed 
for relative changes in GFP protein levels (Figure 22B). There was no significant difference in 
the GFP levels observed between the sod-2(ok1030);SOD-3::GFP and the reciprocal mutant/GFP 
construct. Also, selenium exposure did not result in an increase in SOD-2::GFP or SOD-3::GFP 
protein expression. This suggests that sod-3(gk235) mutant resistance is not due to an increase in 
SOD-2 protein expression, but rather an epistatic interaction.  
Another C. elegans group has been investigating the role of iron-manganese superoxide 
dismutases in terms of longevity. They found that mutations in sod-2 and sod-3, both separately 
and together, had no effect on lifespan when compared to wild-type animals in unstressed 
conditions (Honda et al. 2008). Under hyperoxic conditions or paraquot treatment, single 
mutations in sod-2 and sod-3 had lifespans similar to wild-type animals whereas the double 
mutant was sensitive, but had no effect on longevity (Honda et al. 2008).  This differs from our 
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finding in that sod-2(ok520) was hyper-sensitive to selenium treatment, while sod-3(gk235) was 
resistant. Our results parallel the hyperoxia/paraquot findings in that the double sod-2;sod-3 
mutant was highly sensitive to selenium exposure (Honda et al. 2008). It should also be noted 
that different SOD gene alleles were used between the two labs. 
   
 
Figure 22 Targets of DAF-16, sod-2(ok1030)1 and sod-3(gk235)X have differing sensitivity/resistance 
to selenium 
(A) Two Mn-SOD mutants have different sensitivities to selenium. sod-2(ok1030) was found to be 
significantly more sensitive than N2 at the 24 hour time point (p<0.05). sod-3(gk235) was more resistant to 
N2 at all three time points (p<0.05). This resistance was eliminated when sod-2(ok1030) was crossed into 
the sod-3(gk235) mutant background. sod-2(ok1030);sod-3(gk235) was found to be significantly more 
sensitive than N2 at 24 hours (p<0.005). sod-2(ok1030);sod-3(gk235) was also found to be more sensitive 
than sod-3(gk235) (p<0.005 at 24 hours and p<0.05 at 48 and 72 hours) and sod-2(ok1030) (p<0.05 at 24 
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hours). Twenty developmentally synchronous animals were placed on NGM plates supplemented with 
5mM sodium selenite and scored as for movement deficits as described in Section 2.3.4. Untreated plates 
had greater than 90% survival after 72 hours (data not shown). Statistics were performed using a one-tailed 
student’s t-test with unequal variance as described in Section 2.3.9 comparing mutant populations to N2, 
unless indicated by the bars on the graph. Above is an average of 3 plates containing 20 animals (n=60). 
The experiment was performed 3 times with similar results. (B) Western immunoblot for anti-GFP 
demonstrates that reciprocal expression of protein does not increase in mutant backgrounds and that 
selenium exposure does not induce expression. Developmentally synchronized adult animals were placed 
on NGM plates supplemented with 5mM sodium selenite for 6 hours. Samples were collected and Western 
blot analysis was performed as described in Section 4.3.9 using SOD::GFP fusion constructs. The predicted 
size of sod-2::GFP was 51.9kD and the expected size for sod-3::GFP was 51.6kD. Lane 1: SOD-2::GFP, 
Lane 2: sod-3(gk235);SOD-2::GFP, Lane 3: SOD-3:GFP, Lane 4: sod-2(ok1030);SOD-3::GFP. 
 
4.4.6 Does sod-2(rf) restore sensitivity to selenium in daf-2(e1370) background? 
We have shown that mutations in the insulin-like receptor DAF-2 confer significant resistance to 
selenium exposure (Figures 18 and 19). Two targets of DAF-2, the 2-iron-manganese superoxide 
dismutases, SOD-2 and SOD-3, were found to have differing sensitivities to selenium exposure 
(Figure 22). A mutation in SOD-2, sod-2(ok1030), was found to confer significant sensitivity to 
selenium exposure when compared wild-type animals (Figure 22, p<0.005). This is unsurprising, 
assuming the deletion confers a reduction-of-function to the mutant (wild-type sod-2 is 1121bp 
and the mutant has a 900bp deletion). Next, we asked whether if reducing sod-2 function in the 
daf-2(e1370) background could re-sensitize the animals to selenium exposure.   
To determine whether the resistance observed in daf-2(e1370) is due to the function of 
SOD-2, an assumed reduction-of-function allele for sod-2, sod-2(ok1030) was crossed into the 
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daf-2(e1370) background. Homozygosity for sod-2(ok1030) was confirmed by PCR and daf-
2(e1370) was confirmed by selecting for the constitutive dauer phenotype at 25°C. When these 
animals were tested for altered sensitivity to selenium, daf-2(e1370);sod-2(ok1030) exhibit a 
marginal, but statistically significant, increase in sensitivity to selenium when compared to daf-
2(e1370) (Figure 23, p<0.05 at 48 hours and 96 hours and p<0.005 at 72 hours and 120 hours). 
However, daf-2(e1370);sod-2(ok1030) animals are still more resistant to selenium when 
compared to N2 (Figure 23, p<0.005 at all time points). This suggests that SOD-2 contributes to 
protection from selenium exposure, but is not the only factor involved.  
This finding corresponds to the role of SOD-2 in longevity (Honda et al. 2008). 
Interestingly, including sod-3(rf) in the daf-2 mutant background increased longevity (Honda et 
al. 2008). When oxidative stress was induced by paraquot, knockouts of either Mn-SOD, sod-2 
or sod-3, in the daf-2(rf) background has no effect on survival, but the double mutant, sod-2;sod-
3, was found to be sensitive (Honda et al. 2008). While this experiment was not performed in 
terms of selenium exposure, it is a likely outcome in that both mutant daf-2 and sod-3 have 
increased resistance to selenium. Similarly, it is also likely that a triple mutant of sod-2;sod-
3,daf-2 would be significantly more sensitive to selenium toxicity than the sod-2;daf-2 double 




 Figure 23 sod-2(ok1030)I partially restores selenium sensitivity to daf-2(e1370)III 
sod-2(ok1030) was found to marginally, but significantly, restore selenium sensitivity to daf-2(e1370). sod-
2(ok1030) was sensitive to selenium when compared to N2 (p<0.05). Both daf-2(e1370) and daf-
2(e1370);sod-2(ok1030) had a significant resistance to selenium when compared to N2 (p<0.005, not 
indicated on the graph). When compared to daf-2(e1370), daf-2(e1370);sod-2(ok1030) animals were more 
sensitive except at the 24 hour time point (at 48 hours p<0.05, at 72 hours p<0.005, at 96 hours p<0.05, and 
120 hours p<0.005). Twenty developmentally synchronous animals were placed on NGM plates 
supplemented with 5mM sodium selenite and scored as for movement deficits as described in Section 2.3.4. 
Statistical analysis was performed as described in Section 2.3.9 using a one-tailed student’s t-test with 
unequal variance. On the graph, significance is indicated by * (p<0.05) or ** (p<0.005) comparing mutant 
populations to N2, unless indicated by bars on the graph. Untreated animals had greater than 90% survival 




The DAF-2-insulin-like pathway has been and continues to be the focus of research on stress 
response and longevity in C. elegans. Here, we find that animals containing mutations in genes 
of the insulin pathway have altered sensitivity to high selenium exposure (5mM sodium selenite). 
Mutations in the insulin-like receptor, daf-2, and the downstream PI-3 kinase, age-1, confer 
increased resistance to selenium exposure consistent with their effects on stress and longevity 
(Kenyon et al. 1993; Murakami and Johnson 1996). Correspondingly, a gain-of-function allele 
for akt-1, which results in increased phosphorylation of the FOXO-transcription DAF-16, is 
sensitive to selenium exposure (Paradis and Ruvkun 1998; Lin et al. 2001). Similarly, reduction-
of-function mutations in daf-16, which have shortened lifespan and increased sensitivity to 
stress, also have increased sensitivity to selenium (Figure 18).  
Here, we also confirmed that the selenium resistance observed in DAF-2 mutants was due 
to the function of DAF-16 (Figure 19). This is significant, since autophagy is up-regulated in 
daf-2 mutants, but has yet to be shown as a target of DAF-16 (McElwee et al. 2003; Melendez et 
al. 2003; Murphy et al. 2003; Oh et al. 2006). This was further demonstrated when daf-16(mu86) 
was crossed into the daf-2(e1370)III background and no difference in autophagy was observed 
(Hansen et al. 2008). Yet, the role of autophagy is likely context dependent, having roles ranging 
from protection to cell death. Inducing autophagy has been found to be protective in models of 
Parkinson’s disease by reducing the accumulation of alpha-synuclein insoluble inclusions 
(Ferrucci et al. 2008). Autophagy is highly active in healthy neurons but disrupted in neurons of 
Alzheimer’s mice (Boland et al. 2008). However, inactivation of the autophagic gene bec-1 leads 
to apoptotic cell death in C. elegans (Takacs-Vellai et al. 2005). It is likely that autophagy is 
protective in the daf-2 mutant background, and while autophagic genes are not known target(s) 
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of DAF-16, they likely interact with DAF-16 target(s), including a BCL-2 interacting protein 
(Oh et al. 2006). BEC-1 and CED-9 (ortholog to mammalian BCL-2) have been found to be in 
complex, and BEC-1 depletion triggers caspase-dependent cell death (Takacs-Vellai et al. 2005). 
Thus, the physiologic output of autophagy is likely altered depending on the genetic context. It 
could be hypothesized that in a daf-16(-) background, the BEC-1 and CED-9 complex is 
disrupted due to a decrease in the BCL-2 interacting protein, leaving the animal susceptible to 
caspase-dependent cell death.  
Further, we have shown that acutely “turning off” the insulin-receptor in adult animals 
does not protect animals from selenium exposure (Figure 20). This is surprising, since DAF-16 is 
known to target several antioxidant enzymes and antioxidants have been shown to protect from 
selenium exposure in both C. elegans (Figure 8) and in an vertebrate model of selenium toxicity 
(McElwee et al. 2003; Murphy et al. 2003; Deore et al. 2005; Oh et al. 2006). Since a 
developmental adaptation is implied, further experiments could be designed to determine at 
which larval stage “turning off” the DAF-2 receptor confers protection to selenium toxicity. This 
can be done by shifting developmentally synchronized m41 animals to the non-permissive 
temperature at various larval stages, transferring adults to selenium treating plates and scoring 
for movement deficits. This experiment would provide insight as to what other signaling 
cascades may be interacting with the DAF-2-insulin pathway to confer resistance to selenium. 
This experiment has another caveat, in that no time was allowed for de-phosphorylation 
of DAF-16 and subsequent transcription and translation of target genes. To confirm that there is 
a developmental effect, further experiments would need to be performed to determine how long 
after the shift to the non-permissive temperature is required for the consequences of “turning off” 
the receptor to be observed (like increase in lifespan when compared to N2 animals). The 
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experiment could then be repeated, allowing for the appropriate time at the non-permissive 
temperature, before transferring the animals to selenium supplemented plates. 
Tissue-specific expression of DAF-16 demonstrated that expression in the intestinal tract 
provides the most protection from selenium exposure. These results are not unexpected, as the 
animals are exposed to selenium through their food source. The intestinal track is therefore the 
primary exposure site and deals with absorbing/extruding selenium from food. Somewhat 
surprising is the finding that neuronal expression of DAF-2 in a daf-2 reduction-of-function 
mutant background rescued the extended lifespan (Wolkow et al. 2000). These findings are 
difficult to interpret, since tissue-specific overexpression of DAF-16 in neurons and intestine has 
been shown to upregulate expression of the DAF-16 target, SOD-3, in muscle, demonstrating 
that “tissue-specific” expression of DAF-16 has effects on neighboring tissues (Libina et al. 
2003). However, the majority of the tissue-specific expression occurs in the tissue in which it is 
expressed. Together, these results demonstrate that the DAF-2 insulin signaling pathway is 
involved in protecting wild-type animals from selenium exposure, regardless of tissue 
expression. 
Next, we identified a target of DAF-16, the iron-manganese superoxide dismutase, sod-2, 
that plays a role in protection from excess selenium exposure. Reduction-of-function mutations 
in the two iron-manganese superoxide dismutases, sod-2 and sod-3, had differing sensitivity to 
selenium, while a double sod-2;sod-3 reduction-of-function mutant was relatively sensitive to 
selenium (Figure 22). Our finding agrees with another labs findings that sod-2 is epistatic to sod-
3 (Honda et al. 2008). The role of superoxide dismutases has long been considered as free radical 
scavengers that are thought to protect animals from ROS accumulated with age (Saltzman and 
Fridovich 1973). In line with this, overexpression of MnSOD in Drosophila resulted in an 
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increased lifespan (Sun et al. 2002). However, heterozygous mouse knockouts for MnSOD were 
found to sustain increased oxidative damage but lived a normal lifespan, separating the role of 
oxidative stress from aging (Van Remmen et al. 2003). Our data, combined with these studies, 
support a growing field investigating superoxide anion/hydrogen peroxide as a signaling 
molecule rather than their previously described roles as a free radicals causing cellular damage 
(Veal et al. 2007). As an example of this, MnSOD has been found to signal matrix 
metalloproteinases via H2O2 in a human fibrosarcoma cell line (Ranganathan et al. 2001). 
However, the answer may not be that simple. C. elegans is an unusual organism in that it 
has two iron-manganese superoxide dismutases, whereas most species have only one (Landis and 
Tower 2005). MnSODs localize to the mitochondria and are responsible for protecting the 
organelle from the superoxide anion produced as a byproduct of aerobic respiration. MnSOD 
knockout mice die within 10 days of birth (Li et al. 1995). However, knockouts of MnSOD in C. 
elegans, both individually and combined, are viable and have a normal lifespan (Honda et al. 
2008). Other considerations include the status of other superoxide dismutases, like the 
cytoplasmic copper/zinc superoxide dismutase. In baker’s yeast, a fraction of Cu/Zn SOD-1 
localizes to the mitochondrial intermembrane space (Sturtz et al. 2001). In a murine ALS model, 
mitochondrial localization mutant SOD-1 has been found to trigger caspase-dependent cell death 
(Takeuchi et al. 2002). One potential hypothesis to explain the C. elegans data is that knockouts 
or reduction-of-function mutants of MnSODs may lead to increased SOD-1 localization to the 
mitochondria, making it susceptible to cell death triggers. The opposite findings from the 
reduction-of-function of sod-2 and sod-3 to selenium exposure raise interesting questions as to 
their function(s). Are their roles as free radical scavengers their primary roles? What roles might 
they have in cellular signaling? Is expression/localization of any of the Cu/Zn SODs (SOD-1,4,5) 
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altered as a result of knocking out either/both MnSOD? Viable MnSOD reduction-of–function 
mutants in C. elegans provide a useful tool for understanding potential signaling mechanism(s) 
and provide insight into basic SOD biology. 
Another consideration for investigating SOD regulation and expression is another C. 
elegans FOXO transcription factor, pha-4, since DAF-16 and PHA-4 have similar consensus 
sites (DAF-16: TTGTTTAC and PHA-4; T(A/G)TT(T/G)(A/G)(T/C) ) (Gaudet and Mango 
2002; Lee et al. 2003). In a model of dietary restriction, pha-4 was shown to regulate sod-2, 
contributing to lifespan extension (Panowski et al. 2007). At this time, it is unknown what effect 
selenium exposure has on pha-4 and its targets. 
This chapter demonstrates that the daf-2 insulin-like pathway is protective in response to 
excess selenium exposure. One target of DAF-16, sod-2, was found to contribute to this 
protection. However, our data also suggests that protection from selenium toxicity is more 
complicated than simply increasing expression of SOD-2, as SOD-2 expression was not induced 
by selenium exposure. Further evidence that Mn-SOD expression is more complex than 
previously thought, is that knockouts of both Mn-SODs in C. elegans result in viable animals 
with normal longevity (Honda et al. 2008). In addition to analyzing expression and localization 
of non-Mn-SODs, further work is required using RNAi for pha-4, to determine whether 
regulation of SOD expression could involve multiple transcription factors in response to 
selenium exposure.  
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5.0  OVERALL DISCUSSION 
C. elegans has proven to be a useful system for studying selenium toxicity. Specifically, it 
provides a laboratory model for understanding observations from environmental studies. As 
observed in vertebrates, both organic and inorganic sources of selenium were found to be toxic in 
adult C. elegans (Figure 1) (Panter et al. 1996; Usami and Ohno 1996). Manipulation of the 
environmental conditions in the system has provided further insight into the mechanisms of 
toxicity. For the first time, we show that increased temperature, which increases metabolism, 
resulted in exacerbating selenium toxicity. This suggests that selenium is causing an increase in 
oxidative stress (Figure3) (Klass 1977). Increased oxidative stress resulting from selenium 
exposure was later confirmed (Figure 7) and the resulting movement deficits and mortality could 
be suppressed by treatment with antioxidants (Figure 8), similar to results in a vertebrate model 
(Deore et al. 2005). The antioxidant studies replicate what had been observed in vertebrate 
models, further demonstrating the usefulness C. elegans to study excess selenium exposure. 
Further, the difference between minimal and physiological levels of calcium, as 
originally established by Brenner, altered sensitivity to selenium, suggesting that calcium 
signaling is involved in signaling for death as a result of selenium exposure. Further 
investigations will involve testing animals with mutations in genes responsible for calcium 
signaling for altered sensitivities to selenium. While calcium levels have been observed as a 
result of selenium toxicity in cultured rabbit lenses, these ongoing and future experiments will 
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for the first time provide insight into the role of calcium signaling as a result of excess selenium 
exposure (Hightower and McCready 1989). 
This dissertation concentrates on the effects of selenium toxicity in adult animals, 
although we do establish that selenium causes a decrease in the number of eggs being laid, which 
is also observed in environmental studies (Figure 15) (Ohlendorf et al. 1986; Lemly 1997; Lemly 
2004). Further work needs to be done to investigate the effects of selenium on various larval 
stages. While not formally tested, observations of eggs laid from animals placed on selenium as 
adults suggests that they undergo developmental arrest in the late first or early second larval 
stage (data not shown). Further insight into this phenotype can be gained by investigating a 
reduction-of-function mutation in pdk-1. The protein product from this gene is involved in the 
daf-2-insulin-like cascade and adult animals tested on selenium were found to have no difference 
in sensitivity when compared to wild-type animals (data not shown). However, this was the only 
mutation where eggs laid on selenium developed to adults (personal observation).    
 
5.1 MECHANISMS OF CELL DEATH RESULTING FROM SELENIUM TOXICITY 
High selenium exposure results in the death of adult C. elegans, but the mechanism remain 
unclear. Neither canonical mechanisms of necrosis or apoptosis appear to be involved (Figures 5 
and 6). This is significant, as it differs from other models of neurodegeneration in C. elegans, in 
that reduction-of function mutations in genes implicated in cell death (both apoptosis and 
necrosis) do not protect animals from from paralysis and death due to excess selenium exposure 
(Driscoll and Chalfie 1991; Syntichaki et al. 2002; Driscoll and Gerstbrein 2003; Artal-Sanz et 
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al. 2006). In fact, they sensitize animals. However, it is possible that reducing the function of 
either cell death mechanism could supraphysiologically upregulate the other pathway, resulting 
in sensitivity to selenium. One way to address this issue would be to create a cad-1(rf);ced-3(rf) 
double mutant and test it for altered sensitivity to selenium. However, reducing the function of 
the two-main cell death pathways could lead to unknown developmental problems. Another 
approach for this experiment would be to test cad-1(rf) animals on ced-3 RNAi. However, this 
experiment comes with another series of caveats. In C. elegans, RNAi penetrates well into the 
intestine but poorly into the neurons (Kamath et al. 2001). Results from such an experiment 
could therefore be difficult to interpret if signaling events are neuronally controlled.  
Apoptotic and necrotic mechanisms are not independent, and are connected to one 
another through another cell death pathway, autophagy. Normally, autophagy is involved in 
protein and organelle turnover, and inducing autophagy is protective in models of Parkinson’s 
disease by reducing the accumulation of alpha-synuclein insoluble inclusions (Ferrucci et al. 
2008). Further, autophagy has been found to be highly active in healthy neurons, but disrupted in 
neurons of Alzheimer’s mice (Boland et al. 2008). It is likely that autophagy is protective against 
selenium-induced damage, as suggested by the sensitivity of cad-1(rf) (Figure 5) and ongoing 
experiments in the lab (data not shown).  
Other experiments to investigate the role of autophagy with selenium toxicity might 
involve treating animals with autophagy-promoting drugs, such as rapamycin, geldanamycin, 
and 6-aminonicotinamide and comparing altered sensitivity/resistance to autophagy-inhibiting 
drugs such as cycloheximide, LY294002, and 3-methyladenine. Additionally, RNAi for 
autophagy genes like bec-1 can also be used to check animals for altered sensitivity to selenium, 
with the caveats as described previously for RNAi in C. elegans. To confirm that autophagy is 
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being altered with the various RNAi/drug/and selenium treatments, rates of autophagy can be 
monitored using animals expressing lgg-1::GFP, which is a vacuolar protein that is incorporated 
into the autophagosome (Hansen et al. 2008). 
 
5.2 NEURONAL DAMAGE 
Chapter 3 focused on neuronal damage caused by selenium exposure. Specifically, the 
movement deficits and paralysis resulting from selenium exposure are due to neuronal damage. 
Selenium toxicity causes a decrease in cholinergic signaling that was demonstrated by resistance 
to an acetylcholinesterase inhibitor (aldicarb) and sensitivity to a nicotinic agonist (levamisole). 
Future screens of mutants can be tested with a levamisole/aldicarb assay to separate mutations 
whose altered resistance is due to effects on muscle rather than neurons. However, the limitations 
of this assay must be recognized. Animals containing mutations for genes involved in cholinergic 
signaling will be resistant to aldicarb before selenium exposure. Also, animals containing 
mutations in nicotinic acetylcholine receptor will be resistant to levamisole.  
This dissertation provides provocative evidence that selenium toxicity can be used to 
model motor neuron death, as evidenced by decreased cholinergic signaling and an increase in 
cytosolic muscle protein catabolism. It also strengthens the hypothesis that selenium toxicity can 
be used as a model for sporadic ALS. This is significant as it could provide the first model of 
sporadic ALS. Previous studies have implicated metals in sporadic ALS, but this is the first time 
that an environmental toxin was shown to cause decreased cholinergic signaling (Figure 11 and 
12) (Kasarskis et al. 1995; Vinceti et al. 2002). We have identified a susceptibility factor for 
 140 
sensitivity to selenium, reduction-of-function in the FOXO transcription factor DAF-16 in 
Chapter 4. SNPs of the human ortholog in this gene were found associated with an increased risk 
of developing sporadic ALS, potentially identifying a significant parallel between sporadic ALS 
and selenium neurotoxicity in C. elegans.  Table 2 lists factors identified in ALS patients and 
similarities to selenium toxicity that we have identified to date. While not everyone exposed to 
high environmental selenium develops ALS, our data suggests that certain genetic factors cause 
susceptibility to the environmental toxin. This is exciting since the parallels observed suggests 
our model is relevant environmental toxin neurotoxicity that induces sporadic ALS.    
Further work needs to be performed to determine if other forms of neurotransmission are 
being decreased in response to selenium exposure. Serotonin signaling was shown to be 
significantly decreased by experiments showing partial rescue of the egg-laying deficit caused by 
selenium (Figure 15B). However, the concentration of serotonin used in egg-laying causes 
animals to hyper-contract. Further experiments could determine whether lower concentrations of 
serotonin could suppress the development of movement deficits and mortality. Similarly, 
GABAergic transmission could also be investigated, as described in Chapter 3, by examining the 
“shrinker” phenotype (McIntire et al. 1993; McIntire et al. 1993). GABAergic signaling is also 
likely to be altered in response to selenium exposure, given our preliminary observations that 
selenium-treated animals appeared shorter than untreated animals (data not shown, also observed 
with the BioSorter in experiment 7C).  
One of the benefits of this system can also be a viewed as a weakness. The simplicity of 
the C. elegans makes it easy to work with experimentally. However, with simplicity, complexity 
of higher organisms is lost. While the ventral cord in C. elegans in roughly analogous to a spinal 
cord in mammals, we lose the supporting cells (glial cells and astrocytes) that protect neurons in 
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mammals as well as the higher organization (including sections of the spinal cord like 
cervical/lumbar/etc as well as motor neuron organization in various tracks). To truly model 
motor neuron loss, future experiments will need to be performed in a more complex model, like 
the mouse. However, C. elegans allows for relatively easy and fast identification of candidate 
signaling pathways of interest that would then be studied in a more complex model. For 
example, alterations in a FOXO transcription factor have been implicated as a susceptibility 
factor in both selenium toxicity and sporadic ALS (Dunckley et al. 2007). Initial mouse studies 
would include treating wild-type and knockout mice for a FOXO transcription factor with 
selenium and examining the spinal cord, post-mortem for alterations in neurons of the spinal 
cord.     
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Table 2 Comparison of pathological findings between ALS and high selenium exposure 
(+) indicates a positive association to the pathological finding. (ND) indicates that the 
association has Not been Determined.  
Pathological Findings ALS High Selenium 
Increased Oxidative Stress + + 
(Figures 7 and 8) 
DNA Damage + ? 
(suggested by Figure 9D) 
Mitochondrial Damage + +  
(data not shown by Miguel Estevez) 
Cholinergic Denervation + + 
(Figure 11 by Nate Szewczyk) 
Muscle Protein Catabolism + + 
(Figure 11 by Nate Szewczyk) 
SOD1 effects + ND 
Bax-dependent apoptosis + ND 
Alsin involvement + ND 




5.3 INSULIN PATHWAY AND AMYOTROPHIC LATERAL SCLEROSIS 
The insulin pathway was initially investigated in response to selenium since it is a major, 
well-defined, stress response pathway in C. elegans. One target of the insulin pathway, sod-2, 
was found to partially restore sensitivity in the daf-2 mutant background (Figure 23), although 
our testing of targets was not exhaustive. Other targets of DAF-16 that should be tested for the 
ability to rescue the increased resistance in the daf-2 mutant background include the 3-catalases, 
since they are responsible for converting hydrogen peroxide to water and oxygen. Hydrogen 
peroxide is previously generated by reduction of the superoxide anion by superoxide dismutase. 
This will be a challenge, since all 3 catalases lay sequentially in an 18kb region on chromosome 
2 (Petriv and Rachubinski 2004). Again, it is likely that knocking out any individual catalase 
could result in compensation by another catalase and that the tight linkage makes creating double 
or triple mutants impossible. One possible solution is to create a small chromosomal deletion 
encompassing the 3 catalases. That may prove to cause embryonic lethality. In this situation, a 
non-specific RNAi could be constructed that recognizes all three catalases.  
It should also be noted that knockout of Fe-Mn superoxide dismutase in mice is lethal 
within days (Li et al. 1995). Yet, sod-2(ok1030);sod-3(gk235), a worm MnSOD knockout, was 
viable with no grossly observable phenotype and no decrease in lifespan (Honda et al. 2008). 
This leads to intriguing questions about basic SOD biology between species. Do other SODs 
compensate by changing expression/localization in response to individual or double knockouts? 
This can be addressed using GFP reporter constructs for SOD-1, SOD-4, and SOD-5 in various 
combinations of SOD mutant backgrounds. In our lab, we have unpublished observations that 
SOD-1, which is diffusely expressed in the cytoplasm in unstressed conditions, changes 
localization in a hypoxic environment into punctate granules, which appear to be mitochondria, 
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although this has not been confirmed. What roles do SODs play in cellular signaling? While the 
genetics suggest that SOD-3 selenium resistance was due to function of SOD-2, Western data 
analysis suggests that the resistance is not due to changes in SOD-2 protein levels. This 
highlights the possibility that superoxide dismutases have more functions than simply 
scavenging the superoxide anion. 
Data from the insulin pathway and selenium exposure also tie into ALS literature. DAF-
16 is a FOXO transcription factor and a FOXO transcription factor has been identified as an ALS 
susceptibility factor from SNP analysis in a genome wide scan of sporadic ALS patients 
(Dunckley et al. 2007). Further, the FOXO3a transcription factor has been found to protect 
quiescent cells from oxidative stress by regulating expression of MnSOD (Kops et al. 2002). In a 
mutant SOD-1 transgenic mouse model of ALS, decreased MnSOD exacerbates motor neuron 
loss (Andreassen et al. 2000). In our model, decreased MnSOD has been found to be sensitive to 
selenium exposure (Figure 22).  Decreased MnSOD has also been shown to exacerbate glutamate 
toxicity in rat cortical neurons (Li et al. 1998). While we have yet to demonstrate that decrease in 
MnSOD causes an increase in excitatory signaling, this is an intriguing parallel, since glutamate 
is an excitatory neurotransmitter, and excitotoxicity is one of the pathological findings in ALS. 
Glutamate is also the suspected target of riluzole, the only drug that has been shown to prolong 




5.4 OTHER STRESS RESPONSE PATHWAYS 
The DAF-2 insulin pathway was the only stress response pathway examined in this 
thesis. Other stress response pathways are also well-defined in C. elegans, including mitogen 
activated protein kinase (MAPK) pathways and the transforming growth factor beta (TGFβ) 
pathway. MAPK are likely also to be involved in responding to selenium toxicity, as selenium is 
a metalloid and MAPK have been implicated in response to the metal cadmium in C. elegans 
(Wang et al. 2008). TGFβ is another stress response pathway that might be investigated for a role 
in response to selenium toxicity. Preliminary experiments have demonstrated that reduction-of-
function mutation in the TGFβ receptor, DAF-4, is highly sensitive (data not shown).  Further 
experiments for each of these pathways involve testing reduction-of-function mutations for 
various proteins for altered sensitivity to selenium.  
 
5.5 OVERALL IMPLICATIONS 
This dissertation provides a large body of work that establishes C. elegans as a model for 
studying selenium toxicity. This work also demonstrates that exposure to high selenium can act 
as a motor neuron toxin and potentially as a model for human sporadic ALS. During this course 
this of investigation; we identified multiple genes where reduction-of-function mutation resulted 
in increasing an animal’s sensitivity to selenium. Interestingly, SNP's for a human orthlog for 
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one of these genes (the FOXO transcription factor, daf-16) have been associated with sporadic 
ALS in a genome wide scan for SNP's associated with risk of developing sporadic ALS patients 
(Dunckley et al. 2007).What our data suggest is that certain genetic factors leave individuals 
susceptible to selenium exposure, which might explain why clusters of ALS cases have occurred 
in high selenium environments since genetically related individuals may reside in the same area. 
This also suggests that these genes could be investigated in ALS patients as a “susceptibility 
profile” and can be used to identify unexposed or unaffected individuals expected to be selenium 
sensitive.  
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APPENDIX A   
ABBREVIATIONS 
Abbreviation  Meaning 
5-HT   5-hydroxytryptamine hydrochloride or serotonin 
ACh   Acetylcholine 
ALS   Amyotrophic Lateral Sclerosis  
Ca2+   calcium 
CeMM   Caenorhabditis elegans Maintenance Media 
Daf-c   dauer defective 
Daf-d   dauer constitutive 
Elg-c   Egg-laying constitutive 
Egl-d   Egg-laying defective 
gf   gain-of-function 
HRP   Horse Radish Peroxidase 
lf   loss-of-function 
MnSOD  Iron/Manganese Superoxide Dismutase 
NaSe   Sodium Selenite 
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NGM   Nematode Growth Media 
PCR   Polymerase Chain Reaction 
PVDF   Polyvinylidene Fluoride 
rf   reduction-of-function 
ROS   Reactive Oxygen Species 
Se   Selenium 
SNP   single nucleotide polymorphism 




HPLC ANALYSIS OF SELENIUM TREATED C. ELEGANS 
B.1 RATIONALE FOR USING HPLC DETECTION OF OXIDIZED DAMAGE 
FROM SELENIUM EXPOSURE 
ROS are known to cause many types of cellular damage, including oxidation of lipids, DNA, and 
proteins resulting in carbonyl formation, among others (Martin et al. 1996). Many of these 
oxidative damages can be detected by antibodies. Attempts to detect oxidative damage resulting 
from selenium exposure in C. elegans included single-stranded DNA antibodies and ubiquitin 
staining, were unsuccessful (data not shown). However, using antibodies for detection in C. 
elegans is problematic, especially in the nervous system. Permeablizing the animals results in 
them being susceptible to breaking and losing the structure of interest. Even with 
permeabilization, accessing the nervous system remains problematic, as it is protected from the 
exterior by the cuticle and from the interior by the gut lumen. Lack of staining, therefore, does 
not necessarily mean that the protein/damage detected by the antibody is not there, rather that the 
antibody cannot access a particular area. For these reasons, high performance liquid 
chromatography (HPLC) analysis was performed since it provides the benefit of detecting 
oxidative damage although we lose the advantages of studying an intact organism.  
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B.2 METHODS FOR HPLC SAMPLE COLLECTION 
Worms were developmentally synchronized by treatment with NaOH/Bleach (see 2.3.2) and 
grown to adults without starving after being plated. Adult worms were plated in the absence and 
presence of 5mM NaSe on large plates and in the absence and presence of 800ug/ml quercetin. 
24 hours after plating on the various conditions, worms were collected in 15ml conicals with M9 
The worms were washed 3 times with M9, using ~10ml for the washes. The worms were allowed 
to sediment between washes. Sedimentation was important with the NaSe samples in order to 
remove carcasses of dead animals as they do not sediment. The washes lasted for at least 
30minutes, combined, in order to allow the animals to clear their intestine of food and waste. The 
last wash for each condition was saved to be used as a control. The worms were transferred to 
2ml microcentrifuge tubes and homogenized (setting at 11) with a Poly-tron (PT-2100) for 15-30 
seconds. The tip of the poly-tron was cleaned between samples, first with ethanol and then water 
(homogenized for 30seconds to a minute with each wash). Samples were centrifuged to remove 
carcasses and the supernatants were transferred to new tubes. Soluble samples, pellets, and the 
final washes were snap-frozen and stored at -80°C until taken to Dr Yao for analysis.  
B.3 RESULTS 
 
To examine differences between untreated and selenium-treated animals, large, age synchronous 
populations of animals were placed as adults on untreated NGM plates or NGM plates treated 
with 5mM sodium selenite for 24 hours and samples were collected as described in 2.3.7. In 
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addition, subpopulations were co-treated with 800μg/ml quercetin (the antioxidant in Figure 8A 
that best maintained normal motility in the presence of NaSe) to determine whether quercetin 
could suppress the potential oxidative damage detected by HPLC. Table 3 contains the data 
collected by HPLC analysis in collaboration with Dr. Yao. Specifically, we were looking for 
changes in 3-nitrotyrosine, since increased levels have been observed in both familial and 
sporadic ALS (Beal et al. 1997). While no significant damage was found comparing untreated 
and selenium animals, what was observed was an increase in 3-nitrotyrosine in the washes of 
both selenium-treated and selenium-treated animals that were co-treated with quercetin, 
suggesting that the cells were sufficiently damaged that they were leaking their cellular contents 
prior to homogenization of the animal (Table 3).  
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Table 3 HPLC comparison of selenium treated animals  
Mass numbers of developmentally synchronized N2 animals were grown to adulthood without starvation. 
Animals were then transferred to new plates that were untreated, treated with 5mM NaSe, 800ug/ml 
quercetin, and 800ug/ml quercetin + 5mM NaSe. Animals were treated for 24 hours before processing for 
HPLC analysis as described in the Methods.    
C. elegans 
(ng/mg dry weight, n=4) 
Tyrosine Tryptophan Guanine 3-NT 
Control  1074±692 184±73 773±217 272±154 
Quercetin 415±114 200±45 881±161 203±78 
5mM NaSe 1479±664 166±55 682±254 94±37 
5mM NaSe  
+800ug/ml quercetin 
1044±298 220±130 604±169 105±27 
Washes (ng/ml, n=4)     
Control 21±42 0 108±132 32±18 
Quercetin 1±2 0 32±16 35±34 
5mM NaSe 1±1 0 17±7 153±25 
5mM NaSe 
+800ug/ml quercetin 
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